Document:

exv10w17

 

Exhibit 10.17

Veraz Networks, Inc.

2006 Employee Stock Purchase Plan

Adopted by the Board of Directors: June 29, 2006

Approved by the
Stockholders: ___, 2007

1. General.

     (a) The purpose of the Plan is to provide a means by which Employees of the Company and
certain designated Related Corporations may be given an opportunity to purchase shares of the
Common Stock of the Company.

     (b) The Company, by means of the Plan, seeks to retain the services of such Employees, to
secure and retain the services of new Employees and to provide incentives for such persons to exert
maximum efforts for the success of the Company and its Related Corporations.

     (c) The Company intends that the Purchase Rights be considered options issued under an
Employee Stock Purchase Plan.

2. Administration.

     (a) The Board shall administer the Plan unless and until the Board delegates administration of
the Plan to a Committee, as provided in Section 2(c).

     (b) The Board shall have the power, subject to, and within the limitations of, the express
provisions of the Plan:

          (i) To determine when and how Purchase Rights to purchase shares of Common Stock shall be
granted and the provisions of each Offering of such Purchase Rights (which need not be identical).

          (ii) To designate from time to time which Related Corporations of the Company shall be
eligible to participate in the Plan.

          (iii) To construe and interpret the Plan and Purchase Rights, and to establish, amend and
revoke rules and regulations for its administration. The Board, in the exercise of this power, may
correct any defect, omission or inconsistency in the Plan, in a manner and to the extent it shall
deem necessary or expedient to make the Plan fully effective.

          (iv) To adopt such procedures and sub-plans as are necessary or appropriate to permit
participation in the Plan by Employees who are foreign nationals or employed outside the United
States.

          (v) To amend the Plan as provided in Section 13.

1.

 

          (vi) Generally, to exercise such powers and to perform such acts as it deems necessary or
expedient to promote the best interests of the Company and its Related Corporations and to carry
out the intent that the Plan be treated as an Employee Stock Purchase Plan.

     (c) The Board may delegate some or all of the administration of the Plan to a Committee or
Committees. If administration is delegated to a Committee, the Committee shall have, in connection
with the administration of the Plan, the powers theretofore possessed by the Board that have been
delegated to the Committee, including the power to delegate to a subcommittee any of the
administrative powers the Committee is authorized to exercise (and references in this Plan to the
Board shall thereafter be to the Committee or subcommittee), subject, however, to such resolutions,
not inconsistent with the provisions of the Plan, as may be adopted from time to time by the Board.
The Board may retain the authority to concurrently administer the Plan with the Committee and may,
at any time, revest in the Board some or all of the powers previously delegated.

     (d) All determinations, interpretations and constructions made by the Board in good faith
shall not be subject to review by any person and shall be final, binding and conclusive on all
persons.

3. Shares of Common Stock Subject to the Plan.

     (a) Subject to the provisions of Section 12(a) relating to Capitalization Adjustments, the
shares of Common Stock that may be sold pursuant to Purchase Rights shall not exceed in the
aggregate seven hundred fifty thousand (750,000) (pre-split) shares of Common Stock. In addition,
the number of shares of Common Stock available for issuance under the Plan shall automatically
increase on January 1st of each year, commencing in 2008 and ending on (and including) January 1,
2016, in an amount equal to the lesser of (i) one percent (1%) of the total number of shares of
Common Stock outstanding on December 31st of the preceding calendar year, or (ii) one million five
hundred thousand (1,500,000) (pre-split) shares of Common Stock. Notwithstanding the foregoing,
the Board may act prior to the first day of any calendar year, to provide that there shall be no
increase in the share reserve for such calendar year or that the increase in the share reserve for
such calendar year shall be a lesser number of shares of Common Stock than would otherwise occur
pursuant to the preceding sentence.

     (b) If any Purchase Right granted under the Plan shall for any reason terminate without having
been exercised, the shares of Common Stock not purchased under such Purchase Right shall again
become available for issuance under the Plan.

     (c) The stock purchasable under the Plan shall be shares of authorized but unissued or
reacquired Common Stock, including shares repurchased by the Company on the open market.

4. Grant of Purchase Rights; Offering.

     (a) The Board may from time to time grant or provide for the grant of Purchase Rights to
purchase shares of Common Stock under the Plan to Eligible Employees in an Offering (consisting of
one or more Purchase Periods) on an Offering Date or Offering Dates selected by the Board. Each
Offering shall be in such form and shall contain such terms and conditions as the Board shall deem
appropriate, which shall comply with the requirement of Section 423(b)(5)

2.

 

of the Code that all Employees granted Purchase Rights shall have the same rights and
privileges. The terms and conditions of an Offering shall be incorporated by reference into the
Plan and treated as part of the Plan. The provisions of separate Offerings need not be identical,
but each Offering shall include (through incorporation of the provisions of this Plan by reference
in the document comprising the Offering or otherwise) the period during which the Offering shall be
effective, which period shall not exceed twenty-seven (27) months beginning with the Offering Date,
and the substance of the provisions contained in Sections 5 through 8, inclusive.

     (b) If a Participant has more than one Purchase Right outstanding under the Plan, unless he or
she otherwise indicates in agreements or notices delivered hereunder: (i) each agreement or notice
delivered by that Participant shall be deemed to apply to all of his or her Purchase Rights under
the Plan, and (ii) a Purchase Right with a lower exercise price (or an earlier-granted Purchase
Right, if different Purchase Rights have identical exercise prices) shall be exercised to the
fullest possible extent before a Purchase Right with a higher exercise price (or a later-granted
Purchase Right if different Purchase Rights have identical exercise prices) shall be exercised.

     (c) The Board shall have the discretion to structure an Offering so that if the Fair Market
Value of the shares of Common Stock on the first day of a new Purchase Period within that Offering
is less than or equal to the Fair Market Value of the shares of Common Stock on the Offering Date,
then (i) that Offering shall terminate immediately, and (ii) the Participants in such terminated
Offering shall be automatically enrolled in a new Offering beginning on the first day of such new
Purchase Period.

5. Eligibility.

     (a) Purchase Rights may be granted only to Employees of the Company or, as the Board may
designate as provided in Section 2(b), to Employees of a Related Corporation. Except as provided
in Section 5(b), an Employee shall not be eligible to be granted Purchase Rights under the Plan
unless, on the Offering Date, such Employee has been in the employ of the Company or the Related
Corporation, as the case may be, for such continuous period preceding such Offering Date as the
Board may require, but in no event shall the required period of continuous employment be greater
than two (2) years. In addition, the Board may provide that no Employee shall be eligible to be
granted Purchase Rights under the Plan unless, on the Offering Date, such Employee’s customary
employment with the Company or the Related Corporation is more than twenty (20) hours per week and
more than five (5) months per calendar year or such other criteria as the Board may determine
consistent with Section 423 of the Code.

     (b) The Board may provide that each person who, during the course of an Offering, first
becomes an Eligible Employee shall, on a date or dates specified in the Offering which coincides
with the day on which such person becomes an Eligible Employee or which occurs thereafter, receive
a Purchase Right under that Offering, which Purchase Right shall thereafter be deemed to be a part
of that Offering. Such Purchase Right shall have the same characteristics as any Purchase Rights
originally granted under that Offering, as described herein, except that:

3.

 

          (i) the date on which such Purchase Right is granted shall be the “Offering Date” of such
Purchase Right for all purposes, including determination of the exercise price of such Purchase
Right;

          (ii) the period of the Offering with respect to such Purchase Right shall begin on its
Offering Date and end coincident with the end of such Offering; and

          (iii) the Board may provide that if such person first becomes an Eligible Employee within a
specified period of time before the end of the Offering, he or she shall not receive any Purchase
Right under that Offering.

     (c) No Employee shall be eligible for the grant of any Purchase Rights under the Plan if,
immediately after any such Purchase Rights are granted, such Employee owns stock possessing five
percent (5%) or more of the total combined voting power or value of all classes of stock of the
Company or of any Related Corporation. For purposes of this Section 5(c), the rules of Section
424(d) of the Code shall apply in determining the stock ownership of any Employee, and stock which
such Employee may purchase under all outstanding Purchase Rights and options shall be treated as
stock owned by such Employee.

     (d) As specified by Section 423(b)(8) of the Code, an Eligible Employee may be granted
Purchase Rights under the Plan only if such Purchase Rights, together with any other rights granted
under all Employee Stock Purchase Plans of the Company and any Related Corporations, do not permit
such Eligible Employee’s rights to purchase stock of the Company or any Related Corporation to
accrue at a rate which exceeds twenty five thousand dollars ($25,000) of Fair Market Value of such
stock (determined at the time such rights are granted, and which, with respect to the Plan, shall
be determined as of their respective Offering Dates) for each calendar year in which such rights
are outstanding at any time.

     (e) Officers of the Company and any designated Related Corporation, if they are otherwise
Eligible Employees, shall be eligible to participate in Offerings under the Plan. Notwithstanding
the foregoing, the Board may provide in an Offering that Employees who are highly compensated
Employees within the meaning of Section 423(b)(4)(D) of the Code shall not be eligible to
participate.

6. Purchase Rights; Purchase Price.

     (a) On each Offering Date, each Eligible Employee, pursuant to an Offering made under the
Plan, shall be granted a Purchase Right to purchase up to that number of shares of Common Stock
purchasable either with a percentage or with a maximum dollar amount, as designated by the Board,
but in either case not exceeding fifteen percent (15%) of such Employee’s earnings (as defined by
the Board in each Offering) during the period that begins on the Offering Date (or such later date
as the Board determines for a particular Offering) and ends on the date stated in the Offering,
which date shall be no later than the end of the Offering.

     (b) The Board shall establish one (1) or more Purchase Dates during an Offering as of which
Purchase Rights granted pursuant to that Offering shall be exercised and purchases of shares of
Common Stock shall be carried out in accordance with such Offering.

4.

 

     (c) In connection with each Offering made under the Plan, the Board may specify a maximum
number of shares of Common Stock that may be purchased by any Participant on any Purchase Date
during such Offering. In connection with each Offering made under the Plan, the Board may specify
a maximum aggregate number of shares of Common Stock that may be purchased by all Participants
pursuant to such Offering. In addition, in connection with each Offering that contains more than
one Purchase Date, the Board may specify a maximum aggregate number of shares of Common Stock that
may be purchased by all Participants on any Purchase Date under the Offering. If the aggregate
purchase of shares of Common Stock issuable upon exercise of Purchase Rights granted under the
Offering would exceed any such maximum aggregate number, then, in the absence of any Board action
otherwise, a pro rata allocation of the shares of Common Stock available shall be made in as nearly
a uniform manner as shall be practicable and equitable.

     (d) The purchase price of shares of Common Stock acquired pursuant to Purchase Rights shall be
not less than the lesser of:

          (i) an amount equal to eighty-five percent (85%) of the Fair Market Value of the shares of
Common Stock on the Offering Date; or

          (ii) an amount equal to eighty-five percent (85%) of the Fair Market Value of the shares of
Common Stock on the applicable Purchase Date.

7. Participation; Withdrawal; Termination.

     (a) A Participant may elect to authorize payroll deductions pursuant to an Offering under the
Plan by completing and delivering to the Company, within the time specified in the Offering, an
enrollment form (in such form as the Company may provide). Each such enrollment form shall
authorize an amount of Contributions expressed as a percentage of the submitting Participant’s
earnings (as defined in each Offering) during the Offering (not to exceed the maximum percentage
specified by the Board). Each Participant’s Contributions shall be credited to a bookkeeping
account for such Participant under the Plan and shall be deposited with the general funds of the
Company except where applicable law requires that Contributions be deposited with a third party. To
the extent provided in the Offering, a Participant may begin such Contributions after the beginning
of the Offering. To the extent provided in the Offering, a Participant may thereafter reduce
(including to zero) or increase his or her Contributions. To the extent specifically provided in
the Offering, in addition to making Contributions by payroll deductions, a Participant may make
Contributions through the payment by cash or check prior to each Purchase Date of the Offering.

     (b) During an Offering, a Participant may cease making Contributions and withdraw from the
Offering by delivering to the Company a notice of withdrawal in such form as the Company may
provide. Such withdrawal may be elected at any time prior to the end of the Offering, except as
provided otherwise in the Offering. Upon such withdrawal from the Offering by a Participant, the
Company shall distribute to such Participant all of his or her accumulated Contributions (reduced
to the extent, if any, such Contributions have been used to acquire shares of Common Stock for the
Participant) under the Offering, and such Participant’s Purchase Right in that Offering shall
thereupon terminate. A Participant’s withdrawal from an Offering shall

5.

 

have no effect upon such Participant’s eligibility to participate in any other Offerings under
the Plan, but such Participant shall be required to deliver a new enrollment form in order to
participate in subsequent Offerings.

     (c) Purchase Rights granted pursuant to any Offering under the Plan shall terminate
immediately upon a Participant ceasing to be an Employee for any reason or for no reason (subject
to any post-employment participation period required by law) or other lack of eligibility. The
Company shall distribute to such terminated or otherwise ineligible Employee all of his or her
accumulated Contributions (reduced to the extent, if any, such Contributions have been used to
acquire shares of Common Stock for the terminated or otherwise ineligible Employee) under the
Offering.

     (d) Purchase Rights shall not be transferable by a Participant except by will, the laws of
descent and distribution, or by a beneficiary designation as provided in Section 10. During a
Participant’s lifetime, Purchase Rights shall be exercisable only by such Participant.

     (e) Unless otherwise specified in an Offering, the Company shall have no obligation to pay
interest on Contributions.

8. Exercise of Purchase Rights.

     (a) On each Purchase Date during an Offering, each Participant’s accumulated Contributions
shall be applied to the purchase of shares of Common Stock up to the maximum number of shares of
Common Stock permitted pursuant to the terms of the Plan and the applicable Offering, at the
purchase price specified in the Offering. No fractional shares shall be issued upon the exercise
of Purchase Rights unless specifically provided for in the Offering.

     (b) If any amount of accumulated Contributions remains in a Participant’s account after the
purchase of shares of Common Stock and such remaining amount is less than the amount required to
purchase one share of Common Stock on the final Purchase Date of an Offering, then such remaining
amount shall be held in such Participant’s account for the purchase of shares of Common Stock under
the next Offering under the Plan, unless such Participant withdraws from such next Offering, as
provided in Section 7(b), or is not eligible to participate in such Offering, as provided in
Section 5, in which case such amount shall be distributed to such Participant after the final
Purchase Date, without interest. If the amount of Contributions remaining in a Participant’s
account after the purchase of shares of Common Stock is at least equal to the amount required to
purchase one (1) whole share of Common Stock on the final Purchase Date of the Offering, then such
remaining amount shall be distributed in full to such Participant at the end of the Offering
without interest.

     (c) No Purchase Rights may be exercised to any extent unless the shares of Common Stock to be
issued upon such exercise under the Plan are covered by an effective registration statement
pursuant to the Securities Act and the Plan is in material compliance with all applicable federal,
state, foreign and other securities and other laws applicable to the Plan. If on a Purchase Date
during any Offering hereunder the shares of Common Stock are not so registered or the Plan is not
in such compliance, no Purchase Rights or any Offering shall be exercised on such Purchase Date,
and the Purchase Date shall be delayed until the shares of

6.

 

Common Stock are subject to such an effective registration statement and the Plan is in such
compliance, except that the Purchase Date shall not be delayed more than twelve (12) months and the
Purchase Date shall in no event be more than twenty-seven (27) months from the Offering Date. If,
on the Purchase Date under any Offering hereunder, as delayed to the maximum extent permissible,
the shares of Common Stock are not registered and the Plan is not in such compliance, no Purchase
Rights or any Offering shall be exercised and all Contributions accumulated during the Offering
(reduced to the extent, if any, such Contributions have been used to acquire shares of Common
Stock) shall be distributed to the Participants without interest.

9. Covenants of the Company.

     The Company shall seek to obtain from each federal, state, foreign or other regulatory
commission or agency having jurisdiction over the Plan such authority as may be required to issue
and sell shares of Common Stock upon exercise of the Purchase Rights. If, after commercially
reasonable efforts, the Company is unable to obtain from any such regulatory commission or agency
the authority that counsel for the Company deems necessary for the lawful issuance and sale of
Common Stock under the Plan, the Company shall be relieved from any liability for failure to issue
and sell Common Stock upon exercise of such Purchase Rights unless and until such authority is
obtained.

10. Designation of Beneficiary.

     (a) A Participant may file a written designation of a beneficiary who is to receive any shares
of Common Stock and/or cash, if any, from the Participant’s account under the Plan in the event of
such Participant’s death subsequent to the end of an Offering but prior to delivery to the
Participant of such shares of Common Stock or cash. In addition, a Participant may file a written
designation of a beneficiary who is to receive any cash from the Participant’s account under the
Plan in the event of such Participant’s death during an Offering. Any such designation shall be on
a form provided by or otherwise acceptable to the Company.

     (b) The Participant may change such designation of beneficiary at any time by written notice
to the Company. In the event of the death of a Participant and in the absence of a beneficiary
validly designated under the Plan who is living at the time of such Participant’s death, the
Company shall deliver such shares of Common Stock and/or cash to the executor or administrator of
the estate of the Participant, or if no such executor or administrator has been appointed (to the
knowledge of the Company), the Company, in its sole discretion, may deliver such shares of Common
Stock and/or cash to the spouse or to any one or more dependents or relatives of the Participant,
or if no spouse, dependent or relative is known to the Company, then to such other person as the
Company may designate.

11. Miscellaneous Provisions.

     (a) The Plan and Offering do not constitute an employment contract. Nothing in the Plan or in
the Offering shall in any way alter the at will nature of a Participant’s employment or be deemed
to create in any way whatsoever any obligation on the part of any Participant to continue in the
employ of the Company or a Related Corporation, or on the part of the Company or a Related
Corporation to continue the employment of a Participant.

7.

 

     (b) The provisions of the Plan shall be governed by the laws of the State of Delaware without
resort to that state’s conflicts of laws rules.

     (c) Proceeds from the sale of shares of Common Stock pursuant to Purchase Rights shall
constitute general funds of the Company.

     (d) A Participant shall not be deemed to be the holder of, or to have any of the rights of a
holder with respect to, shares of Common Stock subject to Purchase Rights unless and until the
Participant’s shares of Common Stock acquired upon exercise of Purchase Rights are recorded in the
books of the Company (or its transfer agent).

12. Adjustments upon Changes in Common Stock; Corporate Transactions.

     (a) In the event of a Capitalization Adjustment, the Board shall appropriately and
proportionately adjust: (i) the class(es) and maximum number of securities subject to the Plan
pursuant to Section 3(a), (ii) the class(es) and maximum number of securities by which the share
reserve is to increase automatically each year pursuant to Section 3(a), (iii) the class(es) and
number of securities subject to outstanding Purchase Rights, and (iv) the class(es) and number of
securities imposed by purchase limits under each ongoing Offering. The Board shall make such
adjustments, and its determination shall be final, binding and conclusive.

     (b) In the event of a Corporate Transaction, then: (i) any surviving corporation or acquiring
corporation (or the surviving or acquiring corporation’s parent company) may assume or continue
Purchase Rights outstanding under the Plan or may substitute similar rights (including a right to
acquire the same consideration paid to the stockholders in the Corporate Transaction) for those
outstanding under the Plan, or (ii) if any surviving or acquiring corporation (or its parent
company) does not assume or continue such Purchase Rights or does not substitute similar rights for
Purchase Rights outstanding under the Plan, then the Participants’ accumulated Contributions shall
be used to purchase shares of Common Stock within ten (10) business days prior to the Corporate
Transaction under any ongoing Offerings, and the Participants’ Purchase Rights under the ongoing
Offerings shall terminate immediately after such purchase.

13. Amendment of the Plan.

     (a) The Board at any time, and from time to time, may amend the Plan. However, except as
provided in Section 12(a) relating to Capitalization Adjustments and except as to amendments solely
to benefit the administration of the Plan, to take account of a change in legislation or to obtain
or maintain favorable tax, exchange control or regulatory treatment for Participants or the Company
or any Related Corporation, no amendment shall be effective unless approved by the stockholders of
the Company to the extent stockholder approval is necessary for the Plan to satisfy the
requirements of Section 423 of the Code or other applicable laws or regulations.

     (b) It is expressly contemplated that the Board may amend the Plan in any respect the Board
deems necessary or advisable to provide Employees with the maximum benefits provided or to be
provided under the provisions of the Code and the regulations promulgated thereunder

8.

 

relating to Employee Stock Purchase Plans and/or to bring the Plan and/or Purchase Rights into
compliance therewith.

     (c) The rights and obligations under any Purchase Rights granted before amendment of the Plan
shall not be impaired by any amendment of the Plan except: (i) with the consent of the person to
whom such Purchase Rights were granted, or (ii) as necessary to comply with any laws or
governmental regulations (including, without limitation, the provisions of the Code and the
regulations promulgated thereunder relating to Employee Stock Purchase Plans).

14. Termination or Suspension of the Plan.

     (a) The Board may suspend or terminate the Plan at any time. Unless sooner terminated, the
Plan shall terminate at the time that all of the shares of Common Stock reserved for issuance under
the Plan, as increased and/or adjusted from time to time, have been issued under the terms of the
Plan. No Purchase Rights may be granted under the Plan while the Plan is suspended or after it is
terminated.

     (b) Any benefits, privileges, entitlements and obligations under any Purchase Rights while the
Plan is in effect shall not be impaired by suspension or termination of the Plan except (i) as
expressly provided in the Plan or with the consent of the person to whom such Purchase Rights were
granted, (ii) as necessary to comply with any laws, regulations or listing requirements, or (iii)
as necessary to ensure that the Plan and/or Purchase Rights comply with the requirements of Section
423 of the Code.

15. Effective Date of Plan.

     The Plan shall become effective on the IPO Date, but no Purchase Rights shall be exercised
unless and until the Plan has been approved by the stockholders of the Company, which approval
shall be within twelve (12) months before or after the date the Plan is adopted by the Board.

16. Definitions.

     As used in the Plan, the following definitions shall apply to the capitalized terms indicated
below:

     (a) “Board” means the Board of Directors of the Company.

     (b) “Capitalization Adjustment” means any change that is made in, or other events that occur
with respect to, the Common Stock subject to the Plan or subject to any Purchase Right after the
Effective Date without the receipt of consideration by the Company (through merger, consolidation,
reorganization, recapitalization, reincorporation, stock dividend, dividend in property other than
cash, stock split, liquidating dividend, combination of shares, exchange of shares, change in
corporate structure or other transaction not involving the receipt of consideration by the
Company). Notwithstanding the foregoing, the conversion of any convertible securities of the
Company shall not be treated as a transaction “without receipt of consideration” by the Company.

9.

 

     (c) “Code” means the Internal Revenue Code of 1986, as amended.

     (d) “Committee” means a committee of one (1) or more members of the Board to whom authority
has been delegated by the Board in accordance with Section 2(c).

     (e) “Common Stock” means the common stock of the Company.

     (f) “Company” means Veraz Networks, Inc., a Delaware corporation.

     (g) “Contributions” means the payroll deductions and other additional payments specifically
provided for in the Offering, that a Participant contributes to fund the exercise of a Purchase
Right. A Participant may make additional payments into his or her account, if specifically provided
for in the Offering, and then only if the Participant has not already had the maximum permitted
amount withheld during the Offering through payroll deductions.

     (h) “Corporate Transaction” means the occurrence, in a single transaction or in a series of
related transactions, of any one or more of the following events:

          (i) a sale or other disposition of all or substantially all, as determined by the Board in its
sole discretion, of the consolidated assets of the Company and its Subsidiaries;

          (ii) a sale or other disposition of at least ninety percent (90%) of the outstanding
securities of the Company;

          (iii) the consummation of a merger, consolidation or similar transaction following which the
Company is not the surviving corporation; or

          (iv) the consummation of a merger, consolidation or similar transaction following which the
Company is the surviving corporation but the shares of Common Stock outstanding immediately
preceding the merger, consolidation or similar transaction are converted or exchanged by virtue of
the merger, consolidation or similar transaction into other property, whether in the form of
securities, cash or otherwise.

     (i) “Director” means a member of the Board.

     (j) “Eligible Employee” means an Employee who meets the requirements set forth in the Offering
for eligibility to participate in the Offering, provided that such Employee also meets the
requirements for eligibility to participate set forth in the Plan.

     (k) “Employee” means any person, including Officers and Directors, who is employed for
purposes of Section 423(b)(4) of the Code by the Company or a Related Corporation. However,
service solely as a Director, or payment of a fee for such services, shall not cause a Director to
be considered an “Employee” for purposes of the Plan.

     (l) “Employee Stock Purchase Plan” means a plan that grants Purchase Rights intended to be
options issued under an “employee stock purchase plan,” as that term is defined in Section 423(b)
of the Code.

10.

 

     (m) “Exchange Act” means the Securities Exchange Act of 1934, as amended.

     (n) “Fair Market Value” means, as of any date, the value of the Common Stock determined as
follows:

          (i) If the Common Stock is listed on any established stock exchange or traded on the Nasdaq
Global Select Market or the Nasdaq Global Market (formerly the Nasdaq National Market), the Fair
Market Value of a share of Common Stock shall be the closing sales price for such stock (or the
closing bid, if no sales were reported) as quoted on such exchange (or the exchange or market with
the greatest volume of trading in the Common Stock) on the date of determination, as reported in
The Wall Street Journal or such other source as the Board deems reliable.

          (ii) If the Common Stock is listed or traded on the Nasdaq Capital Market (formerly the Nasdaq
Small Cap Market), the Fair Market Value of a share of Common Stock shall be the mean between the
bid and asked prices for the Common Stock on the date of determination, as reported in The Wall
Street Journal or such other source as the Board deems reliable. Unless otherwise provided by the
Board, if there is no closing sales price (or closing bid if no sales were reported) for the Common
Stock on the date of determination, then the Fair Market Value shall be the mean between the bid
and asked prices for the Common Stock on the last preceding date for which such quotation exists.

          (iii) In the absence of such markets for the Common Stock, the Fair Market Value shall be
determined by the Board in good faith.

     (o) “IPO Date” means the date of the underwriting agreement between the Company and the
underwriter(s) managing the initial public offering of the Common Stock, pursuant to which the
Common Stock is priced for the initial public offering.

     (p) “Offering” means the grant of Purchase Rights to purchase shares of Common Stock under the
Plan to Eligible Employees.

     (q) “Offering Date” means a date selected by the Board for an Offering to commence.

     (r) “Officer” means a person who is an officer of the Company within the meaning of Section 16
of the Exchange Act and the rules and regulations promulgated thereunder.

     (s) “Participant” means an Eligible Employee who holds an outstanding Purchase Right granted
pursuant to the Plan.

     (t) “Plan” means this Veraz Networks, Inc. 2006 Employee Stock Purchase Plan.

     (u) “Purchase Date” means one or more dates during an Offering established by the Board on
which Purchase Rights shall be exercised and as of which purchases of shares of Common Stock shall
be carried out in accordance with such Offering.

11.

 

     (v) “Purchase Period” means a period of time specified within an Offering beginning on the
Offering Date or on the next day following a Purchase Date within an Offering and ending on a
Purchase Date. An Offering may consist of one or more Purchase Periods.

     (w) “Purchase Right” means an option to purchase shares of Common Stock granted pursuant to
the Plan.

     (x) “Related Corporation” means any “parent corporation” or “subsidiary corporation” of the
Company whether now or subsequently established, as those terms are defined in Sections 424(e) and
424(f), respectively, of the Code.

     (y) “Securities Act” means the Securities Act of 1933, as amended.

     (z) “Trading Day” means any day on which the exchange(s) or market(s) on which shares of
Common Stock are listed, whether it be an established stock exchange, the Nasdaq Global Select
Market or the Nasdaq Global Market (formerly the Nasdaq National Market), the Nasdaq Capital Market
(formerly the Nasdaq Small Cap Market), or otherwise, is open for trading.

12.exv10w35

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED

Exhibit 10.35

MASTER MANUFACTURING AGREEMENT

This MANUFACTURING AGREEMENT (this “Agreement”), dated as of October 1st, 2005
(the “Effective Date”), by and between Flextronics (Israel) Ltd. a company organized under
the laws of the State of Israel (“FLEXTRONICS”) having its principal place of business at
Migdal-Haemek, P.O.B 867 Israel and Veraz Networks, Ltd a private company organized under the
laws of the State of Israel (“Veraz”) having its principal place of business at 30 Hasivim
Street, Petah Tikva 49133, Israel.

WITNESSETH:

WHEREAS, FLEXTRONICS is a manufacturer of mechanic equipment, and performs manufacturing,
assembly, integration and packaging of such equipment;

WHEREAS, Veraz among others, develops, designs and sells equipment that enables the
transmission of voice and data communications using the Internet Protocol (“VoIP Equipment”)
worldwide; and

WHEREAS, the parties hereto are interested to enter into this Agreement whereby FLEXTRONICS
will manufacture, assemble, and perform integration and packaging for Veraz of the VoIP
Equipment, in accordance with the terms and conditions of this Agreement;

NOW, THEREFORE, in consideration for their mutual promises and undertakings and other
valuable consideration, the sufficiency of which is acknowledged by the parties, the parties
hereby agree as follows:

1. Manufacture and Sale, and Purchase 

1.1 During the term of this Agreement, and subject to the terms and conditions set forth
herein, FLEXTRONICS shall manufacture and sell to Veraz, and Veraz may purchase from
FLEXTRONICS, the VoIP Equipment listed in Exhibit 1.1 attached hereto, together with
VoIP spare parts, components and accessories as Veraz may choose to purchase and which will
be manufactured by FLEXTRONICS (individually, a “Product”, and collectively, the “Products”).

1.2 The terms and conditions of this Agreement shall govern the manufacture, assembly, and
perform integration and packaging of any Product delivered by FLEXTRONICS to Veraz pursuant
to a purchase order which shall be submitted by Veraz as detailed below in section 6
(“Purchase Order”), each of which shall be deemed a part of this Agreement.

1.3 Nothing in this Agreement shall limit, restrict or otherwise prevent Veraz from purchasing
from any third parties any products or services, including without limitation any products or
services that may be identical to, or have the same or substantially similar functions or features
to the Products that are identified on Exhibit 1.1.

[*] Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED

2. Product Forecast

Once every two weeks, during this Agreement, Veraz will provide FLEXTRONICS with a six (6)
month rolling Product forecast (each a “Forecast”), of which the forecast for the first three
(3) months of such 6-month period shall be binding and the forecast for the following three
(3) months shall be a non-binding description of Veraz’s good faith expectations of the
number of Products it intends to purchase from FLEXTRONICS during such period, in the form
attached as Exhibit 2. Subject to the provisions of Sections 3 and 6.8.2-6.8.4 below,
all commitments made by Veraz for the purchase of Products as indicated in the binding
portion of each Forecast shall be made only upon submission by Veraz of Purchase Orders to
FLEXTRONICS pursuant to Section 6. FLEXTRONICS should either object or accept in writing
each Forecast within five (5) days of the date of Veraz’s submission of the Forecast, and it
may only object on grounds that the Forecast is not in accordance with the terms of this
Agreement. If FLEXTRONICS objects to any Forecast, as aforesaid, it will provide all relevant
details to Veraz regarding its objection, and the parties will work in good faith to resolve
such objection in a prompt and reasonable manner to meet the potential needs of Veraz to its
customers with respect to the supply of Products.

3. Materials Procurement

FLEXTRONICS shall purchase at its own expense, or source from its inventory sufficient
components and raw materials required to provide the Products (“Materials”), using the
Materials Procurement and Control Procedure, set forth in this Section 3 below, to meet the
requirements of (a) the outstanding Purchase Orders and (b) the binding portion of the
Forecast (including without limitation, ordering or otherwise committing to suppliers in
respect of long lead items “LLI”) (the outstanding Purchase Orders together with the Forecast
will be hereinafter defined as the “Demand”); provided, however, that (i) any purchase of
Materials by FLEXTRONICS is subject to this section; (ii) Veraz may, at its sole option,
require FLEXTRONICS to purchase any such Materials at a price to be determined by Veraz from
any vendor and/or upon any terms and conditions as directed by Veraz subject to section 9;.

Veraz may, at any time, with a prior written notice of 30 days in advance, notify
FLEXTRONICS, with respect to any Materials, that Veraz will purchase any such Materials
instead of FLEXTRONICS. If Veraz exercise its right as set forth in the preceding sentence,
then the following shall apply:

(i)___ FLEXTRONICS shall immediately cease purchasing any Materials which Veraz has notified
FLEXTRONICS that it will purchase such Materials on its own account;

(ii) FLEXTRONICS shall place an order to Veraz in accordance with this section;

(iii) It will be Veraz’s responsibility to deliver such Materials purchased by itself to
FLEXTRONICS’ premises, set forth in the preamble of this Agreement;

[*] Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED

(iv) Any delay of delivery of Materials to FLEXTRONICS, due to Veraz’s exercise of said right,
shall be Veraz responsibility.

(v)If FLEXTRONICS has reasonable ground to assume that the costs of such Materials are
un-reasonable, FLEXTRONICS shall have the right to ask from Veraz for documentation showing
the costs of such specific Materials.

Any purchase of Materials by FLEXTRONICS pursuant to the above said will be in the amount of
the last agreed price list for each item + [*]%.

3.1. Materials Procurement 

3.1.1 Based on each Demand, FLEXTRONICS shall prepare an “MRP” run within four (4) working
days from Forecast receipt. Based on the MRP run, FLEXTRONICS will submit to Veraz, for its
information, a report with components and parts identified with catalog numbers and the
quantities that FLEXTRONICS plans to acquire or to cancel or de-expedite pursuant to the
“MRP” run (the “Components and Parts Report”) FLEXTRONICS shall include on the Components and
Parts Report the purchase value of the MRP run. Without the need for further actions from
Veraz, FLEXTRONICS shall proceed promptly to perform the activities set out in such MRP run.

3.1.2 Veraz may, at no charge, and without incurring any liability cancel delivery of all
Products or component as per the Components Cancellation Window Exhibit 3.1.2 (as
such term is defined in section 3.1.3 below). Cancellation by Veraz, done less than the
periods set forth in the Components Cancellation Window may be subject to cancellation
charges which in no event be higher than the documented payment made by FLEXTRONICS as a
result of such cancellation, to any third party provider of the components subject to the
cancellation as aforesaid. The foregoing (i.e. payment of cancellation charge) shall not apply if Veraz has ordered
thereafter Products from the cancelled Purchase Orders. FLEXTRONICS will confirm in writing
within 4 days upon receipt of any request for cancellation as aforesaid, provided that Veraz
will verify upon delivery of such notification that such notification has been received by
FLEXTRONICS. However, if FLEXTRONICS indeed received the notification and failed to confirm
it within the above period it will be deemed to have received the notification.

3.1.3 FLEXTRONICS will submit to Veraz, once a quarter for Veraz’s written approval, an
update for the Components Cancellation Window (Exhibit 3.1.2) detailing the components
cancellation windows i.e. a period of days before the delivery date of each Item, if
applicable, in which period the purchase order to the supplier of such item cannot be
cancelled without any fees or penalties, (the “Components Cancellation Window ”).

3.1.4 Upon execution of this Agreement, FLEXTRONICS will submit to Veraz a report listing
components and parts with long lead time items – LLI Materials (as defined below) greater
than 60 days (the “LLI Report”), attached hereto as Exhibit 3.1.4.The LLI Report will
be updated from time to time

[*] Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED

by FLEXTRONICS, subject to Veraz’s prior written approval. “LLI
Materials” shall mean those Materials with delivery dates exceeding 60 days from the date of
the applicable purchase orders. In each instance whereby FLEXTRONICS intends to place a
purchase order for LLI Materials, it shall obtain Veraz’s prior written approval before
proceeding to do so.

3.1.5 If FLEXTRONICS will be required to purchase Materials (as defined in section 3
above), in excess than the quantity required by Veraz in its Demand, due to minimum order
items/economic order items (hereinafter: “Minimum Order Items”), then FLEXTRONICS will submit
to Veraz the Minimum Order Items for Veraz prior written approval, only if the value is more
than USD$ 500. For the removal of doubt, in the absence of such written approval, Veraz will
have no liability what so ever with respect to such Items in the Minimum Order Items in
excess of USD$500 per purchase.

3.1.6 FLEXTRONICS shall be responsible for any purchases of excess accessories and components
that are: (a) not included in the binding portion of a Forecast; or (b) not in accordance
with section 3.1.2, 3.1.3, 3.1.4 and 3.1.5; and/or (c) not as per section 7.3 of this
agreement.

3.2 Sub-Assembly Control Procedures

FLEXTRONICS will submit to Veraz on the fifteen day (15) of any calendar month a report with
subassemblies identified with catalog numbers and the quantities that FLEXTRONICS plans to
assemble during the next calendar month, for each week, at the production floor on the basis
of the latest binding portion of the Forecast and
Purchase Orders provided by Veraz (the “Subassemblies Report”). By the first day of each
calendar month, Veraz will provide an approval for the last 2 weeks of the current calendar
month. By the 15th of each calendar month, Veraz will provide an approval for the
first 2 weeks of the next calendar month. FLEXTRONICS shall be responsible for all
subassemblies not included in Veraz’s approved Subassemblies Report aforesaid.

4. FLEXTRONICS’ Obligations and Warranties

4.1 FLEXTRONICS shall, at its expense, unless expressly provided otherwise below:

4.1.1 Manufacture, assemble, integrate, investigate production problems, test, packaging and
deliver in accordance with the delivery date specified in any Purchase Order and in
accordance with this Agreement, the Products duly ordered by Veraz under each Purchase Order,
provided, that FLEXTRONICS is expressly permitted to outsource or subcontract to
sub-contractors who are one of Veraz’s qualified vendors in the Approved Vendor List (as such
term is defined in section 7.1 below) for parts, processes or completed or substantially
completed Products supplied to Veraz. Consent of Veraz to the use of any components
manufactured by third parties shall not derogate from FLEXTRONICS’ obligations under this
Agreement, including, without limitation, FLEXTRONICS’ warranty obligations under Section 8
of this Agreement, it being understood that FLEXTRONICS’ obligations concerning

[*] Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED

third party
components and materials is strictly limited to Section 8 and subject to the stipulations
contained in Section 8;

4.1.2 Prepare the Products described in any Purchase Order to be ready for its final
packaging (i.e. unpacked) for shipping as follows. Within no more than two (2) business days
from the date the Purchase Order is sent to FLEXTRONICS, FLEXTRONICS shall notify Veraz in
writing the delivery date, for finished Products i.e. fully integrated, tested and/or packed
Products (“Finished Products”), subject to the following: (i) for any Purchase Order,
contained in the Subassemblies Report , FLEXTRONICS shall prepare the Purchase Order ready
for shipment within no more than five (5) business days from the date set forth in the
Subassemblies Report. (ii) for any Purchase Order not included in the non-binding portion of
the Forecast, FLEXTRONICS shall advise Veraz of the earliest date for delivery possible,
using best commercial efforts, and will specify the reasons such as shortage in Materials
that may prevent expediting such delivery. The party shall cooperate to achieve the earliest
possible delivery date that will be acceptable to both parties.

4.1.3 Supply, at Veraz’s reasonable request, Product manufacturing data that is required for
obtaining necessary governmental approvals, licenses, permits and consents as required
pursuant to Section 5.1 hereof;

4.1.4 Maintain all necessary process design technology, labor, material, tooling, facilities
and other resources for the timely completion and delivery of the Products under this
Agreement;

4.1.5 Commit and use sufficient and qualified personnel to support the requirements of this
Agreement;

4.1.6 (a) Obtain and maintain all necessary governmental and other permits, licenses and
approvals that Veraz notifies FLEXTRONICS in writing are necessary for the performance of
FLEXTRONICS’ undertakings hereunder for intended use by customers within countries that Veraz
plans to distribute such Products, including an ISO certification for FLEXTRONICS’ processes
to be performed under this Agreement (of at least ISO 9001: 2000 or higher), provided however
that if such certifications, permits, licenses or approvals are not already available to
FLEXTRONICS the parties will agree upon the schedule and cost allocation for obtaining them,
and (b) use commercially reasonable efforts to verify that each subcontractor complies with
the requirements set forth in Exhibit 4.1.8.

4.1.7 Provide on a weekly basis to Veraz detailed production and planned delivery schedules
for all Products that are to be manufactured and/or delivered by FLEXTRONICS for Veraz under
this Agreement; and obtain Veraz’s approval for the Subassemblies Report in accordance with
section 3.2;

4.1.8 Manufacture Products to a standard consistent with good manufacturing practices, and
according to their specifications and Veraz’s quality and other requirements, as are set
forth in Exhibit 4.1.8 to this Agreement or otherwise agreed to in writing by Veraz
and FLEXTRONICS and ensure the compliance of its manufacturing processes with any applicable
regulations, including without limitation the EU Directive 2002/95/EC on the restriction of
the use of certain hazardous substances in electrical and electronic equipment (“ROHS
Regulations”).

[*] Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED

4.1.9 Maintain a business continuity plan for the Products that contains protections that are
no less protective than the business continuity plan for other products that FLEXTRONICS uses
generally to protect its business from disruption;

4.1.10 Allow Veraz to identify FLEXTRONICS as the manufacturer of the Products, subject to
Section 8;

4.1.11 Provide Veraz with all manufacturing and quality data reasonably requested by Veraz,
including statistical process control data on all critical processes, yield and failure
analysis information, in accordance with Exhibit 4.1.8, and such other information
and support that Veraz shall reasonably request in order to permit it to comply with its
obligations under this Agreement.

4.1.12 Maintain and control a logistically separate inventory with separate catalog numbers
of all raw materials, WIP (Products which are still in production) and finished goods related
to the Products. On a monthly basis, within five (5) working days following each Forecast,
FLEXTRONIC shall provide Veraz with the then-current status of such inventory, and any
expected changes due to such Forecast.

4.1.13 Provide Veraz, in addition to any report stated in this Agreement, with the Reports
and Metrics on a monthly basis as per Exhibit 4.1.13.

4.2. FLEXTRONICS hereby warrants and undertakes that it will only purchase all Materials as
per the Approved Vendor List (as defined in section 7.1 (a)), and only from the sources
approved by the original manufacturer, stated in the list i.e. representative, franchise
distribution and approved vendor offices. . It is hereby agreed between the parties that for
specific Approved Vendors in the Approved Vendor lists, FLEXTRONICS must purchase the
Materials from the specific sources as set forth in Exhibit 4.2.

4.3 (i) If FLEXTRONICS is unable to manufacture the Products, despite its best efforts to
resume production and manufacturing, for a period that exceed 30 days, then FLEXTRONICS shall
implement the BCP (“Business Continuity Plan”). The BCP shall include the immediate transfer
by FLEXTRONICS of all tools, tooling, test equipment, Loaned Items, Materials, work in
process, and finished goods then in its inventory to either to a replacement manufacturer or
to another facility of FLEXTRONICS, according to Veraz’s sole discretion. In addition
FLEXTRONICS shall make sure that relevant representatives meet with representatives of such
replacement, if needed, to share know-how about the manufacturing process, and providing
reasonable technical assistance and support to such manufacturer for the Products. Any cost
related to the BCP will be negotiated and agreed between the parties.

(ii) As part of the BCP plan, FLEXTRONICS shall adopt all reasonable measures to protect and
secure any information, data, and manufacturing files that shall be stored at its expense for
the duration of this Agreement, in a protected and made safe place presenting all reasonable,
not less than what FLEXTRONICS uses to protect its own data, guarantees of security of
access, confidentiality and

[*] Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED

protection against disasters such as fire, flood, earthquake etc.
in a manner to enable FLEXTRONICS to immediately resume operations if any of the events above
occur.

5 Veraz’s Obligations

Veraz shall, at its expense, unless expressly provided otherwise below:

5.1 Pay any and all sales and use taxes, duties, fees and expenses and such other similar
charges, including interest and penalties thereon levied under any
applicable law or regulation arising out of or in connection with Veraz’s sale of Products to
customers, provided that nothing in this Section shall be interpreted to mitigate
FLEXTRONIC’s obligations under Sections 8 (Warranty, Epidemic Failure, Warranty Service and
Post-Warranty Support) and 13 (Indemnification) of this Agreement.

5.2 not incur or purport to incur, without FLEXTRONICS’ prior written consent, any promise,
representation, warranty, guaranty, liability or commitment on behalf of FLEXTRONICS.

5.3 Provide FLEXTRONIC with (i) design, specification, engineering and manufacturing data
that is reasonably requested by FLEXTRONIC, including maintenance of bill of materials,
including replacements, drawings, quality requirements, technical specification, standard
operation and test procedures; and approved vendors list; and (ii) Purchase Orders’ data,
packing list similar information, specific instructions, date of delivery, and additional
information that FLEXTRONIC shall reasonably request in order to manufacture the Products.

5.4 Loan to FLEXTRONICS ICT fixtures and test equipment and without derogating form the
provisions of section 15 herein below, license or provide FLEXTRONICS with the non-exclusive,
a revocable, non-transferable, royalty-free, fully-paid license while this Agreement is in
effect, without the right to sublicense, solely to use internally, for the sole purpose of
manufacturing and servicing the Products solely for Veraz, the right to use, all design and
manufacturing accessories, all as set forth in Exhibit 5.4 (the “Loaned Items”)
designed by or for Veraz, with all ownership right in such Loaned Items to remain exclusively
in Veraz. For the removal of doubt any design, or development made by FLEXTRONICS but paid
by Veraz will be the sole property of Veraz, whether or not such was listed on EXHIBIT 5.4.
FLEXTRONIC shall reasonably protect all such Loaned Items from misappropriate or misuse, and
ensure that such Loaned Items are properly handled and maintained, including but not limited,
calibration and insured against risk of loss or damage, subject to normal wear and tear, all
with the same degree of care FLEXTRONICS uses for its own items. Upon request by Veraz,
FLEXTRONIC shall return immediately to Veraz all such Loaned Items freight prepaid.
FLEXTRONICS shall not be held liable for delays in production resulting from the return of
the Loaned Items provided that (i) FLEXTRONICS notify Veraz in advance of the possibility
that such return of Loaned Items shall cause delay in production; and (ii) the delay is due
solely to Veraz request.

6. Purchase Orders

[*] Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED

6.1 Veraz will provide FLEXTRONICS from time to time during the term hereof with Purchase
Orders in the form attached hereto as Exhibit 6.1 for each Product covered by a
Forecast that Veraz chooses to order. FLEXTRONICS shall accept any Purchase Order provided
that: (i) the number of Products does not exceed the amount of such Product in the then most
recent Forecast; (ii) it is in accordance with the time schedule set forth in section 4.1.2.

6.2. Veraz is entitled to increase at any time the capacity of production of Products set
forth in the Forecast as detailed herein below (the “Capacity Increase”) by written request
to FLEXTRONICS (the “Request”) or by submitting a revised Forecast, and FLEXTRONICS shall be
obliged to accept the Request or Forecast, subject to the following: (a) availability of
Materials in FLEXTRONIC’s inventory; (b) availability of Materials in the market place at
prices equivalent to the price for such item stated in the most recent price list submitted
by FLEXTRONICS to Veraz and/or (c) availability of Materials in the market place at prices
higher than the price for such item stated in the most recent price list submitted by
FLEXTRONICS to Veraz, and Veraz shall have given its prior written approval to FLEXTRONICS to
purchase such Materials at the higher prices. If for the purpose of this Capacity Increase
FLEXTRONICS requires to purchase any additional Materials, at higher prices as aforesaid,
then Veraz will be responsible to reimburse FLEXTRONICS for such additional cost, subject to
the prior written approval, of Veraz for the extra cost. Except as set forth specifically in
this section, under no circumstances, Veraz shall be liable for any other additional cost
incurred by FLEXTRONICS, as a result of the Request. FLEXTRONICS is obligated to the
following Capacity Increase:

(i) During the first month following the Request or following the month in which the Forecast
was submitted: [*]% increase

(ii) During the period of 30-45 calendar days after the Request or following the month in
which the Forecast was submitted: [*]% increase

(iii) From the 46 calendar days and more, there will be no limitation.

Any purchase order quantities increased pursuant to the foregoing may not be subsequently
increased.

6.3 At any time, Veraz may cancel or reduce any Purchase Order or reduce any Forecast,
subject to the cancellation windows in Exhibit 3.1.2. Any Purchase Order quantities
rescheduled may not be subsequently rescheduled unless approved in writing by FLEXTRONICS.
FLEXTRONICS will issue a report once every month during the term of this Agreement and within
thirty (30) days after the date of expiration or earlier termination of this Agreement,
detailing all Materials and Products that: (a) have been manufactured or purchased by
FLEXTRONICS, as applicable based on Purchase Orders or according to a Forecast submitted by
Veraz and approved by FLEXTRONICS or otherwise according to this Agreement; and (b)
constitute Excess Inventory as defined in Section 6.8.2 or is already a Product.

Veraz shall be responsible and pay for Excess inventory as per Section 6.8 and for Finished
Products as per Section 9.

[*] Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED

6.4 Upon request by Veraz or upon cancellation or rescheduling by Veraz of a Purchase Order
or Forecast, FLEXTRONICS shall perform the following actions:
(i) within four (4) days perform “MRP” and follow the stipulations of section 3.1.1 and
accordingly reduce/cancel FLEXTRONIC’s outstanding purchase orders for Materials in order
beyond those required to meet Veraz’s purchase requirements all in accordance with the
stipulations of this Agreement, and (ii) perform or have performed an inventory of Materials
that constitute unused Excess Inventory (as such term is defined in section 6.8) or Product
subassemblies or finished Products. Upon request by Veraz, FLEXTRONICS shall use
commercially reasonable efforts, according to its business practices to return the unused
Excess Inventory or Product subassemblies to third parties at the same price at which they
were purchased or sell the unused Excess Inventory (excluding MDI as further defined below)
or Product subassemblies to a third party at a price acceptable to Veraz. In the case of
sale, Veraz shall only be responsible to reimburse FLEXTRONIC for the difference, if any,
between the purchase price and the Veraz-approved price at which FLEXTRONIC sold the unused
Excess Inventory or Products subassembly, to a third party. Upon request by Veraz and within
five business (5) days, FLEXTRONICS shall provide Veraz with a list of quantities and kind of
unused Excess Inventory and Product subassemblies that have not been resold, reused or
redirected.

6.5 Subject to Section 16.1, in the event of a failure by FLEXTRONICS to supply Products
specified in any Purchase Order pursuant to the requested delivery dates therein and such
failure to supply is not rectified within 14 days commencing from the requested delivery
date, provided, that such failure arises or results directly from the sole fault of
FLEXTRONICS or FLEXTRONICS’ negligence, when FLEXTRONICS must have adopted all reasonable
measures to prevent such failure to supply, including without limitation notifying in writing
and in advance to Veraz, then the amount due from Veraz to FLEXTRONICS under this Agreement
with respect to the purchase of Products set forth in such Purchase Order shall be reduced by
the price of [*]% per week from FLEXCTRONICS Profit (as defined in section 9.2.9 below)
starting on the fourteenth day of delay of delivery.

6.6 FLEXTRONICS will make a good faith effort to notify Veraz in the event that
FLEXTRONICS reasonably believes that there is or may be a materials or capacity constraint
that could negatively affect FLEXTRONICS’ ability to meet any forecasted needs of Veraz under
this Agreement (“Supply Constraint”). During any period of Supply Constraint, FLEXTRONICS
shall allocate the supply and delivery of Materials and capacity to Veraz under any
allocation formula that FLEXTRONICS uses with any other customer that purchases the same or a
lesser quantity of the same or similar products.

6.7 Manufacture Discontinued (“LTB”)

6.7.1 FLEXTRONICS will inform Veraz in writing, promptly when it comes to FLEXTRONICS’
knowledge upon any manufacture discontinue by any of the vendors (listed on the Approved
Vendors List, as such term is defined in section
7.1(a)). Further FLEXTRONICS shall provide Veraz with any information requested by Veraz and
available to FLEXTRONICS to enable FLEXTRONICS, to place “last time buy” (“LTB”) of any
Materials affected by such notification. Veraz will issue FLEXTRONICS a NC/NR
(non-cancelable/non returnable order) indicating the quantity and the price, according to
which FLEXTRNICS shall issue such order. Veraz will pay an advance payment for such

[*] Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED

order in
accordance with the procedure set forth in section 6.8.4 For the removal of doubt and without
derogating from the stipulations of section 6.3, FLEXTRONICS shall not make any use, sell,
dispose of in any way the Material purchased pursuant to this section as a LTB. Any excess
in Materials resulting from this section will be considered as Excess Inventory for the
purpose of section 6.8 below.

6.7.2 FLEXTRONICS will issue a monthly report in the beginning of each calendar month,
which will detail the Veraz stock at FLEXTRONICS’ premises that constitute Excess Inventory
purchased under LTB, including without limitation, prices and quantity (the “LTB Report”). In
addition FLEXTRONICS shall provide Veraz with a monthly report, which will detail the usage
made with the LTB Materials which are part of the Veraz stock at FLEXTRONICS’ premises, in
the previous calendar month (the “Usage Report”). FLEXTRONICS shall credit Veraz in
accordance with the Usage Report

6.8 Excess Inventory

6.8.1 Supply of Ordered Products. Concurrently with the execution of this Agreement,
FLEXTRONICS will submit a purchase order for the purchase from Veraz of all available
Materials required for the manufacture and supply by FLEXTRONICS of the Products under the
Forecast, and currently owned or on order by Veraz (whether located at Veraz’ facilities,
located at FLEXTRONICS’ facilities or currently on order from third party suppliers) all as
detailed in Exhibit 6.8.1 (the “Existing Ordered Materials”). Veraz will promptly
upon receipt of such purchase order ship all Existing Ordered Materials in its possession to
FLEXTRONICS and direct any third party supplier of Existing Ordered Materials to deliver the
same to FLEXTRONICS. FLEXTRONICS shall pay for the Existing Ordered Materials as per the
actual consumption that will be calculated and agreed by the parties each quarter via
consumption report that will be sent to Veraz by FLEXTRONICS, Veraz will issue an invoice
each quarter cover the relevant portion of the quarterly consumption. The Parties agree that
the purchase price for the Existing Ordered Materials shall be the value of such Material
plus [*]% (“Veraz Existing Material Price”). The Parties further agree that for purposes of
Section 9, the BOM Value (as defined in Sections 9.2.2 and 9.4.3), of such Materials
purchased from Veraz shall be calculated using an amount equal to the Veraz Existing Material
Price before adding the [*]%, i.e. the value of such Material. If during the term of this
Agreement there will be any Materials in Veraz’s inventory, FLEXTRONICS will give priority to
purchasing said inventory and the same terms and conditions that will apply to Veraz Existing
Ordered Materials as set forth in this section shall apply to such kind of Materials at
Veraz’s inventory.

6.8.2 Veraz shall assume full responsibility for Excess Inventory as follows:

(i) “Excess Inventory” shall be defined as inventory purchased or subassemblies
manufactured by FLEXTRONICS for the Products, that will not be under Demand (as defined in
section 3 above), during the following three (3) months from the Decisive Date (as defined in
6.8.4 (i)) (for the removal of doubt Excess Inventory will not include LTB Items/Products).

[*] Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED

(ii) “Quarter” shall be defined as calendar quarter.

     (iii) Excess Inventory shall be calculated at the end of each Quarter. Veraz shall not
be responsible for Excess Inventory that was not purchased in accordance with the terms of
this Agreement, for Veraz’s Purchase Orders or as approved in writing by Veraz for the
Forecast or otherwise approved in writing by Veraz.

(iv) The Excess Inventory will be stored in FLEXTRONICS’ facility separately
(logistically) from other materials stored in FLEXTRONICS premises. FLEXTRONICS agrees to
maintain the Excess Inventory by utilizing the same degree of care it uses to maintain its
own supply of like materials.

(v) Veraz shall pay and purchase Excess Inventory as per Section 6.8.4. below. Following the
purchase, the Excess Inventory shall remain at FLAXTRONICS’ premises, subject to sub-section
(iv) above and 6.8.3 below (unless it qualifies as Excess Ordered Materials, in which case
sub-section (vi) below shall apply). Veraz will retain all title in and to the purchased
Excess Inventory until such time as such Excess Inventory is consumed by FLEXTRONICS in the
manufacture and/or assembly of the Products (“Consumed Materials”).

(vi) Any Excess Ordered Materials (as defined below), shall be, at FLEXTRONICS’ full
discretion, immediately transferred and sold to Veraz. For the purposes hereof, “Excess
Ordered Materials” means Materials that, on the applicable date, have not been used by
FLEXTRONICS for production purposes and are not expected to be used by FLEXTRONICS within the
next 3 months, reflected from Veraz’s binding unchangeable Purchase Orders.

6.8.3 Risk of Excess Inventory 

(i) FLEXTRONICS and Veraz undertake to arrange and maintain the insurance policies as set
forth in Exhibit 6.8.3, with a reputable first class insurance companies, during the
Term of this Agreement(the “Insurance Certificates”).

(ii) FLEXTRONICS and Veraz undertake to provide each other, no later than seven (7) days from
the date of this Agreement, with the attached Insurance Certificates signed by their
insurers.

The above-mentioned Exhibit shall constitute an integral part of the contract.

FLEXTRONICS hereby commits to place within its premises with two fire-extinguisher — type of
Gaz, with weight of three (3) kilos, and acknowledge that the insurance coverage set forth in
Veraz respective Insurance Certificate, as provided above is dependant upon FLEXTRONICS
compliance with such

[*] Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED

commitment, and shall be responsible if Veraz shall not get the said
coverage due to such default by FLEXTRONICS.

Either party will be solely responsible for all costs and risks associated with, execution of
its respective insurance policies as set forth above. Neither party will have any liability
or responsibility in connection with the execution of any insurance policy of the other
party, including any deficiencies in such insurance policies.

In the case of damage to, loss or robbery of the Excess Inventory covered under Veraz
insurance policy, FLEXTRONICS will cooperate in good faith with Veraz in order for Veraz to
receive the insurance proceeds , including but not limited to comply with any demand of the
insurance company in order to receive the insurance proceeds and/or indemnification under
Veraz insurance policy.

(ii) FLEXTRONICS liability concerning the Excess Inventory as per this section 6.8 shall in
any event apply only to the extent the relevant losses and damages are not covered under the
above-mentioned Veraz insurance policy.

(iii) Without derogating from the above said it is agreed that FLEXTRONICS will have the
responsibility for counting and managing all the Excess Inventory. FLEXTRONICS shall be
liable for any discrepancy in the Excess Inventory resulting from any management of such
inventory, it being clarified that its sole responsibility shall be to replace timely,
any missing items from its own sources .

6.8.4  Advance Payment for the Excess Inventory

(i) FLEXTRONICS will provide Veraz with a monthly report listing the Excess Inventory (the
“Excess Inventory Valuation Variances Report"). The calculation shall be performed as follow:
(a) on a quarterly basis and by the 21st day of the last month of each calendar
quarter (the “Decisive Date”). Veraz shall approve the list of the Excess Inventory by the
25th day of the last month of each calendar quarter, unless there is a major
deviation of more than [*]% of value of the Excess Inventory (within the report itself), in
which case, the parties shall reach an agreed list by the 28th day of the last
month of each calendar quarter. Veraz shall pay to FLEXTRONICS the difference between the
Excess Inventory Value in the preceding quarter to the value of the Excess Inventory in the
present quarter, less [*]% of an average month’s forecasted consumption for the Excess
Inventory as listed in the agreed report or FLEXTRONICS shall refund to Veraz an amount equal
to the difference between the value of the Excess Inventory in the preceding quarter to the
value of the Excess Inventory in the present quarter. Payments from one party to another
shall be settled until the end of each quarter, unless agreed
otherwise. In the event Veraz does not pay within thirty (30) days, and without derogating
from FLEXTRONICS’ remedies under law, FLEXTRONICS will issue an invoice to Veraz for the
amount of the Excess Inventory; or (b) upon request of either party, following the same
procedure to be concluded within 7 days.

If there will be a need to execute any invoice for Excess Inventory, pursuant to the terms of
this

[*] Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED

Agreement, then it shall be in the amount of the last agreed price list for each item + [*]%.

     (ii) For the removal of doubt except as provided above, and in section 12.1 below, no
set off, payment or credit of any kind shall be available to Veraz in connection with the
advance payment for the Excess Inventory, Sale of Excess Inventory or the Products. If
either party request to make any set-off, the other party will have to reply to such request
within 7 days.

(iii) Veraz will submit to FLEXTRONICS by each end of Quarter confirmation stating the
reconciliation of the value for the advance payment which record in Veraz books as Inventory
located at 3rd party (i.e. FLEXTRONICS) as well as confirmation for the cycle
count report represent such Inventories values. FLEXTRONICS will submit to Veraz by each
end of Quarter confirmation stating the reconciliation of the value for the advance payment
which record in FLEXTRONICS books.

7. Production, Packaging and Delivery

7.1 Definitions.

(a) “Approved Vendor List” shall mean a list of approved manufacturers for Strategic
Components and Non-Strategic Components that is provided by Veraz to FLEXTRONICS, as such
list may be amended from time to time by Veraz which will also include a list of
manufacturers from which FLEXTRONICS is prohibited from purchasing or using any components,
such manufacturers shall be designated in the above list as either NTB (“Not to Buy”) or NTU
(“Not to Use”). FLEXTRONICS shall purchase all Materials as per the list of the approved
manufacturers set forth above, only from the sources approved by the original manufacturer,
stated in the list i.e. representative, franchise distribution and approved vendor offices.

(b) “Non-Strategic Component” shall mean any component, subassembly, or raw material
that is not a Strategic Component that is physically incorporated into the Products through
the manufacturing process of FLEXTRONICS.

(c) “Strategic Component” shall mean any of the components, subassemblies, or raw materials
used in the manufacture of the Products that Veraz has so designated in writing to
FLEXTRONICS.

7.2 Production. FLEXTRONICS shall procure components, manufacture, test,
package, and prepare for shipment all Products that are the subject of a Purchase Order in
conformity with the applicable process and quality management plans of Veraz and any other
reasonable applicable requirement of Veraz with respect to the procurement, manufacture,
test, packaging, and shipment preparation of any Product, provided in writing to FLEXTRONICS
with sufficient advance notice to enable FLEXTRONICS to comply therewith. FLEXTRONICS shall
(a) provide Veraz with a recovery plan if there is any production problem; (b) inspect all
Products prior to shipment to Veraz to determine whether such Products meet the agreed upon
process controls, test yields, end-of-line audits and out-of-

[*] Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED

box requirements, in accordance
with FLEXTRONICS and Veraz standard procedures; and (c) provide Veraz with process and
quality data as reasonably requested by Veraz.

7.3 Materials Management. FLEXTRONICS shall purchase Materials to manufacture
Products for Veraz solely from manufacturers on the Approved Vendor List of Veraz. From time
to time, FLEXTRONICS may identify alternate sources for the purposes of improving cost,
quality, lead-time and availability. FLEXTRONICS may submit suggestions for alternate
sources to Veraz for its written approval, which approval shall not be unreasonably withheld.

7.4 (a) Non-Strategic Components And Strategic Components FLEXTRONICS shall be
responsible for all aspects of sourcing and commodity management for Non-Strategic Components
and Strategic Components in accordance with the standard procurement and quality procedures
in FLEXTRONICS and the requirements of ISO 9001: 2000.

(b) Strategic Components. For part of the Strategic Components, as Veraz shall
decide, Veraz shall maintain strategic account management responsibilities, such as
contracts, pricing, quality, die banking, supplier tooling management (including budgeting of
tooling cost) and business performance feedback. As and to the extent directed by Veraz,
FLEXTRONICS shall purchase Strategic Components under Veraz’s supply agreements with
suppliers of Strategic Components.

FLEXTRONICSS may purchase the Strategic Components from its inventory only upon receiving
prior written approval from Veraz.

7.5 Packaging and Delivery. All Products shall be packaged by FLEXTRONICS in
accordance with product packaging and labeling specifications issued by Veraz and shall be
delivered EX WORKS (INCOTERMS 2000) at FLEXTRONICS’s relevant Israel factory. Risk of loss
and title shall pass from FLEXTRONICS to Veraz upon delivery.

8. Warranty, Epidemic Failure, Warranty Service and Post-Warranty Support

8.1 Warranty. FLEXTRONICS warrants to Veraz that (i) during and for a period of [*]
months after the date of delivery of a Product to Veraz for the purpose of delivery of the
same to Veraz’s customers (herein the “Warranty Period"), such Product will be free from
material defects in workmanship, manufacturing process or assembly, subject to normal use and
service, (ii) each Product will conform in all material respects to the specifications
applicable to such Product at the time of its manufacture; (iii) each product will conform in
all respects to Veraz’s quality requirements as set forth in Exhibit 4.1.8 and manufacture
standard no. IPC610C. Materials are warranted to the same extent that the original
manufacturer warrants the Material (i.e. full back to back coverage. FLEXTRONICS must
provide Veraz and keep Veraz well informed of all the terms and conditions related to
Warranty provided by any applicable manufacturer, upon request by Veraz.

[*] Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED

Without limiting Section 8.3, this express limited warranty does not apply to (a) Materials
consigned or supplied by Veraz to FLEXTRONICS; For the removal of doubt, this limitation
will not apply to Excess Inventory as defined in section 6.8.2., and the warranty contained
in this section will apply to the Excess Inventory at all times and in all respects; (b)
defects to the extent resulting from Veraz’s specifications or the design of the Products or
instructions in writing by Veraz; With respect to, prototypes, and NPI (new product
introduction), section 8 shall not apply, and FLEXTRONICS makes no representations and
warranties with respect thereto. Notwithstanding anything else in this Agreement, without
derogating from the stipulations of section 5.4, FLEXTRONICS assumes no liability for or
obligation related to the performance, accuracy, specifications, failure to meet
specification or defects due to tooling, designs or instructions produced or supplied by
Veraz in writing, and Veraz shall be liable for documented costs or expenses incurred by
FLEXTRONICSS resulting there from. Veraz will provide its own warranties directly to any of
its end users or other third parties. Veraz will not pass through to end users or other
third parties the warranties made by FLEXTRONICSS under this Agreement. Furthermore, Veraz
will not make any representations to end users or other third parties on behalf of
FLEXTRONICSS, and Veraz will expressly indicate to the end users and third parties that they
must look solely to Veraz in connection with any problems, warranty claim or other matters
concerning the Products, provided that nothing herein shall derogate from (i) FLEXTRONICS
obligations as set forth in section 8.1 above to be responsible for handling any warranty
claims against third party suppliers of Materials; and (ii) prevent from Veraz to notify and
describe to its end users or any other third party about FLEXTRONICS’ obligations herein.

Upon any failure of a Product to comply with the above warranty, if Veraz promptly reports to
FLEXTRONICS in writing, prior to the end of the Warranty
Period, then FLEXTRONICSS’s sole obligation, and Veraz’s sole remedy shall be for
FLEXTRONICS, at its cost and option, either to replace or repair, at its factory, provided
that any repair will be performed in accordance with Veraz’s required specification, all
the Products that: (i) are not in compliance with the warranty set forth above, and
(ii) Veraz ask for warranty services as set forth herein, whether such Products are
functioning or not, at Veraz’s sole discretion, and bear all costs related to delivery to and
from Veraz warehouse in Israel. Veraz shall return Products covered by the warranty to the
end user at its own account. Veraz shall bear all of the risk, and all costs and expenses,
associated with the delivery of the Products that have been returned to FLEXTRONICS for which
there is no defect found. In addition, Veraz shall provide to FLEXTRONICS on commercially
reasonable terms with all engineering support which is reasonably required by FLEXTRONICS to
meet its warranty obligations in respect of the Products returned to FLEXTRONICS under this
Section 8.1 of this Agreement. In the event that there shall be a dispute as to whether a
defective Product is under warranty by FLEXTRONICS or by a third party supplier of Materials,
then the parties shall submit the defective Product for analysis by an independent
laboratory, which determination shall be conclusive and accepted by FLEXTRONICS and
Veraz.

     8.2 Post-Warranty Support. Veraz may offer post-warranty service for the
Products on commercial terms that it determines. With respect to service and maintenance
required on the Products (other than pursuant to the aforesaid Product warranties) under
service agreements and on a “time and material” basis, Veraz shall perform such services and
may purchase the parts and related repair services

[*] Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED

from FLEXTRONICS at commercially
reasonable terms to be negotiated by the parties, FLEXTRONICS shall be obligated to make such
parts (to the extent they are available on the market at the relevant time) and services
available subject to the terms to be agreed between the parties.

8.3 Warranty Exclusions. FLEXTRONICS shall not be obligated under any of the above
warranty provisions if any such warranty service is necessitated in whole or in part by
normal wear and tear, catastrophe, accident, fault or negligence of Veraz or any third party,
improper use, alteration or modification, unusual stress, installation, service or repair
performed other than pursuant to this Agreement (other than installation, service or repair
performed by FLEXTRONICS pursuant to this Agreement), engineering or design as aforesaid, or
any other cause other than ordinary use. FLEXTRONICS MAKES NO OTHER WARRANTIES OR CONDITIONS
ON THE PRODUCTS, EXPRESS, IMPLIED, OR OTHERWISE. THE WARRANTY IN THIS SECTION 8 IS EXCLUSIVE
AND IN LIEU OF ANY AND ALL SUCH WARRANTIES, INCLUDING ANY WARRANTY OF MERCHANTABILITY OR
FITNESS FOR PURPOSE. THE REMEDY PROVIDED IN SECTION 8.1 ABOVE SHALL BE THE SOLE REMEDY OF
VERAZ FOR ANY FAILURE OF FLEXTRONICS TO CONFORM WITH SUCH WARRANTY IN SECTION 8.1.

8.4 Additional Services. Veraz may purchase, on a monthly basis, additional services
from FLEXTRONICS as listed in Exhibit 8.5 attached hereto at commercially reasonable
terms to be negotiated by the parties.

8.5 Spare Parts. At all times during the term of this Agreement and a period
thereafter to be agreed during which Veraz may provide post-warranty support to final
customers identified to FLEXTRONICS, FLEXTRONICS shall maintain, on commercially reasonable
terms to be negotiated by the parties (including terms concerning Veraz’ obligation to pay
for the parts and components) and for the benefit of Veraz, a mutually agreed supply of
replacement parts and components at FLEXTRONICS’s manufacturing facility, subject to their
availability on the market at the relevant time. FLEXTRONIC shall maintain a supply of
replacement parts and components to support each of the Products for at least [*] years
following the date of final delivery of the Products to Veraz’s customers, at Veraz’s cost to
be agreed between the Parties.

8.6 RMA Process. Each party will follow the RMA Process set forth in
Exhibit 8.6 and the quality requirements set forth in Exhibit 4.1.8, with
respect to the return and delivery of Products that are subject to in-warranty or
out-of-warranty repair by FLEXTRONICS. FLEXTRONICS will promptly repair or replace Products
returned for repair and rework to their most current version at commercially reasonable terms
to be negotiated by the parties, unless otherwise directed by Veraz, within thirty (30) days
after their receipt and will redeliver to Veraz such repaired or reworked products prior to
the expiration of such period. In the event of any conflict or inconsistency between the
provisions of Exhibit 8.6 and the provisions within Section 8, the provisions within
Section 8 shall govern and control such conflict or inconsistency.

[*] Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED

9. Pricing, Payment Terms and Audit Rights

9.1
Pricing Model Summary.

[*]

9.2
Definitions for Pricing Model Summary.

     9.2.1 “Bill of Materials” shall mean a complete and detailed list of all components,
subassemblies, materials, and other items that are necessary for FLEXTRONICS to manufacture a
particular Product, as provided to FLEXTRONICS by Veraz.

9.2.2 “BOM Value” (“BV”) shall mean, for a specific Product, the price in the last price
list, which was approved by Veraz, to each item multiply by the quantity in the Bill of
Materials for such Product.

9.2.3 “Material Handling Fee” (“MH%”) shall mean the multiplier which reflects: the
costs for labor for production planning, material management, purchasing, storage and quality
inspection of incoming items; freight and insurance; material scrap and attrition (component
level); and finance, which is [*]%.

9.2.4 “Assembly Cost” (ASC) shall mean the cost for each component placement, which is
[*]cent.

9.2.5 “Testing, and Final Assembly “ (“TF”) shall mean fully loaded cost of testing per hour,
final assembly and integration of the Product, as set forth in Exhibit 9.2.

9.2.6 “Packing Time” (“PT”) shall mean fully loaded cost of Packing as set forth in
Exhibit 9.2;

9.2.7 “Packing Cost” (“PC”) shall mean fully loaded cost per hour of packing, as set forth in
EXHIBIT 9.2;

9.2.8 “TT” – shall mean agreed number of hours for testing for each product.

9.2.9 “Profit” (“PR%”) shall mean the FLEXTRONICS’ fixed profit percentage which is [*] %.

9.3 Pricing Model Summary for NPI (New Product Introduction)

[*]

9.4
Definitions for Pricing Model Summary for NPI.

     9.4.1“Bill of Materials” shall mean a complete and detailed list of all components,
subassemblies, materials, and other items that are necessary for FLEXTRONICS to manufacture a
particular Product, as provided to FLEXTRONICS by Veraz.

[*] Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED

9.4.2 “BOM Value” (“BV”) shall mean, for a specific Product, an amount equal to the
aggregate total of FLEXTRONICS last price list which was approved by Veraz, to each item
multiply by the quantity in the Bill of Materials for such Product.

9.4.3 “Material Handling Fee” (“MH%”) shall mean the multiplier which reflects: costs
for labor for production planning, material management, purchasing, storage and quality
inspection of incoming items; freight and insurance; material scrap and attrition (component
level); and finance, which is [*]%.

9.4.4 “Assembly Cost” (ASC) shall mean the cost for each component placement, which is [*]
cent.

9.4.5 “Set Up Cost” (“SUC”) shall mean the initial cost of the setting up of the machines
required for the manufacturing process.

9.5 Pricing Variants per Item in the BV

9.5.1 In first day of each calendar quarter (the “Determining Date”), FLEXTRONICS shall
calculate the new price per item in the BV (hereinafter the “Item”), as follows, the Item
value shall be:

(a) The [*] of [*] per [*], in the next [*] calendar days, following the [*];

(b) In case option (a) is not possible, as there are no such open purchase orders, then the
calculation shall be made in accordance with the [*] of [*] placed by FLEXTRONICS in the
preceding [*] calendar days prior to the [*], excluding any prior calculations and payments
already made pursuant to this section.

(c) In case option (b) is not possible as well, as there are no previous purchase
orders, during the period set forth in sub section (b), then, the price per Item
shall be based on the last approved [*], by Veraz.

(d) By the end of each fiscal quarter FLEXTRONICS must transfer to Veraz a report
detailing any Item cost changes as per sub section (a).

9.5.2 FLEXTRONICS shall produce to Veraz on the Determining Date a written report which will
include the following information: Item catalog number, description of the Item, the new
price per section 9.5.1, old price, item quantity demand, item stock demand, manufactures
(the “New Price List Report”).

9.5.3 After Veraz has approved in writing the New Price List Report, FLEXTRONICS shall
perform a reevaluation to the current stock, in order to enable the immediate use of the new
prices listed in the New Price List Report. FLEXTRONICS shall provide Veraz with a pricing
Variances Per Item Report which will include the revaluation results (the “Pricing Variances
Per Item Report”). The reevaluation shall be performed in accordance with the following
formula:

[*] Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED

A=old price (per Item)

B=the new price (per Item)

C=quantity within the stock

D=amount for debit/credit pursuant to the reevaluation per Item.

[*]

9.6 Prices.

     9.6.1 Products. The price for each Product (the “Purchase Price”) shall be
calculated at the beginning of each calendar month, in accordance with the pricing model set
forth in Section 9.1-9.5 above. The current prices are set forth in Exhibit 9.6.1,
attached hereto.

9.6.2 Pricing Model. Upon request by Veraz, FLEXTRONICS shall share promptly
with Veraz all information related to and elements of pricing, including without limitation
an itemized list of all current BOM Value, assembly, manufacturing and test labor rates and
costs, directly apportioned selling, general and administrative expenses, profit and
manufacturing overhead costs.

9.7 Price Reviews.

9.7.1 Cost Reduction Programs. FLEXTRONICS shall use its commercially
reasonable efforts in accordance with its customary practices to implement a price reduction
program that targets the reduction of the cost of specific components included in the
manufacturing process for the Products and the improvement of the efficiency of the
manufacturing process.  

9.7.2 Price changes and cost reduction Methodology. The Total Price is fixed for each
applicable fiscal quarter in accordance with the above said. Only major and substantial
changes in the Total Price may be changed by FLEXTRONICS, provided that Veraz’s management
has approved the change in advance and in writing, which approval shall not be unreasonably
withheld. Any change in the prices as aforesaid and the time schedule for implementation of
such change shall be mutually agreed in advance and in writing by the both Parties.

9.8 Audit Rights and Business Review.

9.8.1 Business Review (“BR”). Veraz shall have the right, at its expense, to conduct audits
of the manufacturing services and related facilities, for the purpose of auditing
FLEXTRONICS’ compliance with the provisions of this Agreement as follows: The audits may
include only the equipment designated for the services specified herein, the facility at
FLEXTRONICS’ premises, finished goods warehouse, the

[*] Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED

Inventory designated for the Product(s)
and any technical records (manufacturing specifications, production files and quality
documentation). All audits shall be performed within FLEXTRONICS facility. No documents or
data of any kind, or any copies, may be removed from FLEXTRONICS’ facility, without prior
written approval of FLEXTRONICS. Veraz shall have the sole discretion, not to be unreasonably
applied, to determine the frequency of the audit. Veraz will conduct the audits in a
reasonable manner so as not to cause undue disruption to FLEXTRONICS’ work. Audit shall be
conducted during business hours, and shall be coordinated with FLEXTRONICS at least 72 hours
in advance. In the course of
such audits FLEXTRONICS shall provide, and shall cause its subcontractors to provide, such
auditors any reasonable assistance that they may require.

9.8.2 Verification. Veraz or its authorized agent may perform source verifications
and quality assurance audits at FLEXTRONIC plant of manufacturer at times agreed upon by both
Parties, provided that Veraz has first approached FLEXTRONICS to receive the requisite
information, and the information received from FLEXTRONICS does not satisfy Veraz’s needs, or
FLEXTRONICS did not supply the information within 7 days of receipt of such request, in cases
where:

(i) Veraz claims that there is any problem with an Item, Materials, and/or Product regarding
quality of the Product or performance of the Item, Materials and/or Product or the
performance FLEXTRONICS of its obligations pursuant to section 8; (ii) Veraz has a reasonable
suspicion that the quality and/or the source of the Materials /Items is not in accordance
with the stipulations of this Agreement, and such resulted in the derogation of quality of
the Materials, Item and/or Product; and/or (iii) A failure to supply, as mentioned in section
6.5 has accrued, and Veraz has reasonable grounds to assume that FLEXTRONICS did not adopt
all reasonable measures to prevent such failure to supply, unless FLEXTRONICS pay in advance
the amount set forth in section 6.5 above.

9.9 Veraz shall pay the Purchase Price in united states dollar, net plus [*] or [*] in case it
is agreed between the parties that payment shall be made though a clearance house, from the
date of delivery to Veraz of the Products together with a corresponding invoice in USD ($)
(“Invoice”). All other payment required from Veraz pursuant to this Agreement, shall be paid
net plus [*] from the date of Invoice. Notwithstanding the foregoing, if Veraz fails to make
any payment when due or if FLEXTRONICS has any reason to believe that Veraz may not be able
or willing to make any payment when due, FLEXTRONICS shall be entitled to demand appropriate
securities, such as bank guarantees and pre-payments as a condition to the performance
thereby of any further work or service.

9.10 All payments hereunder shall be made by wire transfer to FLEXTRONICS’ bank account
as instructed by FLEXTRONICS. Without limiting FLEXTRONICS remedies under law, payments,
when more than [*] days overdue, shall bear an interest at the rate of [*] plus [*] per
annum. Payments hereunder shall be made net of any local, state, or federal sales, use,
excise, personal property or other similar taxes (other than V.A.T to be added to the
payments by Veraz and stamp duty which will be paid by both FLEXTRONICS and Veraz in equal
share.) or duties, and any such taxes or duties shall be assumed and paid for by Veraz
(except that, for the removal of doubt, FLEXTRONICS shall pay its own income tax). If however
after the Effective Date of execution of this Agreement, there will be imposed any local,
state, or federal sales, use, excise, personal property or other similar taxes or duties,
these will

[*] Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED

be paid in accordance with the law and in the absence of clear guidance by the law, in
accordance with customary business practice in the market.

9.11 FLEXTRONICS shall keep true and accurate books of account with respect to the
manufacture for and delivery and sale to Veraz of the Products for the term of this Agreement
and for any legally required period thereafter.

9.12 Custom and Tax Expenses

9.12.1 Veraz shall be responsible to bear all custom duty resulting from FLEXTRONICSS
purchasing abroad any components required for the manufacturing the Products, in a manner that
will enable Veraz a complete and appropriate control over such payments. .

9.12.2 Once every calendar quarter on the last day of such quarter, FLEXTRONICS shall perform
a calculation relating to the costs of the custom duty deriving directly from FLEXTRONICS’
purchases abroad of any component relating directly and exclusively to the Products. During
the following month, after the end of each calendar quarter, FLEXTRONICS shall debit Veraz
through a tax invoice, to which it will attach a detailed report which set forth the way the
calculation of said costs relating to custom and tax expenses were performed.

9.12.3 In the end of each calendar year, FLEXTRONICS shall submit Veraz all the information
and documentation required in order for Veraz to be able to submit reports in order to get a
refund from the tax authorities (“Hashavon”). FLEXTRONICS hereby guarantee to make every
reasonable effort and to cooperate fully with Veraz in order that all custom and tax expenses
incurred by it for the purpose of manufacturing of the Products of Veraz, shall be refunded to
Veraz by the Israeli tax authorities, in accordance with the applicable law.

10. Engineering Changes

FLEXTRONICS shall not make any engineering changes to the Products to be supplied to Veraz
hereunder that may impact the form, fit or function of such Products, or may cause the
Products to deviate from their specifications, without first obtaining the prior written
consent of Veraz to such engineering changes. However, even if said approval has been granted
by Veraz, for the removal of doubt, any such change which was initiated by FLEXTRONICS, due
its internal needs/requirements, shall be fully paid by FLEXTRNICS. Veraz may submit
engineering changes for incorporation into any Product, whether already delivered prior to the
date of such request for engineering changes or due to be supplied after such request, and
whether under warranty or not, which shall be subject to FLEXTRONICS’ approval, which shall
not be unreasonably withheld, delayed or conditioned, provided that Veraz shall be responsible
for all “reworking” of the Products at its sole cost and expense. FLEXTRONICS will make a
reasonable effort to review the engineering change and report to Veraz within three (3)
business days of any implications of the proposed changes. The report shall include all
possible implications on material, delivery schedule, manufacturing process, quality and
product cost.

[*] Confidential information in this Exhibit has been omitted and filed separately with the Commission.
Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

Such changes will be reflected in revised Purchase Orders and, if applicable,
Veraz shall pay for Inventory that become Excess Inventory, all as per Section 6.8.4 (vi).
Veraz shall bear all costs associated with the development and implementation of engineering
changes, unless such were initiated by FLEXTRONICS, due its internal needs/requirements. FLEXTRONICS shall use commercially
reasonable efforts to quickly implement all of the foregoing engineering changes and any other
agreed engineering changes.

11. Term; Termination

11.1 This Agreement shall commence on the date hereof and shall continue until December 31,
2006, unless earlier terminated pursuant to this Section 11. This Agreement shall
automatically renew for additional successive one (1)- year periods unless either party
informs the other in writing of its intention not to renew this Agreement at least six (6)
months prior the expiration date of the then-current term.

11.2 Either party may terminate this agreement without any cause, subject to a prior written
notice of 180 days, subject to section 12. However, If FLEXTRONICS is unable to manufacture
the Products, despite its best commercial efforts to resume production and manufacturing,
notwithstanding the stipulations of section 4.3, and the implementation of FLEXTRONICS of the
BCP, Veraz will have the option to terminate this agreement subject to a 7 days prior written
notice, subject to section 12.

11.3 If a party fails to meet one or more of the material terms and conditions hereof (a
“Default”), FLEXTRONICS and Veraz agree to negotiate in good faith to resolve such Default. If
the defaulting party fails to cure such Default or submit an acceptable written plan to
resolve such Default within thirty (30) days following notice of Default, the non-defaulting
party shall have the right to terminate this Agreement by furnishing the defaulting party with
thirty (30) days written notice of termination.

11.4 A party shall have the right to immediately terminate this Agreement should the other
party become insolvent; enter into or file a petition, arrangement or proceeding seeking an
order for relief under the bankruptcy laws of its respective jurisdiction; have filed against
it an involuntary petition, arrangement or proceeding seeking an order for relief under the
bankruptcy laws of its respective jurisdiction, which is not dismissed within ninety (90) days
after filing; enter into a receivership of any of its assets; or enter into a dissolution or
liquidation of its assets or an assignment for the benefit of its creditors.

11.5 Veraz shall have the right to terminate this Agreement in the event of a force majeure
event that continues in effect for a period of ninety (90) days and affects the ability of
Veraz to obtain Products from FLEXTRONICS.

[*] Confidential information in this Exhibit has been omitted and filed separately with the Commission.
Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

11.6 The provisions of Sections 8 (Warranty, Epidemic Failure, Warranty Service and
Post-Warranty Support), 9 (Pricing, Payment Terms and Audit Rights), 11 (Term; Termination),
12 (Effect of Termination), 13 (Indemnification), 14 (Dispute Resolution), 15 (Intellectual
Property) and 16 (General) shall survive the expiration or earlier termination of this
Agreement for a period of [*] years.

12. Effect of Termination

For the removal of any doubt, expiration or termination of this Agreement shall not affect any
prior obligations incurred by either party prior to the expiration or termination of this
Agreement. .

12.1 In the event of any termination, for any reason:

12.1.1. Veraz shall compensate FLEXTRONICS for unused Excess Inventory in accordance with
Section 6.8, and FLEXTRONICS shall issue an invoice for such Excess Inventory, and will be
paid in accordance with the terms of this Agreement. Any prior advance payment that was paid
by Veraz in accordance with this agreement for the Excess Inventory being invoiced, shall be
set-off against said payment

12.1.2. Each party will promptly return to the other party, all tools, tooling and test
equipment and other property and Proprietary Information of the other party (as defined
below).

12.1.3 FLEXTRONICS shall immediately transfer to Veraz all Material, work in process, and
finished goods then in its inventory, and Veraz shall pay to FLEXTRONICS in accordance with
the terms of this Agreement, provided that as a condition to the transfer of Material, work in
process, and finished goods to Veraz, Veraz shall provide FLEXTRONICS a letter signed by
Veraz’s VP Finance confirming its agreement and ability to pay in full the amounts invoiced by
such date, by FLEXTRONICS for all of the foregoing upon the due date of payment.

     12.1.4. FLEXTRONIC shall transfer the manufacturing of such Product to such replacement
manufacturer, have relevant representatives meet with representatives of such replacement,
sharing know-how about the manufacturing process, and providing all necessary tools and
tooling for the Product, to such replacement manufacturer, and providing reasonable technical
assistance and support to such manufacturer for the Products subject to an agreement between
the parties to be reached in good faith.

     12.4 Neither party shall be liable for any expenses incurred by the other party or any
of its employees, distributors or agents and which arise out of or in connection with this
Agreement or relate to the development of goodwill for the Product whatsoever or wheresoever.
Furthermore, neither party shall have any obligation whatsoever to the other party, by reason
of the expiration or termination hereof, for loss of profits or anticipated profits,
reimbursement of expenditure or otherwise.

[*] Confidential information in this Exhibit has been omitted and filed separately with the Commission.
Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

12.5 Neither party shall be obligated to compensate the other party for any loss, cost or
expense incurred by the latter by virtue of any investments in buildings, stock, machinery,
transport equipment or other property which may be undertaken by either Party in connection
with this Agreement. Either Party agree that all such investments shall be for its own account
and at its own risk.

13. Indemnification 

13.1 FLEXTRONICS shall defend, indemnify and hold harmless Veraz and its affiliates, and each
of their respective officers, directors, employees, and assigns and successors permitted
hereunder from and against any direct loss, damage, expense, cost (including, but not limited
to, reasonable attorneys’ fees and costs incurred in the enforcement of this indemnity) or
liability solely to the extent that it is based upon a claim that (a) FLEXTRONICS’s
manufacturing process, process technology or methodology: (1) infringes or misappropriates any
patent, copyright, trade secret or other intellectual property right of a third party , or (2)
has caused personal injury (including death) or damage to property or (b) any failure to
comply by FLEXTRONICS of its obligations to use commercially reasonable efforts to obtain all
necessary governmental approvals, licenses, permits and consents as required under this
Agreement; provided that Veraz (i) gives FLEXTRONICS prompt written notice of any such claim
made to Veraz in writing, (ii) cooperates with FLEXTRONICS, at FLEXTRONICS’ expense, in the
defense of such claim, and (iii) gives FLEXTRONICS the sole right to control the defense and
settlement of any such claim to the extent covered by the indemnification provided herein.
FLEXTRONICS will: (a) defend or settle, at its own expense, any such claim; (b) keep Veraz
advised of the status of any such claim and of its defense and/or negotiation efforts; and (c)
afford Veraz reasonable opportunity to review and comment on significant actions planned to be
taken by FLEXTRONICS on behalf of Veraz. FLEXTRONICS shall not enter into any settlement that
adversely affects Veraz’s rights or interests, without Veraz’s prior written approval, which
approval will not be unreasonably withheld, delayed or conditioned. Veraz shall have no
authority to settle any claim on behalf of FLEXTRONICS.

13.2 Should the manufacture, use, distribution or sale of a Product, or any part thereof,
FLEXTRONICS’ manufacturing process, process technology or methodology be enjoined, all of
the foregoing as a result of a claim of infringement for which indemnity is provided under
Section 13.1, FLEXTRONICS shall at its option, and at no expense to Veraz (a) by license or
other release, procure for Veraz the right to continue to use and distribute the same, or (b)
replace or modify the same to make it non-infringing without materially changing the form, fit
and function of the Product or (c) terminate the Agreement subject to the terms of Section 12.

13.3 Veraz shall defend, indemnify and hold harmless FLEXTRONICS and affiliates, and each of
their respective officers, directors, employees, and assigns and successors permitted
hereunder from and against any direct loss, damage, expense, cost (including, but not limited
to, reasonable attorneys’ fees and costs incurred in the enforcement of this indemnity) or
liability solely to the extent that it is based upon a claim concerning (1) that the Products,
Veraz’s written instructions, tooling, specifications: (i) infringe any patents, trademarks,
copyrights, trade secrets, (ii) has caused personal injury (including death) or damage to
property (2) a failure to comply by Veraz of its obligations to use commercially reasonable
efforts to obtain all necessary governmental approvals, licenses, permits and consents as

[*] Confidential information in this Exhibit has been omitted and filed separately with the Commission.
Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

required by Veraz under this Agreement; provided that FLEXTRONICS (i) gives Veraz prompt
written notice of any such claim made to FLEXTRONICS in writing, (ii) cooperates with Veraz,
at Veraz’s expense, in the defense of such claim, and (iii) gives Veraz the sole right to
control the defense and settlement of any such claim to the extent covered by the
indemnification provided herein. Veraz will: (a) defend or settle, at its own expense, any
such claim; (b) keep FLEXTRONICS advised of the status of any such claim and of its defense
and/or negotiation efforts; and (c) afford FLEXTRONICS reasonable opportunity to review and
comment on significant actions planned to be taken by Veraz on behalf of FLEXTRONICS. Veraz
shall not enter into any settlement that adversely affects Veraz’s rights or interest, without
Veraz’s prior written approval, which approval will not be unreasonably withheld, delayed or
conditioned. FLEXTRONICS shall have no authority to settle any claim
on behalf of Veraz. Veraz will not reimburse FLEXTRONICS for any expenses incurred without the prior written
approval of Veraz, provided that Veraz shall not unreasonably withhold such approval, and
shall response to such request promptly within 1 business day. FLEXTRONICS may engage counsel
of its choice at its own expense.

If a claim is brought, or Veraz in good faith determines that such a claim is likely to be
made, Veraz shall notify FLEXTRONICS and either: (1) procure for FLEXTRONICS the right to
continue to perform this Agreement; (2) modify the Specification or Products or other
instructions or files so that there will no longer be an infringement or misappropriation or
(3) terminate this Agreement subject to the terms of Section 12.

13.4 FLEXTRONICS must provide Veraz and keep Veraz well informed of all the terms and
conditions of indemnification provided by any applicable manufacturer, upon request by Veraz.

If a claim is brought against Veraz
alleging that any Material (1) infringes or misappropriates any patent, copyright, trade secret or
other intellectual property right of a third party, or (2) has caused personal injury (including death)
or damage to property, Flextronics shall  enable Veraz , at Veraz’s expense, so as to allow Veraz to benefit
from any indemnity obligation available to Flextronics from the relevant supplier to the full extent available to
Flextronics, subject to any limitation in law or in the relevant contract with the relevant manufacturer on FLEXTRONICS’
ability to do so. Flextronics shall not be required to incur any liability or expense connected with such claim.
If such claim is also brought against Flextronics, Flextronics shall only cooperate with Veraz to the extent the suppliers’ indemnity obligation can benefit Veraz after Flextronics is made whole by the supplier.

14. Dispute Resolution

14.1 In the spirit of continued cooperation, the parties intend to and hereby establish the
following dispute resolution procedure to be utilized in the unlikely event any controversy
should arise out of or concerning the performance of this Agreement.

14.2 It is the intent of the parties that any dispute be resolved informally and promptly
through good faith negotiation between FLEXTRONICS and Veraz. Either party may initiate
negotiation proceedings by written notice to the other party setting forth the particulars of
the dispute. The parties agree to meet in good faith to jointly define the scope and a method
to remedy the dispute. If these proceedings are not productive of a resolution within
twenty-five (25) days, then senior management of FLEXTRONICS (Position: Chief Executive
Officer) and Veraz (Position: Chief Executive Officer) are authorized to and will meet
personally within five (5) days to confer in a bona fide attempt to resolve the matter. If
senior management is not able to resolve the dispute within fifteen (15) days thereafter,
either party may seek remedy from a court of competent jurisdiction.

[*] Confidential information in this Exhibit has been omitted and filed separately with the Commission.
Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

14.3 Notwithstanding anything to the contrary, the dispute resolution process set forth in
this Agreement shall not affect or limit the ability of a party to seek immediate injunctive
or equitable relief as permitted under this Agreement.

15. Intellectual Property 

15.1. License to FLEXTRONICS. Veraz hereby grants FLEXTRONICS a revocable,
non-exclusive, non-transferable, royalty-free, fully-paid license while this Agreement is in
effect, without the right to sublicense, solely to use internally Veraz’s intellectual
property for the sole purpose of manufacturing and servicing the Products solely for Veraz,
and for no other purpose. For the removal of doubt, the above license shall be revoked
immediately if FLEXTRNICS does not comply with any of its obligations under this Agreement and
as a result thereof the Agreement is being terminated per section 12.

15. 2. Proprietary Rights Notices. FLEXTRONICS shall properly mark each Product and
any accompanying documentation with Veraz’s copyright or other proprietary rights notice, as
reasonably requested by Veraz, to indicate Veraz’s intellectual property rights in such
Products. Except as expressly provided herein, nothing in this Agreement shall be construed
as a grant of any license, right or interest in any trademark, trade name or service mark of
either party, or any third party from whom either party may have acquired license rights.

15.3 Reserved Rights. Veraz retains all rights, title and interest in and to any
Veraz intellectual property that is provided by Veraz to FLEXTRONICS for use in the
manufacturing of the Products for supply to Veraz under this Agreement. Except for the
limited license rights provided to FLEXTRONICS in Section 15.1 of this Agreement, Veraz does
not grant to FLEXTRONICS any rights in or to any of Veraz’s intellectual property. All such
rights in and to any such intellectual property are expressly reserved by Veraz.

16. General 

16.1 Force Majeure. Neither of the parties shall be liable for any failure or delay
in its performance under this Agreement (except for payment of money) due to acts of God, acts
of civil or military authority, fires, floods, earthquakes, riots, wars, sabotage, labor
shortages or disputes, destruction of production facilities, material unavailability or any
other cause beyond the reasonable control of the delayed party provided that the delayed party
(i) gives the other party written notice of such cause; and (ii) uses its reasonable
commercial efforts to remedy such delay in its performance. Each party will reasonably
cooperate with the other party to mitigate harm caused as a result of a force majeure event in
a manner that is reasonably acceptable to the party to whose cooperation is sought.

16.2. Severability. If any provision of this Agreement is held by a court of competent
jurisdiction to be unenforceable, such provision shall be deemed null and void, and the
remainder of the Agreement shall continue to be in full force and effect, while the parties
shall negotiate in good faith to replace the provision with another enforceable one reflecting
as closely as possible the parties initial intention.

[*] Confidential information in this Exhibit has been omitted and filed separately with the Commission.
Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

16.3 Relationship of the Parties. Each of the parties shall at all times during the
term of this Agreement act as, and shall represent itself to be, an independent contractor.
Neither party shall have any right or authority to assume or create any obligations or to make
any representations or warranties on behalf of the other party whether express or implied, or
to bind the other party in a respect whatsoever. Neither party shall be liable to any third
party in any way for any engagement, obligation, contract, representation or transaction or
for any act or omission to an act of the other, and each party shall indemnify the other and
hold it harmless against and from any liabilities as aforesaid.

16.4 Governing Law. The construction, interpretation and performance of this Agreement
and all transactions under it shall be governed by the laws of the State of Israel (without
giving effect to conflict of laws provisions), and both parties consent to exclusive
jurisdiction by the competent courts of the Tel Aviv district. This Agreement shall not be
governed by the provisions of the 1980 United Nations Convention on Contracts for the
International Sale of Goods.

16.5 Choice of Language. The original of this Agreement has been written in English.
Each party waives any right it may have under the laws of either party’s country to have this
Agreement written in the language of either party’s country. Further any notices given to
either party as required by this Agreement shall be written in the English language.

16.6 Entire Agreement. No amendment of this Agreement will be valid unless made in
writing signed by a duly authorized representative of both parties. No provision of this
Agreement will be deemed waived and breach or default excused unless the waiver or excuse is
in writing and signed by the party issuing it. The terms and conditions contained in this
Agreement supersede all prior oral or written understandings between the parties and shall
constitute the entire agreement between them concerning the subject matter of this Agreement.
No additional terms in any Purchase Order or other document to be exchanged between the
parties pursuant to this Agreement shall alter this Agreement and this Agreement shall
supersede such terms unless expressly indicated otherwise and in writing by both parties.

16.7 Assignment: This Agreement shall be binding upon and inure to the benefit of each
party’s successors and assigns. Notwithstanding the foregoing, neither party shall assign, by
operation of law or otherwise, any of its rights or obligations hereunder nor permit the same
to be assigned by operation of law, except with the other party’s prior written consent, which
will not be unreasonably withheld, provided however, that nothing contained herein shall
restrict the ability of each party to assign by operation of law or otherwise, this Agreement
or any of its rights or obligations hereunder, nor prohibit the same to be assigned by
operation of law, or otherwise to a successor-in-interest to it, or to a person or entity who
acquires all or substantially all of the assets or business of either Party, whether by sale,
merger or otherwise or to an affiliate that agrees to be bound by all of the terms and
conditions in this Agreement, provided that FLEXTRONIC or Veraz, as the case may be,
guarantees the undertakings and obligations of any such affiliate hereunder.

If FLEXTRONICS shall have, in good faith, grounds to assume that any person or entity who
acquires all or substantially all of the assets or business of Veraz, may not be able to
comply with all Veraz obligations in accordance with this Agreement, then FLEXTRONICS will
have the right to ask for guarantees, in good faith, to secure such compliance with said
obligations.

[*] Confidential information in this Exhibit has been omitted and filed separately with the Commission.
Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

16.8 Confidentiality. Proprietary information disclosed by either party to the other
in connection with this Agreement must be used only for the purpose of this Agreement and for
no other purpose, and shall not be utilized by the recipient party in competition with the
other party and shall be protected by the recipient party from divulgement to others with the
degree of care given to its own proprietary information that is intended to be protected from
disclosure. The obligations in this Section 16.8 shall continue for both parties for a period
of five (5) years after the termination of this Agreement or any renewal thereof. In this
Agreement “Proprietary Information” shall mean all non-public schematics, drawings,
specifications and manuals, and all other technical and business and financial information
provided by a party to the other party during the term of, or in connection with the
negotiation, performance or enforcement of this Agreement. The parties will only disclose the
terms of this Agreement as part of their ordinary business and commercial activity. For the
removal of doubt and for the sake of clarification only, nothing herein shall derogate from
either party’s right to disclose the terms of this Agreement as part of a due diligence or to
auditors. Notwithstanding the aforesaid, the terms of this Agreement shall not be disclosed to
either parties’ business partners: customers, potential customers and suppliers, or to its
competitors, except with the other party’s prior written consent, which shall not be
unreasonably withheld. Notwithstanding the foregoing, “Proprietary Information” shall not
include any information which the receiving party can show: (i) is now or subsequently becomes
legally and publicly available without breach of this Agreement by the receiving party, (ii)
was rightfully in the possession of the receiving party without any obligation of
confidentiality prior to receiving it from the disclosing party, (iii) was rightfully obtained
by the receiving party from a source other than the disclosing party without any obligation of
confidentiality, or (iv) was developed by or for the receiving party independently and without
reference to such information that can be shown by documentary evidence . The receiving party
agrees to take appropriate measures by instruction and written agreement prior to disclosure
of Proprietary Information to its employees and contractors to prevent unauthorized use or
disclosure. Proprietary Information must be returned by the receiving party upon termination
or expiration of this Agreement. Proprietary Information may be disclosed to the extent
necessary to comply with an order of an administrative agency or court of competent
jurisdiction provided, however, that the party so required to disclose Proprietary Information
shall provide prior written notice thereof to the other party in sufficient time (to the
extent possible) to enable that party to seek a protective order or otherwise prevent such
disclosure.

16.9 Injunctive Relief. In the event of a breach or violation of the provisions in
Sections 15 and 16.8, each party hereby acknowledges and agrees that the harm suffered by the
affected party would not be compensable by monetary damages alone and, accordingly, that the
affected party shall, in addition to any other available legal or equitable remedies, be
entitled to seek an injunction or other equitable relief against the other party in connection
with any breach or violation of any such provisions.

16.10 Notices. Any notice or other communication required or which may be given
hereunder shall be in writing and either delivered personally to an officer of the addressee
or mailed, certified or registered mail, postage prepaid, or by facsimile transmission (with a
confirming copy sent by registered mail) and shall be deemed given (i) when so delivered
personally; (ii) if mailed, five (5) days after the time of mailing; (iii) if faxed, when the
copy sent by the mail was deemed delivered. Notices may be sent

[*] Confidential information in this Exhibit has been omitted and filed separately with the Commission.
Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

through an email, but shall be deemed given only if the recipient approves the receipt of
such email by a return email.

Addresses for notices are as follows:

	 	 	 
	Veraz Networks, Ltd.

	 	FLEXTRONICSs (Israel)
	30 Hasivim Street

	 	Ltd.
	Petah Tikva 49133, Israel

	 	FLEXTRONICS
	Attention: General Manager

	 	1st Hatahsia Street
	Fax: 972-3-928-7010

	 	Migdal-Haemek 23108
	 

	 	P.O. Box 867
	 

	 	Israel
	 

	 	Phone: +972.4.6448200
	 

	 	Fax: +972.4.6040850
	 

	 	Attn: [       ]

16.11 Limitation of Liability. EXCEPT WITH RESPECT TO DAMAGES ARISING FROM BREACHES,
KNOWINGLY, OR RESULTING FROM GROSS NEGLIGENCE, COMMITTED BY EITHER PARTY OF CONFIDENTIALITY
OBLIGATIONS, WHERE THE FOLLOWING LIMITATION OF LIABILITY SHALL BE REPLACED BY A LIMITATION OF
LIABILITY IN AN AGGREGATE AMOUNT OF $ [*]. NEITHER PARTY SHALL BE LIABLE TO THE OTHER UNDER
ANY CONTRACT, STRICT LIABILITY, NEGLIGENCE OR OTHER THEORY FOR ANY INDIRECT, INCIDENTAL OR
CONSEQUENTIAL DAMAGES INCLUDING WITHOUT LIMITATION LOST PROFITS IN CONNECTION WITH THE SUBJECT
MATTER OF THIS AGREEMENT OR ANY PURCHASE ORDER IRRESPECTIVE OF WHETHER SUCH PARTY HAD ADVANCE
NOTICE OR KNOWLEDGE OF THE POSSIBILITY OF SUCH DAMAGES. NOTWITHSTANDING THE FOREGOING, THIS
SECTION SHALL NOT LIMIT EITHER PARTY’S LIABILITY FOR INJURY TO A PERSON IF IT MAY NOT BE
LIMITED UNDER LAW.

16.12 Counterparts. This Agreement may be executed in two or more counterparts, each
of which will be an original and together which will constitute one and the same instrument.

16.13 Order of Precedence. In the event of a contradiction between any of the
provisions of this Agreement and the provisions of any of the Exhibits attached hereto, the
provisions of this Agreement shall prevail.

[SIGNATURE PAGE FOLLOWS]

[*] Confidential information in this Exhibit has been omitted and filed separately with the Commission.
Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

IN WITNESS WHEREOF, the parties have caused this Agreement to be signed by their respective
duly authorized representatives as of the date first above written.

	 	 	 	 	 
	Veraz Networks, Ltd.	 	 
	 
	 	 	 	 
	By:

	 	/s/ Israel Zohar	 	 
	 

	 	 	 	 
	Name:

	 	Israel Zohar	 	 
	 

	 	 	 	 
	Title:

	 	GM Veraz Networks, Ltd.	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	FLEXTRONICS (Israel) Ltd.	 	 
	 
	 	 	 	 
	By:

	 	/s/ Shaibel Ravi Redria Tzahi	 	 
	 

	 	 	 	 
	Name:

	 	Shaibel Ravi Redria Tzahi	 	 
	 

	 	 	 	 
	Title:

	 	GM Flextronics (Israel) Ltd.	 	 
	 

	 	 	 	 

[Signature Page to Master Manufacturing Agreement]

[*] Confidential information in this Exhibit has been omitted and filed separately with the Commission.
Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED

Exhibit 1.1 — VoIP Products

	 	 	 
	 

	 	I-Gate
 4000
	 

	 	I-Gate 4000
 PRO
	 

	 	I-Gate 4000
 Edge

[*] Confidential information in this Exhibit has been omitted and filed separately with the Commission. Confidential
treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

Exhibit 2 — Product Forecast Form

	 	 	 	 	 	 	 
	Item Part Number	 	Forecast Date	 	Forecast Quantity	Item Description
	 
	 	 	 	 	 	 

[*] Confidential information in this Exhibit has been omitted and filed separately with
the Commission. Confidential treatment has been requested with respect to the omitted
portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

Exhibit 3.1.2 Components Cancellation Window

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH100008
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH100050
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH100051
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH100174
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	60	 	 	[*]
	VR-CH100182
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH100257
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH100269
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH100270
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH100299
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH100313
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH100319
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH100334
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH100419
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	35	 	 	[*]
	VR-CH100441
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH100624
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH100750
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH100828
	 	[*]	 	[*]	 	[*]	 	 	100	 	 	 	30	 	 	[*]
	VR-CH100853
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH100891
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	0	 	 	[*]
	VR-CH100948
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH100976
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH100986
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH101100
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH101101
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH101121
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH101123
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH101135
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH101161
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH101193
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH101199
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH101203
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH101287
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH101288
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH101304
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH101320
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH101326
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH101374
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH101418
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	30	 	 	[*]
	VR-CH101420
	 	[*]	 	[*]	 	[*]	 	 	52	 	 	 	60	 	 	[*]
	VR-CH101466
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH101482
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH101497
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-CH101521
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH101524
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-CH101572
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH101610
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	60	 	 	[*]
	VR-CH101616
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH101617
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH101669
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH101676
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH101680
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH101748
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH101769
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH101838
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH101846
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH101864
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH101878
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH101928
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH101929
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH101933
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH101935
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH101939
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH101940
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH101943
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH101970
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH102055
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH102133
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH102147
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH102184
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH102199
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH102270
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH102271
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH102288
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH102336
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH102351
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH102352
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH102353
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH102354
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH102355
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH102356
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH102364
	 	[*]	 	[*]	 	[*]	 	 	180	 	 	 	30	 	 	[*]
	VR-CH102375
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH102420
	 	[*]	 	[*]	 	[*]	 	 	52	 	 	 	60	 	 	[*]
	VR-CH102436
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH102460
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH102465
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	7	 	 	[*]
	VR-CH102473
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH102481
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH102504
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH102505
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH102510
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH102533
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH102534
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH102535
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH102554
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH102614
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH102618
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH102620
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH102625
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH102649
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH102693
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH102704
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH102707
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH102794
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH102795
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH102822
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH103090
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH103092
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-CH103298
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH103376
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	0	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH103378
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH103387
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	60	 	 	[*]
	VR-CH103397
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH103847
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	0	 	 	[*]
	VR-CH103939
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH103940
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	60	 	 	[*]
	VR-CH103941
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	60	 	 	[*]
	VR-CH103942
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	60	 	 	[*]
	VR-CH103943
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	60	 	 	[*]
	VR-CH103948
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH104021
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH104022
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH104068
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH104084
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH104121
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH104459
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH104461
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH104750
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH104762
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH104786
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH104787
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	45	 	 	[*]
	VR-CH104800
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH104801
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH104819
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH104840
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH104852
	 	[*]	 	[*]	 	[*]	 	 	52	 	 	 	60	 	 	[*]
	VR-CH104853
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH104875
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH104876
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH104877
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH104878
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH104943
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-CH105177
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH105596
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH105677
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH105678
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH105791
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH105845
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH105848
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH105849
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH105863
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH105864
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH105867
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	7	 	 	[*]
	VR-CH105873
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH105887
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH14144
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	0	 	 	[*]
	VR-CH14186
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	0	 	 	[*]
	VR-CH14278
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH14279
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH14300
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	0	 	 	[*]
	VR-CH14301
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	0	 	 	[*]
	VR-CH14302
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	0	 	 	[*]
	VR-CH14324
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	0	 	 	[*]
	VR-CH14880
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH16373
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH16374
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH16530
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	0	 	 	[*]
	VR-CH200094
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH200095
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH200128
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH200130
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH200132
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH200134
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH200240
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH200242
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH200243
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH200772
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH200773
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH200775
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH200776
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH200777
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH200778
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH200779
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH200780
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH200781
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH200782
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH200783
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH200798
	 	[*]	 	[*]	 	[*]	 	 	42	 	 	 	30	 	 	[*]
	VR-CH200855
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH200874
	 	[*]	 	[*]	 	[*]	 	 	80	 	 	 	30	 	 	[*]
	VR-CH200885
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH200887
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH200926
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH201003
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH201137
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH201150
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH201282
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH201284
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH201498
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH201531
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH201576
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH201873
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH202021
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH202300
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH202301
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH202302
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH202310
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH202368
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	35	 	 	[*]
	VR-CH202371
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH202372
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH202432
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH202498
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH202499
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH202541
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH202576
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH202577
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH202603
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH202616
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH202689
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH202744
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH202798
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	30	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH202871
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH202873
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	1	 	 	[*]
	VR-CH202888
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH202968
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH203183
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH203302
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	30	 	 	[*]
	VR-CH203344
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH203386
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH203424
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH203427
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH203429
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH203440
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH203459
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH203517
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH203526
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH203533
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH203605
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH203621
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH203682
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH203683
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH203698
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH203706
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH203720
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH203722
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH203725
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	45	 	 	[*]
	VR-CH203726
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH203751
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH203793
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH203805
	 	[*]	 	[*]	 	[*]	 	 	70	 	 	 	30	 	 	[*]
	VR-CH203806
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH203808
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH203815
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH203816
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH203890
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH203917
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH203918
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-CH203919
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH203920
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-CH203972
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH203975
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH203998
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH204012
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204029
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH204057
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH204074
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH204083
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH204115
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204116
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH204122
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH204155
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204189
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH204193
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204236
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH204244
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204248
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204252
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204330
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204332
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204337
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH204339
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH204368
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH204373
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH204374
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH204376
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204407
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH204443
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204444
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204449
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204485
	 	[*]	 	[*]	 	[*]	 	 	52	 	 	 	60	 	 	[*]
	VR-CH204494
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH204497
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	60	 	 	[*]
	VR-CH204526
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH204535
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	35	 	 	[*]
	VR-CH204537
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	7	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH204546
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH204593
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH204629
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204647
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH204657
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH204668
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH204676
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH204679
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH204689
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204691
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH204692
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH204706
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH204744
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH204798
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	45	 	 	[*]
	VR-CH204800
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH204803
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	45	 	 	[*]
	VR-CH204804
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH204807
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	15	 	 	[*]
	VR-CH204859
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204860
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204861
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH204865
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH204866
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	60	 	 	[*]
	VR-CH204870
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH204871
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH204872
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	7	 	 	[*]
	VR-CH204880
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH204896
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH204904
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204909
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204914
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204915
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204917
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204918
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204921
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204922
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204927
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH204931
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH204975
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204989
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH204995
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH204996
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH204998
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH205010
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH205023
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH205024
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH205026
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH205039
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH205055
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH205087
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH205088
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH205103
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH205128
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH205136
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	7	 	 	[*]
	VR-CH205219
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH205221
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH205234
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH205235
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH205244
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH205250
	 	[*]	 	[*]	 	[*]	 	 	70	 	 	 	30	 	 	[*]
	VR-CH205273
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH205276
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH205301
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH205333
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH205342
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH205344
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH205363
	 	[*]	 	[*]	 	[*]	 	 	70	 	 	 	30	 	 	[*]
	VR-CH205365
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH205392
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH205393
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	7	 	 	[*]
	VR-CH205400
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	30	 	 	[*]
	VR-CH205401
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH205402
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH205405
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH205417
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH205426
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH205435
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH205439
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	60	 	 	[*]
	VR-CH205547
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH205563
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH205578
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	45	 	 	[*]
	VR-CH205614
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH205631
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH205634
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH205643
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH205644
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH205649
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH205650
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH205651
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH205754
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	60	 	 	[*]
	VR-CH205767
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH205782
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	60	 	 	[*]
	VR-CH205807
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	30	 	 	[*]
	VR-CH205809
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH205815
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH205825
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH205867
	 	[*]	 	[*]	 	[*]	 	 	72	 	 	 	30	 	 	[*]
	VR-CH205874
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH205887
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	60	 	 	[*]
	VR-CH205910
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH205911
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH205916
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH205917
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH205955
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH205956
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH205957
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH205975
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH206040
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH206094
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-CH206096
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH206103
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH206161
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH206169
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH206259
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH206267
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	0	 	 	[*]
	VR-CH206291
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH206310
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH206331
	 	[*]	 	[*]	 	[*]	 	 	20	 	 	 	0	 	 	[*]
	VR-CH206367
	 	[*]	 	[*]	 	[*]	 	 	100	 	 	 	30	 	 	[*]
	VR-CH206369
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH206404
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	60	 	 	[*]
	VR-CH206405
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH206433
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH206455
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH206462
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH206470
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH206482
	 	[*]	 	[*]	 	[*]	 	 	54	 	 	 	30	 	 	[*]
	VR-CH206501
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH206515
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	45	 	 	[*]
	VR-CH206520
	 	[*]	 	[*]	 	[*]	 	 	85	 	 	 	30	 	 	[*]
	VR-CH206525
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH206630
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH206631
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH206655
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	0	 	 	[*]
	VR-CH206715
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH206738
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH206739
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH206753
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH206765
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH206770
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	35	 	 	[*]
	VR-CH206775
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH206778
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH206787
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH206812
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH206869
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH206918
	 	[*]	 	[*]	 	[*]	 	 	20	 	 	 	30	 	 	[*]
	VR-CH206920
	 	[*]	 	[*]	 	[*]	 	 	20	 	 	 	0	 	 	[*]
	VR-CH206962
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH206996
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH207006
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH207019
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH207023
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH207034
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH207060
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH207061
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH207081
	 	[*]	 	[*]	 	[*]	 	 	80	 	 	 	45	 	 	[*]
	VR-CH207100
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	7	 	 	[*]
	VR-CH207121
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH207189
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	30	 	 	[*]
	VR-CH207233
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH207252
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH207286
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH207288
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-CH207298
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH207318
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH207338
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH207361
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH207389
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH207425
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH207437
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH207448
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH207450
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH207454
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH207482
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH207483
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH207490
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH207522
	 	[*]	 	[*]	 	[*]	 	 	52	 	 	 	30	 	 	[*]
	VR-CH207525
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH207551
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	60	 	 	[*]
	VR-CH207554
	 	[*]	 	[*]	 	[*]	 	 	120	 	 	 	30	 	 	[*]
	VR-CH207556
	 	[*]	 	[*]	 	[*]	 	 	85	 	 	 	30	 	 	[*]
	VR-CH207571
	 	[*]	 	[*]	 	[*]	 	 	85	 	 	 	30	 	 	[*]
	VR-CH207621
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH207630
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH207635
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	60	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH207647
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH207751
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH207931
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH207932
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH208012
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH208015
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	60	 	 	[*]
	VR-CH208016
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	60	 	 	[*]
	VR-CH208021
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH208035
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	30	 	 	[*]
	VR-CH208039
	 	[*]	 	[*]	 	[*]	 	 	52	 	 	 	60	 	 	[*]
	VR-CH208062
	 	[*]	 	[*]	 	[*]	 	 	100	 	 	 	30	 	 	[*]
	VR-CH208109
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	7	 	 	[*]
	VR-CH208116
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	30	 	 	[*]
	VR-CH208157
	 	[*]	 	[*]	 	[*]	 	 	90	 	 	 	30	 	 	[*]
	VR-CH208186
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	30	 	 	[*]
	VR-CH208222
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH208314
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	60	 	 	[*]
	VR-CH208367
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	60	 	 	[*]
	VR-CH208378
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH208399
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH208450
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	60	 	 	[*]
	VR-CH208495
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH208502
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH208536
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	30	 	 	[*]
	VR-CH208537
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH208540
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH208543
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH208597
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH208598
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH208678
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH208683
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH208686
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH208700
	 	[*]	 	[*]	 	[*]	 	 	75	 	 	 	30	 	 	[*]
	VR-CH208743
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH208746
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	60	 	 	[*]
	VR-CH208748
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH208757
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	0	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH208765
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH208778
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	60	 	 	[*]
	VR-CH208870
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	45	 	 	[*]
	VR-CH208899
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH208931
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH208959
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH209040
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	60	 	 	[*]
	VR-CH209057
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH209061
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH209114
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	60	 	 	[*]
	VR-CH209129
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH209153
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH209156
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH209157
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH209165
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH209168
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH209205
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH209324
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	60	 	 	[*]
	VR-CH209335
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH209389
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	30	 	 	[*]
	VR-CH209406
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH209444
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH209467
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH209469
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH209471
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH209476
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH209480
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH209482
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH209483
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH209484
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH209485
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH209486
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH209487
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH209489
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH209493
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH209495
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH209496
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH209498
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH209499
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH209502
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH209503
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH209504
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH209505
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH209506
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH209509
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH209511
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH209514
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH209521
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH209537
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH209553
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH209603
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH209605
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH209622
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH209640
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH209705
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH209751
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH209761
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH209765
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH209771
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH209772
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH209786
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH209787
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH209822
	 	[*]	 	[*]	 	[*]	 	 	75	 	 	 	30	 	 	[*]
	VR-CH209823
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH209826
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH209828
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	45	 	 	[*]
	VR-CH209830
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH209850
	 	[*]	 	[*]	 	[*]	 	 	70	 	 	 	45	 	 	[*]
	VR-CH209879
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH209901
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	60	 	 	[*]
	VR-CH209919
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH209928
	 	[*]	 	[*]	 	[*]	 	 	70	 	 	 	60	 	 	[*]
	VR-CH209930
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH209980
	 	[*]	 	[*]	 	[*]	 	 	75	 	 	 	30	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH210026
	 	[*]	 	[*]	 	[*]	 	 	80	 	 	 	30	 	 	[*]
	VR-CH210038
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH210040
	 	[*]	 	[*]	 	[*]	 	 	70	 	 	 	30	 	 	[*]
	VR-CH210057
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH210064
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	30	 	 	[*]
	VR-CH210069
	 	[*]	 	[*]	 	[*]	 	 	75	 	 	 	30	 	 	[*]
	VR-CH210105
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH210123
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH210131
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH210157
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH210275
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH210301
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	35	 	 	[*]
	VR-CH210325
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH210351
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH210379
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH210487
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH210634
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH210647
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH210648
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH210686
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH210687
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-CH210715
	 	[*]	 	[*]	 	[*]	 	 	20	 	 	 	0	 	 	[*]
	VR-CH210740
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH210777
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	35	 	 	[*]
	VR-CH210783
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	30	 	 	[*]
	VR-CH210792
	 	[*]	 	[*]	 	[*]	 	 	70	 	 	 	60	 	 	[*]
	VR-CH210810
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH210812
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH210813
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH210820
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH210856
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH210969
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	0	 	 	[*]
	VR-CH210979
	 	[*]	 	[*]	 	[*]	 	 	70	 	 	 	60	 	 	[*]
	VR-CH210984
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	35	 	 	[*]
	VR-CH211010
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH211019
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH211030
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH211049
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH211068
	 	[*]	 	[*]	 	[*]	 	 	70	 	 	 	60	 	 	[*]
	VR-CH211072
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	35	 	 	[*]
	VR-CH211077
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH211078
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH211102
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH211126
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH211158
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH211165
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH211207
	 	[*]	 	[*]	 	[*]	 	 	20	 	 	 	0	 	 	[*]
	VR-CH211223
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	35	 	 	[*]
	VR-CH211265
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH211273
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH211275
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH211277
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	35	 	 	[*]
	VR-CH211283
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH211284
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH211285
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH211286
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH211287
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH211288
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH211289
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH211302
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH211366
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH211392
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH211407
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH211408
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH211415
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH211451
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	30	 	 	[*]
	VR-CH211452
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	30	 	 	[*]
	VR-CH211455
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH211456
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH211457
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH211458
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH211460
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH211461
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH211462
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH211463
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH211464
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH211473
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH211521
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH211568
	 	[*]	 	[*]	 	[*]	 	 	70	 	 	 	60	 	 	[*]
	VR-CH211572
	 	[*]	 	[*]	 	[*]	 	 	70	 	 	 	60	 	 	[*]
	VR-CH211589
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH211619
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH211620
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH211649
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH211684
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH211685
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH211734
	 	[*]	 	[*]	 	[*]	 	 	72	 	 	 	30	 	 	[*]
	VR-CH211761
	 	[*]	 	[*]	 	[*]	 	 	85	 	 	 	60	 	 	[*]
	VR-CH211764
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	45	 	 	[*]
	VR-CH211766
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH211787
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH211790
	 	[*]	 	[*]	 	[*]	 	 	72	 	 	 	30	 	 	[*]
	VR-CH211791
	 	[*]	 	[*]	 	[*]	 	 	72	 	 	 	30	 	 	[*]
	VR-CH211814
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH211815
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH211825
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH211826
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH211827
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH211868
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH211887
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH211920
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH211924
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH211932
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH211935
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH211937
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH211943
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH212082
	 	[*]	 	[*]	 	[*]	 	 	75	 	 	 	30	 	 	[*]
	VR-CH212101
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH212102
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	45	 	 	[*]
	VR-CH212103
	 	[*]	 	[*]	 	[*]	 	 	75	 	 	 	30	 	 	[*]
	VR-CH212105
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH212148
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH212171
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH212211
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH212226
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH212250
	 	[*]	 	[*]	 	[*]	 	 	70	 	 	 	60	 	 	[*]
	VR-CH212324
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH212399
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH212465
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH212530
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH212531
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH212546
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH212568
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH212570
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH212571
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	30	 	 	[*]
	VR-CH212589
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH212681
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH212683
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH212725
	 	[*]	 	[*]	 	[*]	 	 	70	 	 	 	60	 	 	[*]
	VR-CH212751
	 	[*]	 	[*]	 	[*]	 	 	78	 	 	 	30	 	 	[*]
	VR-CH212768
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH212773
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-CH212778
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH212815
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH212824
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH212865
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH212866
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH212965
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH213039
	 	[*]	 	[*]	 	[*]	 	 	70	 	 	 	60	 	 	[*]
	VR-CH213058
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH213060
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH213061
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH213066
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH213088
	 	[*]	 	[*]	 	[*]	 	 	70	 	 	 	60	 	 	[*]
	VR-CH213094
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH213097
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	45	 	 	[*]
	VR-CH213137
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH213140
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH213188
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH213190
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH213192
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH213200
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH213217
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH213228
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH213232
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH213275
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	60	 	 	[*]
	VR-CH213308
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH213313
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH213314
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH213315
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH213316
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH213319
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	7	 	 	[*]
	VR-CH213377
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH213378
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH213379
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH213380
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH213383
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH213384
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH213385
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH213386
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH213389
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH213397
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH213398
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH213449
	 	[*]	 	[*]	 	[*]	 	 	120	 	 	 	30	 	 	[*]
	VR-CH213512
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH213516
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH213529
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	60	 	 	[*]
	VR-CH213553
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH213593
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH213601
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH213685
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH213686
	 	[*]	 	[*]	 	[*]	 	 	70	 	 	 	60	 	 	[*]
	VR-CH213687
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH213688
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	35	 	 	[*]
	VR-CH213689
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	35	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH213697
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH213698
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH213713
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH213716
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH213718
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH213724
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH213742
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH213746
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH213747
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH213748
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH213751
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH213753
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH213755
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH213774
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH213780
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	60	 	 	[*]
	VR-CH213822
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-CH213826
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH213827
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH213837
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH213842
	 	[*]	 	[*]	 	[*]	 	 	70	 	 	 	60	 	 	[*]
	VR-CH213847
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH213849
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH22615
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH23243
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH27829
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH28022
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH28050
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH28168
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH28169
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	30	 	 	[*]
	VR-CH28304
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH28308
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-CH28477
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH28502
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH28641
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH28961
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH28962
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH28964
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH29232
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH29285
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH29298
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH29305
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH29385
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH29387
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH29388
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH29394
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH29395
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH29396
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH29397
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH29398
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH29400
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH29401
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH29402
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH29403
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH29473
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH29476
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH300119
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH300121
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH300125
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH300126
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH300127
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH300233
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH300322
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH300404
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH300405
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH300423
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH300479
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH300485
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH300489
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH300573
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH300678
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH300748
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH300851
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH301026
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	60	 	 	[*]
	VR-CH301054
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH301081
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH301177
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	30	 	 	[*]
	VR-CH301272
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH301273
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH301287
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH301325
	 	[*]	 	[*]	 	[*]	 	 	49	 	 	 	30	 	 	[*]
	VR-CH301358
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH301366
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH301378
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH301381
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	0	 	 	[*]
	VR-CH301384
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH301399
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH301483
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH301517
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH301518
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH301527
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH301529
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH301530
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH301531
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH301606
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH301620
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH301838
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH301854
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	30	 	 	[*]
	VR-CH301855
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	30	 	 	[*]
	VR-CH302174
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-CH302223
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH302229
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH302238
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH302239
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH302240
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH302241
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH302322
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH302346
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH302411
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH302415
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH302424
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH302567
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH302588
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH302596
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH302777
	 	[*]	 	[*]	 	[*]	 	 	80	 	 	 	30	 	 	[*]
	VR-CH302805
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH302860
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH302874
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	30	 	 	[*]
	VR-CH302921
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH302988
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH303136
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH303205
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH303248
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH303263
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH303297
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH303330
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH303346
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH303353
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH303414
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH303420
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH303473
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH303517
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH303538
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH303540
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH303568
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH303570
	 	[*]	 	[*]	 	[*]	 	 	80	 	 	 	60	 	 	[*]
	VR-CH303778
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH303845
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH303890
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH303892
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH303893
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH303909
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH303910
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH303913
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH303923
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH303934
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH303935
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH303939
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH303940
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH303951
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	30	 	 	[*]
	VR-CH303956
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH303958
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH303999
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH304049
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH304050
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH304060
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH304072
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH304076
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH304077
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH304079
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH304090
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-CH304099
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	60	 	 	[*]
	VR-CH304101
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH304107
	 	[*]	 	[*]	 	[*]	 	 	80	 	 	 	60	 	 	[*]
	VR-CH304108
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH304116
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH304126
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH304127
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH304128
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH304147
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH304180
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH304182
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH304183
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH304198
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	30	 	 	[*]
	VR-CH304259
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-CH304305
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH304347
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH304365
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH304387
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH304424
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	30	 	 	[*]
	VR-CH304434
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH304512
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH304630
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH304634
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH304675
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH304697
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH304709
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH304724
	 	[*]	 	[*]	 	[*]	 	 	80	 	 	 	60	 	 	[*]
	VR-CH304768
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH304775
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH304799
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH304800
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH304801
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH304802
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH304803
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH304804
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH304823
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH304824
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH304843
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH304849
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH304891
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH304927
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH304928
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH304953
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH305003
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH305081
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH305086
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH305091
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH305138
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH305164
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH305178
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH305179
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH305184
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	90	 	 	[*]
	VR-CH305214
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH305222
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH305233
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	30	 	 	[*]
	VR-CH305247
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH305250
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH305259
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH305260
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH305276
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH305305
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH305339
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	60	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH305343
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH305356
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH305357
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	0	 	 	[*]
	VR-CH305398
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH305412
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH305415
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH305416
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH305417
	 	[*]	 	[*]	 	[*]	 	 	52	 	 	 	30	 	 	[*]
	VR-CH305441
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH305456
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH305465
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH305509
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH305516
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH305525
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH305532
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH305557
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	35	 	 	[*]
	VR-CH305589
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH305610
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH305616
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH305626
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH305629
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH305630
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH305642
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH305649
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH305656
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH305658
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH305711
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH305737
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH305757
	 	[*]	 	[*]	 	[*]	 	 	70	 	 	 	30	 	 	[*]
	VR-CH305759
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH305774
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH305776
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH305818
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH30594
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH305944
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH306007
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH306014
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH306018
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH306100
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH306106
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH306107
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH306112
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH306118
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH306175
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	0	 	 	[*]
	VR-CH306329
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH306369
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH306385
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH306404
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH306438
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH306717
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH306767
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH306809
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH306815
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH306850
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH306954
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH307130
	 	[*]	 	[*]	 	[*]	 	 	52	 	 	 	60	 	 	[*]
	VR-CH307184
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH307455
	 	[*]	 	[*]	 	[*]	 	 	80	 	 	 	30	 	 	[*]
	VR-CH307478
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH307556
	 	[*]	 	[*]	 	[*]	 	 	20	 	 	 	0	 	 	[*]
	VR-CH307622
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH307685
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH307692
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH307693
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH307715
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH307718
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH307735
	 	[*]	 	[*]	 	[*]	 	 	52	 	 	 	60	 	 	[*]
	VR-CH307737
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	60	 	 	[*]
	VR-CH307738
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	60	 	 	[*]
	VR-CH307745
	 	[*]	 	[*]	 	[*]	 	 	72	 	 	 	30	 	 	[*]
	VR-CH307750
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH307773
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH307775
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH307776
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH307777
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH307816
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH307831
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH307862
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-CH307863
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-CH307909
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH307924
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH307927
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	35	 	 	[*]
	VR-CH307947
	 	[*]	 	[*]	 	[*]	 	 	75	 	 	 	30	 	 	[*]
	VR-CH308197
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	30	 	 	[*]
	VR-CH308199
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH308205
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH308219
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	7	 	 	[*]
	VR-CH308253
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	30	 	 	[*]
	VR-CH308257
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH308261
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH308265
	 	[*]	 	[*]	 	[*]	 	 	72	 	 	 	30	 	 	[*]
	VR-CH308324
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH308338
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH308339
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	60	 	 	[*]
	VR-CH308340
	 	[*]	 	[*]	 	[*]	 	 	20	 	 	 	0	 	 	[*]
	VR-CH308341
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH308390
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH308391
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH308392
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH308393
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH308394
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH308423
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH308437
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH308439
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH308440
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH308441
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH308447
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH308461
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH308487
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH308510
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH308513
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH308670
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH308673
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH308675
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH308676
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH308677
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH308706
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH308710
	 	[*]	 	[*]	 	[*]	 	 	90	 	 	 	30	 	 	[*]
	VR-CH308723
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH308727
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH308736
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH309023
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH309073
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH309177
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH309178
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH309184
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH309208
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH309219
	 	[*]	 	[*]	 	[*]	 	 	20	 	 	 	30	 	 	[*]
	VR-CH309247
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH309260
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH309294
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH309301
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH309331
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH309382
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	60	 	 	[*]
	VR-CH309383
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	60	 	 	[*]
	VR-CH309418
	 	[*]	 	[*]	 	[*]	 	 	52	 	 	 	60	 	 	[*]
	VR-CH309432
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH309435
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH309469
	 	[*]	 	[*]	 	[*]	 	 	1	 	 	 	0	 	 	[*]
	VR-CH309470
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH309478
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH309479
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	35	 	 	[*]
	VR-CH309480
	 	[*]	 	[*]	 	[*]	 	 	20	 	 	 	0	 	 	[*]
	VR-CH309484
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH309495
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH309505
	 	[*]	 	[*]	 	[*]	 	 	1	 	 	 	30	 	 	[*]
	VR-CH309530
	 	[*]	 	[*]	 	[*]	 	 	52	 	 	 	60	 	 	[*]
	VR-CH309531
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	60	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH309584
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH309586
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH309587
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH309634
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH309653
	 	[*]	 	[*]	 	[*]	 	 	1	 	 	 	0	 	 	[*]
	VR-CH309682
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH309705
	 	[*]	 	[*]	 	[*]	 	 	70	 	 	 	30	 	 	[*]
	VR-CH309710
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH309712
	 	[*]	 	[*]	 	[*]	 	 	20	 	 	 	30	 	 	[*]
	VR-CH309742
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH309743
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH309755
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH309800
	 	[*]	 	[*]	 	[*]	 	 	20	 	 	 	0	 	 	[*]
	VR-CH309804
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH309808
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH309810
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH309811
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH309812
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH309826
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH309865
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	30	 	 	[*]
	VR-CH309899
	 	[*]	 	[*]	 	[*]	 	 	20	 	 	 	0	 	 	[*]
	VR-CH309913
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH309944
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	30	 	 	[*]
	VR-CH309949
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH309967
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH309968
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH309978
	 	[*]	 	[*]	 	[*]	 	 	90	 	 	 	30	 	 	[*]
	VR-CH309979
	 	[*]	 	[*]	 	[*]	 	 	90	 	 	 	30	 	 	[*]
	VR-CH309980
	 	[*]	 	[*]	 	[*]	 	 	90	 	 	 	30	 	 	[*]
	VR-CH310000
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH310053
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH310109
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH310126
	 	[*]	 	[*]	 	[*]	 	 	20	 	 	 	0	 	 	[*]
	VR-CH310131
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	60	 	 	[*]
	VR-CH310189
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH310198
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH310275
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH310277
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH310294
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH310356
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	30	 	 	[*]
	VR-CH310366
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH310367
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH310369
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-CH310370
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-CH310372
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH310447
	 	[*]	 	[*]	 	[*]	 	 	52	 	 	 	60	 	 	[*]
	VR-CH310448
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH310453
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH310458
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH310471
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH310563
	 	[*]	 	[*]	 	[*]	 	 	20	 	 	 	0	 	 	[*]
	VR-CH310564
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-CH310566
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	60	 	 	[*]
	VR-CH310601
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH31066
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH310671
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH310678
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH310720
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH31074
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH310749
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH31075
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH310753
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH310765
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH310788
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH31080
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH310825
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH310950
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH310951
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH310952
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH310963
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH310968
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH310981
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH311020
	 	[*]	 	[*]	 	[*]	 	 	20	 	 	 	30	 	 	[*]
	VR-CH311044
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH311103
	 	[*]	 	[*]	 	[*]	 	 	90	 	 	 	30	 	 	[*]
	VR-CH311109
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH311142
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-CH311150
	 	[*]	 	[*]	 	[*]	 	 	52	 	 	 	60	 	 	[*]
	VR-CH311176
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH311189
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH311190
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH311191
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH311203
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH311209
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH311213
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH311215
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH311219
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH311220
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH311221
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH311271
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-CH311274
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH311482
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH311491
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	60	 	 	[*]
	VR-CH311574
	 	[*]	 	[*]	 	[*]	 	 	20	 	 	 	30	 	 	[*]
	VR-CH311575
	 	[*]	 	[*]	 	[*]	 	 	1	 	 	 	30	 	 	[*]
	VR-CH311579
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH311594
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH311616
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH311620
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH311621
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH311634
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH311651
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-CH311671
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH311672
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH311673
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH311759
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH32846
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-CH33287
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH34295
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH34394
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH34719
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH34782
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH35105
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH35582
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH35583
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH36083
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH36198
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH37484
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH37484R
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH37485
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH37622
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH39575
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	60	 	 	[*]
	VR-CH39857
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH400084
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH40118
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH40599
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH41427
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH42573
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH42593
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-CH44525
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH44543
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH47439
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH47677
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH48244
	 	[*]	 	[*]	 	[*]	 	 	10	 	 	 	30	 	 	[*]
	VR-CH48256
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH49716
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH49729
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH49909
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	60	 	 	[*]
	VR-CH49919
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH49974
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH50101
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH51153
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH51473
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH51514
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH51536
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH51673
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH51762
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH51763
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH51766
	 	[*]	 	[*]	 	[*]	 	 	120	 	 	 	30	 	 	[*]
	VR-CH51767
	 	[*]	 	[*]	 	[*]	 	 	120	 	 	 	30	 	 	[*]
	VR-CH51768
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	7	 	 	[*]
	VR-CH51774
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH51786
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH51867
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH51876
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH51878
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH53264
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH53269
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH53318
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH53387
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH53395
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	7	 	 	[*]
	VR-CH53464
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH53678
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH53980
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH54677
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	0	 	 	[*]
	VR-CH54884
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	0	 	 	[*]
	VR-CH55612
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH55939
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH56005
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH56014
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH56026
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH56050
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH56093
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH56094
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH56096
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH56107
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH56152
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH56162
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH56171
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH56175
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH56189
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH56212
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH56218
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH56241
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH56298
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH56312
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH56327
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH56329
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH56330
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH56332
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH56342
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH56353
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH57128
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH57244
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH57324
	 	[*]	 	[*]	 	[*]	 	 	72	 	 	 	30	 	 	[*]
	VR-CH57376
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	7	 	 	[*]
	VR-CH57387
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH57400
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	45	 	 	[*]
	VR-CH57410
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH57518
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	30	 	 	[*]
	VR-CH57531
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH57635
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH57660
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	7	 	 	[*]
	VR-CH57933
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH58249
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH58848
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH58851
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH58895
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH58896
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH58898
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH58918
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH59018
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH59041
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	7	 	 	[*]
	VR-CH59389
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	45	 	 	[*]
	VR-CH59799
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH59804
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH59913
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH60655
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH61141
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH62671
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH62856
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH64717
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH66294
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH70030
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH70142
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH70143
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH70144
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH70145
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH70146
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH70150
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH70151
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH70159
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH70160
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH70293
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH70294
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH70295
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH70413
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH70501
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH70542
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH70579
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH70894
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH70944
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH70945
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH70951
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH71009
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH71069
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH71154
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH71211
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH71235
	 	[*]	 	[*]	 	[*]	 	 	52	 	 	 	60	 	 	[*]
	VR-CH71320
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH71331
	 	[*]	 	[*]	 	[*]	 	 	80	 	 	 	30	 	 	[*]
	VR-CH71388
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH71409
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH71462
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH71504
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	60	 	 	[*]
	VR-CH71603
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH71625
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH71671
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH71720
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH71721
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH71769
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH71801
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	30	 	 	[*]
	VR-CH71867
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH71942
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH72083
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH72258
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH72284
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH72672
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH73055
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH73443
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH73497
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH73684
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH73697
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH73701
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH73704
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH73706
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH73749
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH73781
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH73830
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	0	 	 	[*]
	VR-CH73878
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH73922
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH74201
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH74206
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH74208
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH74607
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH74616
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH74796
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH74885
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH74886
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH75407
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH75454
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH75459
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH75468
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH75484
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH75593
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH75684
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH75687
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH75903
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH75943
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH76018
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH76091
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH76093
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH76097
	 	[*]	 	[*]	 	[*]	 	 	48	 	 	 	30	 	 	[*]
	VR-CH76101
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH76108
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	60	 	 	[*]
	VR-CH76207
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	60	 	 	[*]
	VR-CH76583
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH76666
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH76677
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH76884
	 	[*]	 	[*]	 	[*]	 	 	48	 	 	 	30	 	 	[*]
	VR-CH76937
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH77032
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH77118
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH77302
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH77303
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH77304
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH77305
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH77306
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH77307
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH77356
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH77368
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH77405
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH77408
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH77512
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH77527
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH77581
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH80163
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	30	 	 	[*]
	VR-CH81332
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH81421
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH81422
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH81423
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH81424
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH81427
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH81429
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH81431
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH81582
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH81584
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH81757
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH84263
	 	[*]	 	[*]	 	[*]	 	 	20	 	 	 	0	 	 	[*]
	VR-CH84955
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH84956
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-CH84957
	 	[*]	 	[*]	 	[*]	 	 	1	 	 	 	0	 	 	[*]
	VR-CH89563
	 	[*]	 	[*]	 	[*]	 	 	3	 	 	 	0	 	 	[*]
	VR-CH89702
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH89712
	 	[*]	 	[*]	 	[*]	 	 	20	 	 	 	0	 	 	[*]
	VR-CHT00367
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	30	 	 	[*]
	VR-P_57836
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P_69506
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P_X0818
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P102754
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P104615
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P10573
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P17868
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P17956
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P17959
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P17962
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P18142
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P18936
	 	[*]	 	[*]	 	[*]	 	 	20	 	 	 	0	 	 	[*]
	VR-P18937
	 	[*]	 	[*]	 	[*]	 	 	20	 	 	 	0	 	 	[*]
	VR-P19048
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P19049
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19050
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19055
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-P19056
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P19057
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P19058
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19072
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P19073
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P19075
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19076
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-P19086
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19087
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19130
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P19130R
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P19131
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19132
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P19133
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P19134
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19134R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19135
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P19135R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19154
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P19154R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P19160
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P19161
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P19162
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P19163
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P19164
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P19165
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P19193
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P19194
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19195
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19199
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19207
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P19210
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P19211
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P19213
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P19214
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P19215
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P19224
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P19225
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P19228
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P19234
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P19235
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19261
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P19275
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P19277
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-P19279
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P19302
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P19303
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P19306
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P19307
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P19308
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P19309
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P19313
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19314
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19319
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P19320
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19320R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19355
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19356
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19357
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P19380
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-P19398
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P19402
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-P19458
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P19458R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P19459
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P19459R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P19460
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P19460R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P19461
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P19461R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P19476
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P19477
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P19486
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P19487
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P19488
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19509
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-P19516
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P19518
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P19520
	 	[*]	 	[*]	 	[*]	 	 	90	 	 	 	30	 	 	[*]
	VR-P19529
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19530
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-P19531
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P19532
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P19533
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P19540
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P19540R
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P19542
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P19542R
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P19544
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P19554
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19555
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P19574
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P19577
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19578
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P19579
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19587
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19628
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P19629
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P19648
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19651
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P19652
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P19657
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P19678
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P19679
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19687
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P19688
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P19689
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P19690
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P19691
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P19693
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P19731
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P19734
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P19750
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P19751
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P19755
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P19777
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P19784
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P19793
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-P19795
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19799
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-P19802
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	0	 	 	[*]
	VR-P19819
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19819R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19820
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19820R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19821
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19821R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19835
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P19845
	 	[*]	 	[*]	 	[*]	 	 	20	 	 	 	0	 	 	[*]
	VR-P19855
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P19858
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19860
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P19863
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P19876
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19908
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	0	 	 	[*]
	VR-P19913
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P19941
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19973
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P19980
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P19981
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P20000
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P20006
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P20007
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P20009
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P20010
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P20018
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P20019
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20023
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20024
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20031
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P20053
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20054
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P20055
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P20066
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	0	 	 	[*]
	VR-P20067
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-P20068
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20079
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20092
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P20093
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P20119
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20129
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20138
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20139
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20140
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20159
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20160
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20161
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20162
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20164
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20167
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20168
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20170
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20171
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20172
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20177
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20182
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20184
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20187
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20189
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20190
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20191
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20203
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20209
	 	[*]	 	[*]	 	[*]	 	 	20	 	 	 	0	 	 	[*]
	VR-P20210
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20215
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20232
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P20243
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P20283
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P20286
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20287
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20288
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-P20333
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-P20333R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20334
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P20334R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20335
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20335R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20336
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P20336R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20337
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20342
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20343
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20344
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20345
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20353R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20354R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20355R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20356
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20356R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20361
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P20361R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20362R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20363R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20364R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20396
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P20401
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20411
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20450
	 	[*]	 	[*]	 	[*]	 	 	20	 	 	 	0	 	 	[*]
	VR-P20451
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20452
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P20466
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P20467
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P20468
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P204877
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20498
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P20499
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20500
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	30	 	 	[*]
	VR-P20500R
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	0	 	 	[*]
	VR-P20532
	 	[*]	 	[*]	 	[*]	 	 	20	 	 	 	0	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-P20536
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P20537
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P20554
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20559
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20571
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20573
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20585
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20586
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20587
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20587R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20594
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	30	 	 	[*]
	VR-P20594R
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	0	 	 	[*]
	VR-P20598
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P20603
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P20612
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20612R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20619
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P20620
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P20642
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	30	 	 	[*]
	VR-P20642R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20643
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P20643R
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P20644
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20644R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20645
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20645R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20647
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20651
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20652
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20652R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20653
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20654
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20655
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20655R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20663
	 	[*]	 	[*]	 	[*]	 	 	20	 	 	 	30	 	 	[*]
	VR-P20665
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20665R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-P20666
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20666R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20671
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20672
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20675
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P20675R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20694
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20694R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20697
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20697R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20699
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20699R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20702
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20702R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20703
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20706
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20711
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P20711R
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P20712
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20712R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20715
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P20715R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20716
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20716R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20719
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20720
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20722
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P20729
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20729R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20730
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P20731
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P20731R
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P20732
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20732R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20733
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20735
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20737
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-P20737R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20751
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20751R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20752
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20752R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20758
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20766
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20766R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20767
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20767R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20779
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20779R
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P20797
	 	[*]	 	[*]	 	[*]	 	 	70	 	 	 	0	 	 	[*]
	VR-P20798
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20830
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20830R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20844
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20848
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P20848R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P20849
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P20849R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P20850
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P20850R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20851
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20859
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-P20859R
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-P20863
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20863R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20873
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20873R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20877
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20878
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20890
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	30	 	 	[*]
	VR-P20891
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	30	 	 	[*]
	VR-P20895
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20895R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20901
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-P20902
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P20909
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	0	 	 	[*]
	VR-P20910
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	0	 	 	[*]
	VR-P20911
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	0	 	 	[*]
	VR-P20912
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	0	 	 	[*]
	VR-P20913
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	0	 	 	[*]
	VR-P20915
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20921
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20925
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20927
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20930
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20934
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20934R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20935
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	30	 	 	[*]
	VR-P20935R
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	0	 	 	[*]
	VR-P20936
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P20936R
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P20937
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	30	 	 	[*]
	VR-P20940
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20940R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20944
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20944R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20947
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P20947R
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P20948
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P20948R
	 	[*]	 	[*]	 	[*]	 	 	#N/A	 	 	 	0	 	 	[*]
	VR-P20949
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P20949R
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P20950
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P20950R
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P20951
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P20951R
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P20952
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P20952R
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P20961
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20961R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20962R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-P209641
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20984
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P20984R
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P20985
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P20986R
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-P20987
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20987R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20988
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20988R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20989
	 	[*]	 	[*]	 	[*]	 	 	80	 	 	 	30	 	 	[*]
	VR-P20989R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20991
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20992
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20993
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	30	 	 	[*]
	VR-P20993R
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	0	 	 	[*]
	VR-P20994
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	30	 	 	[*]
	VR-P20994R
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	0	 	 	[*]
	VR-P20998R
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	0	 	 	[*]
	VR-P21006
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	0	 	 	[*]
	VR-P21018R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P21019R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P21020R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P21024R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P21034R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P304066
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P304555
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P69105
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-PZ10025
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ10195
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-PZ10209
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ10210
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ10398
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-PZ10522
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ10523
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ11075
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ11146
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ11147
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-PZ11153
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ11154
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ11155
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ11156
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ11309
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-PZ11310
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-PZ11505
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ11507
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-PZ11509
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ11511
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-PZ11673
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-PZ11850
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ11851
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ11958
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-PZ12056
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ12057
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ12138
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ12139
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ12140
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ12405
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-PZ12443
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-PZ12472
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-PZ13048
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-PZ13049
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-PZ13057
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ13134
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-PZ13166
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-PZ13176
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-PZ13178
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-PZ13233
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ13377
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ13667
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ13675
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ13677
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ13679
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ13680
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ14516
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-PZ14592
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	30	 	 	[*]
	VR-PZ14648
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-PZ14801
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-PZ14867
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ15405
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ15406
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ15407
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ15408
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ15495
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ15631
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ15640
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-PZ15641
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ15722
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ15724
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ15726
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ15728
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ15939
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-PZ15978
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-PZ15979
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-PZ16151
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ16152
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ16153
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ16251
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-PZ16268
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ16269
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ16270
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ16271
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ16272
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ16507
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ16535
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ16544
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-PZ16756
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-PZ16762
	 	[*]	 	[*]	 	[*]	 	 	70	 	 	 	60	 	 	[*]
	VR-PZ16776
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ16964
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ16965
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	0	 	 	[*]
	VR-PZ16966
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	1	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-PZ17035
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ17041
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ17042
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ17097
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-PZ17098
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ17099
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ17128
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ17152
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ17213
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-PZ17222
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-PZ17346
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-PZ17347
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-PZ17375
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ17424
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ17487
	 	[*]	 	[*]	 	[*]	 	 	70	 	 	 	60	 	 	[*]
	VR-PZ17501
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ17502
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ17503
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ17504
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ17505
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ17542
	 	[*]	 	[*]	 	[*]	 	 	70	 	 	 	60	 	 	[*]
	VR-PZ17544
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ17545
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ17555
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ17556
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ17629
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ17630
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ17631
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ17632
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ17650
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-PZ17651
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-PZ17652
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ17776
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-PZ17777
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-PZ17778
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-PZ17831
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ17834
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-PZ17846
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ17850
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-PZ17934
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-PZ17948
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-PZ17949
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-PZ17950
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-PZ17953
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-PZ17955
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-PZ17956
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ17966
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ17967
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ17968
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ17969
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ17970
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ17971
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ17983
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ17984
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ17985
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ17987
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ18020
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-PZ18021
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-PZ18022
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-PZ18035
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-PZ18036
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-PZ18037
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-PZ18059
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-PZ18064
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-PZ18088
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ18109
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ18111
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ18112
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ18113
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ18132
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ18133
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ18134
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ18198
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ18199
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-PZ18202
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ18210
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ18211
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ18212
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ18213
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ18214
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ18216
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ18250
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-PZ18251
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-PZ18370
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-PZ18372
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ18373
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-PZ18407
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ18408
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ18442
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ18443
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ18452
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ18453
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ18454
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ18458
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ18458R
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-PZ18514
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-PZ18606
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ18607
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ19556
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-PZ19909
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	0	 	 	[*]
	VR-PZ3101
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-PZ3117
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-PZ3158
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-PZ3159
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-PZ3160
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-PZ6654
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ6655
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ6782
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ6783
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-PZ6783R
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-PZ6953
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-PZ6963
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ7067
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ7299
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ7576
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ7577
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ7692
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ7693
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ7694
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ7695
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ7696
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ7708
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	0	 	 	[*]
	VR-PZ7709
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ7892
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ7896
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ7897
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ7898
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ7899
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ7900
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ7901
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ8061
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ8066
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ8261
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-PZ8291
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-PZ8372
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-PZ8387
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ8392
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ8408
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ8462
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	0	 	 	[*]
	VR-PZ8463
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ8464
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ8476
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	0	 	 	[*]
	VR-PZ8477
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ8478
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	0	 	 	[*]
	VR-PZ8479
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ8487
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-PZ8488
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-PZ8489
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-PZ8533
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ8688
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-PZ8688R
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-PZ8748
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-PZ8750
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ8769
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ8836
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ8860
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ8861
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	0	 	 	[*]
	VR-PZ8865
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ8883
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ8884
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ8885
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ8886
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-PZ8887
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ8891
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ8893
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ8895
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-PZ8897
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ8900
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ8907
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-PZ8908
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-PZ8909
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-PZ8910
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-PZ8928
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	0	 	 	[*]
	VR-PZ8929
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-PZ9064
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-PZ9106
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ9120
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ9263
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ9904
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

Exhibit 3.1.4 LLI Materials

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH100008
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH100050
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH100051
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH100174
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	60	 	 	[*]
	VR-CH100182
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH100257
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH100269
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH100270
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH100299
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH100313
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH100319
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH100334
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH100419
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	35	 	 	[*]
	VR-CH100441
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH100624
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH100750
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH100828
	 	[*]	 	[*]	 	[*]	 	 	100	 	 	 	30	 	 	[*]
	VR-CH100853
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH100891
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	0	 	 	[*]
	VR-CH100948
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH100976
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH100986
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH101100
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH101101
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH101121
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH101123
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH101135
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH101161
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH101193
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH101199
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH101203
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH101287
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH101288
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH101304
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH101320
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH101326
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH101374
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH101418
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	30	 	 	[*]
	VR-CH101420
	 	[*]	 	[*]	 	[*]	 	 	52	 	 	 	60	 	 	[*]
	VR-CH101466
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH101482
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH101497
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-CH101521
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH101524
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-CH101572
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH101610
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	60	 	 	[*]
	VR-CH101616
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH101617
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH101669
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH101676
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH101680
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH101748
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH101769
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH101838
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH101846
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH101864
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH101878
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH101928
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH101929
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH101933
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH101935
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH101939
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH101940
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH101943
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH101970
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH102055
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH102133
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH102147
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH102184
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH102199
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH102270
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH102271
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH102288
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH102336
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH102351
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH102352
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH102353
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH102354
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH102355
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH102356
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH102364
	 	[*]	 	[*]	 	[*]	 	 	180	 	 	 	30	 	 	[*]
	VR-CH102375
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH102420
	 	[*]	 	[*]	 	[*]	 	 	52	 	 	 	60	 	 	[*]
	VR-CH102436
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH102460
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH102465
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	7	 	 	[*]
	VR-CH102473
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH102481
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH102504
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH102505
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH102510
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH102533
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH102534
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH102535
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH102554
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH102614
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH102618
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH102620
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH102625
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH102649
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH102693
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH102704
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH102707
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH102794
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH102795
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH102822
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH103090
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH103092
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-CH103298
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH103376
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	0	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH103378
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH103387
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	60	 	 	[*]
	VR-CH103397
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH103847
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	0	 	 	[*]
	VR-CH103939
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH103940
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	60	 	 	[*]
	VR-CH103941
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	60	 	 	[*]
	VR-CH103942
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	60	 	 	[*]
	VR-CH103943
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	60	 	 	[*]
	VR-CH103948
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH104021
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH104022
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH104068
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH104084
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH104121
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH104459
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH104461
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH104750
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH104762
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH104786
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH104787
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	45	 	 	[*]
	VR-CH104800
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH104801
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH104819
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH104840
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH104852
	 	[*]	 	[*]	 	[*]	 	 	52	 	 	 	60	 	 	[*]
	VR-CH104853
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH104875
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH104876
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH104877
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH104878
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH104943
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-CH105177
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH105596
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH105677
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH105678
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH105791
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH105845
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH105848
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH105849
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH105863
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH105864
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH105867
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	7	 	 	[*]
	VR-CH105873
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH105887
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH14144
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	0	 	 	[*]
	VR-CH14186
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	0	 	 	[*]
	VR-CH14278
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH14279
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH14300
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	0	 	 	[*]
	VR-CH14301
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	0	 	 	[*]
	VR-CH14302
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	0	 	 	[*]
	VR-CH14324
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	0	 	 	[*]
	VR-CH14880
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH16373
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH16374
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH16530
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	0	 	 	[*]
	VR-CH200094
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH200095
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH200128
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH200130
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH200132
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH200134
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH200240
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH200242
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH200243
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH200772
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH200773
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH200775
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH200776
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH200777
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH200778
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH200779
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH200780
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH200781
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH200782
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH200783
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH200798
	 	[*]	 	[*]	 	[*]	 	 	42	 	 	 	30	 	 	[*]
	VR-CH200855
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH200874
	 	[*]	 	[*]	 	[*]	 	 	80	 	 	 	30	 	 	[*]
	VR-CH200885
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH200887
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH200926
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH201003
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH201137
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH201150
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH201282
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH201284
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH201498
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH201531
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH201576
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH201873
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH202021
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH202300
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH202301
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH202302
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH202310
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH202368
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	35	 	 	[*]
	VR-CH202371
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH202372
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH202432
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH202498
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH202499
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH202541
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH202576
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH202577
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH202603
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH202616
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH202689
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH202744
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH202798
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	30	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH202871
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH202873
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	1	 	 	[*]
	VR-CH202888
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH202968
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH203183
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH203302
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	30	 	 	[*]
	VR-CH203344
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH203386
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH203424
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH203427
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH203429
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH203440
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH203459
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH203517
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH203526
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH203533
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH203605
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH203621
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH203682
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH203683
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH203698
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH203706
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH203720
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH203722
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH203725
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	45	 	 	[*]
	VR-CH203726
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH203751
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH203793
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH203805
	 	[*]	 	[*]	 	[*]	 	 	70	 	 	 	30	 	 	[*]
	VR-CH203806
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH203808
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH203815
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH203816
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH203890
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH203917
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH203918
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-CH203919
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH203920
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-CH203972
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH203975
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH203998
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH204012
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204029
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH204057
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH204074
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH204083
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH204115
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204116
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH204122
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH204155
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204189
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH204193
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204236
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH204244
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204248
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204252
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204330
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204332
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204337
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH204339
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH204368
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH204373
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH204374
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH204376
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204407
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH204443
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204444
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204449
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204485
	 	[*]	 	[*]	 	[*]	 	 	52	 	 	 	60	 	 	[*]
	VR-CH204494
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH204497
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	60	 	 	[*]
	VR-CH204526
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH204535
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	35	 	 	[*]
	VR-CH204537
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	7	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH204546
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH204593
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH204629
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204647
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH204657
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH204668
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH204676
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH204679
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH204689
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204691
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH204692
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH204706
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH204744
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH204798
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	45	 	 	[*]
	VR-CH204800
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH204803
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	45	 	 	[*]
	VR-CH204804
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH204807
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	15	 	 	[*]
	VR-CH204859
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204860
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204861
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH204865
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH204866
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	60	 	 	[*]
	VR-CH204870
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH204871
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH204872
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	7	 	 	[*]
	VR-CH204880
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH204896
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH204904
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204909
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204914
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204915
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204917
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204918
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204921
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204922
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204927
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH204931
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH204975
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH204989
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH204995
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH204996
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH204998
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH205010
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH205023
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH205024
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH205026
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH205039
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH205055
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH205087
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH205088
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH205103
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH205128
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH205136
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	7	 	 	[*]
	VR-CH205219
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH205221
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH205234
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH205235
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH205244
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH205250
	 	[*]	 	[*]	 	[*]	 	 	70	 	 	 	30	 	 	[*]
	VR-CH205273
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH205276
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH205301
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH205333
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH205342
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH205344
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH205363
	 	[*]	 	[*]	 	[*]	 	 	70	 	 	 	30	 	 	[*]
	VR-CH205365
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH205392
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH205393
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	7	 	 	[*]
	VR-CH205400
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	30	 	 	[*]
	VR-CH205401
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH205402
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH205405
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH205417
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH205426
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH205435
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH205439
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	60	 	 	[*]
	VR-CH205547
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH205563
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH205578
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	45	 	 	[*]
	VR-CH205614
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH205631
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH205634
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH205643
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH205644
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH205649
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH205650
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH205651
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH205754
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	60	 	 	[*]
	VR-CH205767
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH205782
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	60	 	 	[*]
	VR-CH205807
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	30	 	 	[*]
	VR-CH205809
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH205815
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH205825
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH205867
	 	[*]	 	[*]	 	[*]	 	 	72	 	 	 	30	 	 	[*]
	VR-CH205874
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH205887
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	60	 	 	[*]
	VR-CH205910
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH205911
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH205916
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH205917
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH205955
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH205956
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH205957
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH205975
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH206040
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH206094
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-CH206096
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH206103
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH206161
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH206169
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH206259
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH206267
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	0	 	 	[*]
	VR-CH206291
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH206310
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH206331
	 	[*]	 	[*]	 	[*]	 	 	20	 	 	 	0	 	 	[*]
	VR-CH206367
	 	[*]	 	[*]	 	[*]	 	 	100	 	 	 	30	 	 	[*]
	VR-CH206369
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH206404
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	60	 	 	[*]
	VR-CH206405
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH206433
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH206455
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH206462
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH206470
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH206482
	 	[*]	 	[*]	 	[*]	 	 	54	 	 	 	30	 	 	[*]
	VR-CH206501
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH206515
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	45	 	 	[*]
	VR-CH206520
	 	[*]	 	[*]	 	[*]	 	 	85	 	 	 	30	 	 	[*]
	VR-CH206525
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH206630
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH206631
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH206655
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	0	 	 	[*]
	VR-CH206715
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH206738
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH206739
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH206753
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH206765
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH206770
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	35	 	 	[*]
	VR-CH206775
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH206778
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH206787
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH206812
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH206869
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH206918
	 	[*]	 	[*]	 	[*]	 	 	20	 	 	 	30	 	 	[*]
	VR-CH206920
	 	[*]	 	[*]	 	[*]	 	 	20	 	 	 	0	 	 	[*]
	VR-CH206962
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH206996
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH207006
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH207019
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH207023
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH207034
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH207060
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH207061
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH207081
	 	[*]	 	[*]	 	[*]	 	 	80	 	 	 	45	 	 	[*]
	VR-CH207100
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	7	 	 	[*]
	VR-CH207121
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH207189
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	30	 	 	[*]
	VR-CH207233
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH207252
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH207286
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH207288
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-CH207298
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH207318
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH207338
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH207361
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH207389
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH207425
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH207437
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH207448
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH207450
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH207454
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH207482
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH207483
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH207490
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH207522
	 	[*]	 	[*]	 	[*]	 	 	52	 	 	 	30	 	 	[*]
	VR-CH207525
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH207551
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	60	 	 	[*]
	VR-CH207554
	 	[*]	 	[*]	 	[*]	 	 	120	 	 	 	30	 	 	[*]
	VR-CH207556
	 	[*]	 	[*]	 	[*]	 	 	85	 	 	 	30	 	 	[*]
	VR-CH207571
	 	[*]	 	[*]	 	[*]	 	 	85	 	 	 	30	 	 	[*]
	VR-CH207621
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH207630
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH207635
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	60	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH207647
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH207751
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH207931
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH207932
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH208012
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH208015
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	60	 	 	[*]
	VR-CH208016
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	60	 	 	[*]
	VR-CH208021
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH208035
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	30	 	 	[*]
	VR-CH208039
	 	[*]	 	[*]	 	[*]	 	 	52	 	 	 	60	 	 	[*]
	VR-CH208062
	 	[*]	 	[*]	 	[*]	 	 	100	 	 	 	30	 	 	[*]
	VR-CH208109
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	7	 	 	[*]
	VR-CH208116
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	30	 	 	[*]
	VR-CH208157
	 	[*]	 	[*]	 	[*]	 	 	90	 	 	 	30	 	 	[*]
	VR-CH208186
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	30	 	 	[*]
	VR-CH208222
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH208314
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	60	 	 	[*]
	VR-CH208367
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	60	 	 	[*]
	VR-CH208378
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH208399
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH208450
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	60	 	 	[*]
	VR-CH208495
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH208502
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH208536
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	30	 	 	[*]
	VR-CH208537
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH208540
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH208543
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH208597
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH208598
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH208678
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH208683
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH208686
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH208700
	 	[*]	 	[*]	 	[*]	 	 	75	 	 	 	30	 	 	[*]
	VR-CH208743
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH208746
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	60	 	 	[*]
	VR-CH208748
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH208757
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	0	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH208765
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH208778
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	60	 	 	[*]
	VR-CH208870
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	45	 	 	[*]
	VR-CH208899
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH208931
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH208959
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH209040
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	60	 	 	[*]
	VR-CH209057
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH209061
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH209114
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	60	 	 	[*]
	VR-CH209129
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH209153
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH209156
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH209157
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH209165
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH209168
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH209205
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH209324
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	60	 	 	[*]
	VR-CH209335
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH209389
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	30	 	 	[*]
	VR-CH209406
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH209444
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH209467
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH209469
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH209471
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH209476
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH209480
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH209482
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH209483
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH209484
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH209485
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH209486
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH209487
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH209489
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH209493
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH209495
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH209496
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH209498
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH209499
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH209502
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH209503
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH209504
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH209505
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH209506
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH209509
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH209511
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH209514
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH209521
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH209537
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH209553
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH209603
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH209605
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH209622
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH209640
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH209705
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH209751
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH209761
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH209765
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH209771
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH209772
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH209786
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH209787
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH209822
	 	[*]	 	[*]	 	[*]	 	 	75	 	 	 	30	 	 	[*]
	VR-CH209823
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH209826
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH209828
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	45	 	 	[*]
	VR-CH209830
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH209850
	 	[*]	 	[*]	 	[*]	 	 	70	 	 	 	45	 	 	[*]
	VR-CH209879
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH209901
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	60	 	 	[*]
	VR-CH209919
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH209928
	 	[*]	 	[*]	 	[*]	 	 	70	 	 	 	60	 	 	[*]
	VR-CH209930
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH209980
	 	[*]	 	[*]	 	[*]	 	 	75	 	 	 	30	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH210026
	 	[*]	 	[*]	 	[*]	 	 	80	 	 	 	30	 	 	[*]
	VR-CH210038
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH210040
	 	[*]	 	[*]	 	[*]	 	 	70	 	 	 	30	 	 	[*]
	VR-CH210057
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH210064
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	30	 	 	[*]
	VR-CH210069
	 	[*]	 	[*]	 	[*]	 	 	75	 	 	 	30	 	 	[*]
	VR-CH210105
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH210123
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH210131
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH210157
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH210275
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH210301
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	35	 	 	[*]
	VR-CH210325
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH210351
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH210379
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH210487
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH210634
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH210647
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH210648
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH210686
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH210687
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-CH210715
	 	[*]	 	[*]	 	[*]	 	 	20	 	 	 	0	 	 	[*]
	VR-CH210740
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH210777
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	35	 	 	[*]
	VR-CH210783
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	30	 	 	[*]
	VR-CH210792
	 	[*]	 	[*]	 	[*]	 	 	70	 	 	 	60	 	 	[*]
	VR-CH210810
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH210812
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH210813
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH210820
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH210856
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH210969
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	0	 	 	[*]
	VR-CH210979
	 	[*]	 	[*]	 	[*]	 	 	70	 	 	 	60	 	 	[*]
	VR-CH210984
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	35	 	 	[*]
	VR-CH211010
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH211019
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH211030
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH211049
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH211068
	 	[*]	 	[*]	 	[*]	 	 	70	 	 	 	60	 	 	[*]
	VR-CH211072
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	35	 	 	[*]
	VR-CH211077
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH211078
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH211102
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH211126
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH211158
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH211165
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH211207
	 	[*]	 	[*]	 	[*]	 	 	20	 	 	 	0	 	 	[*]
	VR-CH211223
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	35	 	 	[*]
	VR-CH211265
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH211273
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH211275
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH211277
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	35	 	 	[*]
	VR-CH211283
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH211284
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH211285
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH211286
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH211287
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH211288
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH211289
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH211302
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH211366
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH211392
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH211407
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH211408
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH211415
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH211451
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	30	 	 	[*]
	VR-CH211452
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	30	 	 	[*]
	VR-CH211455
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH211456
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH211457
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH211458
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH211460
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH211461
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH211462
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH211463
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH211464
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH211473
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH211521
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH211568
	 	[*]	 	[*]	 	[*]	 	 	70	 	 	 	60	 	 	[*]
	VR-CH211572
	 	[*]	 	[*]	 	[*]	 	 	70	 	 	 	60	 	 	[*]
	VR-CH211589
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH211619
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH211620
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH211649
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH211684
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH211685
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH211734
	 	[*]	 	[*]	 	[*]	 	 	72	 	 	 	30	 	 	[*]
	VR-CH211761
	 	[*]	 	[*]	 	[*]	 	 	85	 	 	 	60	 	 	[*]
	VR-CH211764
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	45	 	 	[*]
	VR-CH211766
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH211787
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH211790
	 	[*]	 	[*]	 	[*]	 	 	72	 	 	 	30	 	 	[*]
	VR-CH211791
	 	[*]	 	[*]	 	[*]	 	 	72	 	 	 	30	 	 	[*]
	VR-CH211814
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH211815
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH211825
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH211826
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH211827
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH211868
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH211887
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH211920
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH211924
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH211932
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH211935
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH211937
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH211943
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH212082
	 	[*]	 	[*]	 	[*]	 	 	75	 	 	 	30	 	 	[*]
	VR-CH212101
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH212102
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	45	 	 	[*]
	VR-CH212103
	 	[*]	 	[*]	 	[*]	 	 	75	 	 	 	30	 	 	[*]
	VR-CH212105
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH212148
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH212171
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH212211
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH212226
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH212250
	 	[*]	 	[*]	 	[*]	 	 	70	 	 	 	60	 	 	[*]
	VR-CH212324
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH212399
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH212465
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH212530
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH212531
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH212546
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH212568
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH212570
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH212571
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	30	 	 	[*]
	VR-CH212589
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH212681
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH212683
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH212725
	 	[*]	 	[*]	 	[*]	 	 	70	 	 	 	60	 	 	[*]
	VR-CH212751
	 	[*]	 	[*]	 	[*]	 	 	78	 	 	 	30	 	 	[*]
	VR-CH212768
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH212773
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-CH212778
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH212815
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH212824
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH212865
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH212866
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH212965
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH213039
	 	[*]	 	[*]	 	[*]	 	 	70	 	 	 	60	 	 	[*]
	VR-CH213058
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH213060
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH213061
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH213066
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH213088
	 	[*]	 	[*]	 	[*]	 	 	70	 	 	 	60	 	 	[*]
	VR-CH213094
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH213097
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	45	 	 	[*]
	VR-CH213137
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH213140
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH213188
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH213190
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH213192
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH213200
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH213217
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH213228
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH213232
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH213275
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	60	 	 	[*]
	VR-CH213308
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH213313
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH213314
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH213315
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH213316
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH213319
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	7	 	 	[*]
	VR-CH213377
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH213378
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH213379
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH213380
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH213383
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH213384
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH213385
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH213386
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH213389
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH213397
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH213398
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH213449
	 	[*]	 	[*]	 	[*]	 	 	120	 	 	 	30	 	 	[*]
	VR-CH213512
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH213516
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH213529
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	60	 	 	[*]
	VR-CH213553
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH213593
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH213601
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH213685
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH213686
	 	[*]	 	[*]	 	[*]	 	 	70	 	 	 	60	 	 	[*]
	VR-CH213687
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH213688
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	35	 	 	[*]
	VR-CH213689
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	35	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH213697
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH213698
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH213713
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH213716
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH213718
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH213724
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH213742
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH213746
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH213747
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH213748
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH213751
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH213753
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH213755
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH213774
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH213780
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	60	 	 	[*]
	VR-CH213822
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-CH213826
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH213827
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH213837
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH213842
	 	[*]	 	[*]	 	[*]	 	 	70	 	 	 	60	 	 	[*]
	VR-CH213847
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH213849
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH22615
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH23243
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH27829
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH28022
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH28050
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH28168
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH28169
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	30	 	 	[*]
	VR-CH28304
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH28308
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-CH28477
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH28502
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH28641
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH28961
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH28962
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH28964
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH29232
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH29285
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH29298
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH29305
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH29385
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH29387
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH29388
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH29394
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH29395
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH29396
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH29397
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH29398
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH29400
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH29401
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH29402
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH29403
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH29473
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH29476
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH300119
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH300121
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH300125
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH300126
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH300127
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH300233
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH300322
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH300404
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH300405
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH300423
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH300479
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH300485
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH300489
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH300573
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH300678
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH300748
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH300851
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH301026
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	60	 	 	[*]
	VR-CH301054
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH301081
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH301177
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	30	 	 	[*]
	VR-CH301272
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH301273
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH301287
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH301325
	 	[*]	 	[*]	 	[*]	 	 	49	 	 	 	30	 	 	[*]
	VR-CH301358
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH301366
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH301378
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH301381
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	0	 	 	[*]
	VR-CH301384
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH301399
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH301483
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH301517
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH301518
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH301527
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH301529
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH301530
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH301531
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH301606
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH301620
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH301838
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH301854
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	30	 	 	[*]
	VR-CH301855
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	30	 	 	[*]
	VR-CH302174
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-CH302223
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH302229
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH302238
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH302239
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH302240
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH302241
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH302322
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH302346
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH302411
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH302415
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH302424
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH302567
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH302588
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH302596
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH302777
	 	[*]	 	[*]	 	[*]	 	 	80	 	 	 	30	 	 	[*]
	VR-CH302805
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH302860
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH302874
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	30	 	 	[*]
	VR-CH302921
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH302988
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH303136
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH303205
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH303248
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH303263
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH303297
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH303330
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH303346
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH303353
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH303414
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH303420
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH303473
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH303517
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH303538
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH303540
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH303568
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH303570
	 	[*]	 	[*]	 	[*]	 	 	80	 	 	 	60	 	 	[*]
	VR-CH303778
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH303845
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH303890
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH303892
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH303893
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH303909
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH303910
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH303913
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH303923
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH303934
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH303935
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH303939
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH303940
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH303951
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	30	 	 	[*]
	VR-CH303956
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH303958
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH303999
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH304049
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH304050
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH304060
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH304072
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH304076
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH304077
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH304079
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH304090
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-CH304099
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	60	 	 	[*]
	VR-CH304101
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH304107
	 	[*]	 	[*]	 	[*]	 	 	80	 	 	 	60	 	 	[*]
	VR-CH304108
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH304116
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH304126
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH304127
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH304128
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH304147
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH304180
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH304182
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH304183
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH304198
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	30	 	 	[*]
	VR-CH304259
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-CH304305
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH304347
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH304365
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH304387
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH304424
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	30	 	 	[*]
	VR-CH304434
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH304512
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH304630
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH304634
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH304675
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH304697
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH304709
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH304724
	 	[*]	 	[*]	 	[*]	 	 	80	 	 	 	60	 	 	[*]
	VR-CH304768
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH304775
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH304799
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH304800
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH304801
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH304802
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH304803
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH304804
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH304823
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH304824
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH304843
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH304849
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH304891
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH304927
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH304928
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH304953
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH305003
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH305081
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH305086
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH305091
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH305138
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH305164
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH305178
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH305179
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH305184
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	90	 	 	[*]
	VR-CH305214
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH305222
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH305233
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	30	 	 	[*]
	VR-CH305247
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH305250
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH305259
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH305260
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH305276
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH305305
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH305339
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	60	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH305343
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH305356
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH305357
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	0	 	 	[*]
	VR-CH305398
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH305412
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH305415
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH305416
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH305417
	 	[*]	 	[*]	 	[*]	 	 	52	 	 	 	30	 	 	[*]
	VR-CH305441
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH305456
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH305465
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH305509
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH305516
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH305525
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH305532
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH305557
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	35	 	 	[*]
	VR-CH305589
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH305610
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH305616
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH305626
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH305629
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH305630
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH305642
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH305649
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH305656
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH305658
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH305711
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH305737
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH305757
	 	[*]	 	[*]	 	[*]	 	 	70	 	 	 	30	 	 	[*]
	VR-CH305759
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH305774
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH305776
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH305818
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH30594
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH305944
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH306007
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH306014
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH306018
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH306100
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH306106
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH306107
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH306112
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH306118
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH306175
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	0	 	 	[*]
	VR-CH306329
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH306369
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH306385
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH306404
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH306438
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH306717
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH306767
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH306809
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH306815
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH306850
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH306954
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH307130
	 	[*]	 	[*]	 	[*]	 	 	52	 	 	 	60	 	 	[*]
	VR-CH307184
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH307455
	 	[*]	 	[*]	 	[*]	 	 	80	 	 	 	30	 	 	[*]
	VR-CH307478
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH307556
	 	[*]	 	[*]	 	[*]	 	 	20	 	 	 	0	 	 	[*]
	VR-CH307622
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH307685
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH307692
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH307693
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH307715
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH307718
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH307735
	 	[*]	 	[*]	 	[*]	 	 	52	 	 	 	60	 	 	[*]
	VR-CH307737
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	60	 	 	[*]
	VR-CH307738
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	60	 	 	[*]
	VR-CH307745
	 	[*]	 	[*]	 	[*]	 	 	72	 	 	 	30	 	 	[*]
	VR-CH307750
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH307773
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH307775
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH307776
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH307777
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH307816
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH307831
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH307862
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-CH307863
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-CH307909
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH307924
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH307927
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	35	 	 	[*]
	VR-CH307947
	 	[*]	 	[*]	 	[*]	 	 	75	 	 	 	30	 	 	[*]
	VR-CH308197
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	30	 	 	[*]
	VR-CH308199
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH308205
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH308219
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	7	 	 	[*]
	VR-CH308253
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	30	 	 	[*]
	VR-CH308257
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH308261
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH308265
	 	[*]	 	[*]	 	[*]	 	 	72	 	 	 	30	 	 	[*]
	VR-CH308324
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH308338
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH308339
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	60	 	 	[*]
	VR-CH308340
	 	[*]	 	[*]	 	[*]	 	 	20	 	 	 	0	 	 	[*]
	VR-CH308341
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH308390
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH308391
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH308392
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH308393
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH308394
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH308423
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH308437
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH308439
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH308440
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH308441
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH308447
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH308461
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH308487
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH308510
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH308513
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH308670
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH308673
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH308675
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH308676
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH308677
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH308706
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH308710
	 	[*]	 	[*]	 	[*]	 	 	90	 	 	 	30	 	 	[*]
	VR-CH308723
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH308727
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH308736
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH309023
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH309073
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH309177
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH309178
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH309184
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH309208
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH309219
	 	[*]	 	[*]	 	[*]	 	 	20	 	 	 	30	 	 	[*]
	VR-CH309247
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH309260
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH309294
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH309301
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH309331
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH309382
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	60	 	 	[*]
	VR-CH309383
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	60	 	 	[*]
	VR-CH309418
	 	[*]	 	[*]	 	[*]	 	 	52	 	 	 	60	 	 	[*]
	VR-CH309432
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH309435
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH309469
	 	[*]	 	[*]	 	[*]	 	 	1	 	 	 	0	 	 	[*]
	VR-CH309470
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH309478
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH309479
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	35	 	 	[*]
	VR-CH309480
	 	[*]	 	[*]	 	[*]	 	 	20	 	 	 	0	 	 	[*]
	VR-CH309484
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH309495
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH309505
	 	[*]	 	[*]	 	[*]	 	 	1	 	 	 	30	 	 	[*]
	VR-CH309530
	 	[*]	 	[*]	 	[*]	 	 	52	 	 	 	60	 	 	[*]
	VR-CH309531
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	60	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH309584
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH309586
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH309587
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH309634
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH309653
	 	[*]	 	[*]	 	[*]	 	 	1	 	 	 	0	 	 	[*]
	VR-CH309682
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH309705
	 	[*]	 	[*]	 	[*]	 	 	70	 	 	 	30	 	 	[*]
	VR-CH309710
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH309712
	 	[*]	 	[*]	 	[*]	 	 	20	 	 	 	30	 	 	[*]
	VR-CH309742
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH309743
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH309755
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH309800
	 	[*]	 	[*]	 	[*]	 	 	20	 	 	 	0	 	 	[*]
	VR-CH309804
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH309808
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH309810
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH309811
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH309812
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH309826
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH309865
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	30	 	 	[*]
	VR-CH309899
	 	[*]	 	[*]	 	[*]	 	 	20	 	 	 	0	 	 	[*]
	VR-CH309913
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH309944
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	30	 	 	[*]
	VR-CH309949
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH309967
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH309968
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH309978
	 	[*]	 	[*]	 	[*]	 	 	90	 	 	 	30	 	 	[*]
	VR-CH309979
	 	[*]	 	[*]	 	[*]	 	 	90	 	 	 	30	 	 	[*]
	VR-CH309980
	 	[*]	 	[*]	 	[*]	 	 	90	 	 	 	30	 	 	[*]
	VR-CH310000
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH310053
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH310109
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH310126
	 	[*]	 	[*]	 	[*]	 	 	20	 	 	 	0	 	 	[*]
	VR-CH310131
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	60	 	 	[*]
	VR-CH310189
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH310198
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH310275
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH310277
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH310294
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH310356
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	30	 	 	[*]
	VR-CH310366
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH310367
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH310369
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-CH310370
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-CH310372
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH310447
	 	[*]	 	[*]	 	[*]	 	 	52	 	 	 	60	 	 	[*]
	VR-CH310448
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH310453
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH310458
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH310471
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH310563
	 	[*]	 	[*]	 	[*]	 	 	20	 	 	 	0	 	 	[*]
	VR-CH310564
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-CH310566
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	60	 	 	[*]
	VR-CH310601
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH31066
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH310671
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH310678
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH310720
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH31074
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH310749
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH31075
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH310753
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH310765
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH310788
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH31080
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH310825
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH310950
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH310951
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH310952
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH310963
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH310968
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH310981
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH311020
	 	[*]	 	[*]	 	[*]	 	 	20	 	 	 	30	 	 	[*]
	VR-CH311044
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH311103
	 	[*]	 	[*]	 	[*]	 	 	90	 	 	 	30	 	 	[*]
	VR-CH311109
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH311142
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-CH311150
	 	[*]	 	[*]	 	[*]	 	 	52	 	 	 	60	 	 	[*]
	VR-CH311176
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH311189
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH311190
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH311191
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH311203
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH311209
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH311213
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH311215
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH311219
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH311220
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH311221
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH311271
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-CH311274
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH311482
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH311491
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	60	 	 	[*]
	VR-CH311574
	 	[*]	 	[*]	 	[*]	 	 	20	 	 	 	30	 	 	[*]
	VR-CH311575
	 	[*]	 	[*]	 	[*]	 	 	1	 	 	 	30	 	 	[*]
	VR-CH311579
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH311594
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH311616
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH311620
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH311621
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH311634
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH311651
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-CH311671
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH311672
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH311673
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH311759
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH32846
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-CH33287
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH34295
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH34394
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH34719
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH34782
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH35105
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH35582
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH35583
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH36083
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH36198
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH37484
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH37484R
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH37485
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH37622
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH39575
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	60	 	 	[*]
	VR-CH39857
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH400084
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH40118
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH40599
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH41427
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH42573
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH42593
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-CH44525
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH44543
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH47439
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH47677
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH48244
	 	[*]	 	[*]	 	[*]	 	 	10	 	 	 	30	 	 	[*]
	VR-CH48256
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH49716
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH49729
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH49909
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	60	 	 	[*]
	VR-CH49919
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH49974
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH50101
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH51153
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH51473
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH51514
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH51536
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH51673
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH51762
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH51763
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH51766
	 	[*]	 	[*]	 	[*]	 	 	120	 	 	 	30	 	 	[*]
	VR-CH51767
	 	[*]	 	[*]	 	[*]	 	 	120	 	 	 	30	 	 	[*]
	VR-CH51768
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	7	 	 	[*]
	VR-CH51774
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH51786
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH51867
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH51876
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH51878
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH53264
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH53269
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH53318
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH53387
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH53395
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	7	 	 	[*]
	VR-CH53464
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH53678
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH53980
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH54677
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	0	 	 	[*]
	VR-CH54884
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	0	 	 	[*]
	VR-CH55612
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH55939
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH56005
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH56014
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH56026
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH56050
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH56093
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH56094
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH56096
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH56107
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH56152
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH56162
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH56171
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH56175
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH56189
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH56212
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH56218
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH56241
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH56298
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH56312
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH56327
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH56329
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH56330
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH56332
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH56342
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH56353
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH57128
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH57244
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH57324
	 	[*]	 	[*]	 	[*]	 	 	72	 	 	 	30	 	 	[*]
	VR-CH57376
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	7	 	 	[*]
	VR-CH57387
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH57400
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	45	 	 	[*]
	VR-CH57410
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH57518
	 	[*]	 	[*]	 	[*]	 	 	65	 	 	 	30	 	 	[*]
	VR-CH57531
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH57635
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH57660
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	7	 	 	[*]
	VR-CH57933
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH58249
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH58848
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH58851
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH58895
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH58896
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH58898
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH58918
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH59018
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH59041
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	7	 	 	[*]
	VR-CH59389
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	45	 	 	[*]
	VR-CH59799
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH59804
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH59913
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH60655
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH61141
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH62671
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH62856
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH64717
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH66294
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH70030
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH70142
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH70143
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH70144
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH70145
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH70146
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH70150
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH70151
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH70159
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH70160
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH70293
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH70294
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH70295
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH70413
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH70501
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH70542
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH70579
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH70894
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH70944
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH70945
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH70951
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH71009
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH71069
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH71154
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH71211
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH71235
	 	[*]	 	[*]	 	[*]	 	 	52	 	 	 	60	 	 	[*]
	VR-CH71320
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH71331
	 	[*]	 	[*]	 	[*]	 	 	80	 	 	 	30	 	 	[*]
	VR-CH71388
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH71409
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH71462
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH71504
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	60	 	 	[*]
	VR-CH71603
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH71625
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH71671
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH71720
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH71721
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH71769
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH71801
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	30	 	 	[*]
	VR-CH71867
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH71942
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH72083
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH72258
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH72284
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH72672
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH73055
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-CH73443
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH73497
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH73684
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH73697
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH73701
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH73704
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH73706
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH73749
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH73781
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH73830
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	0	 	 	[*]
	VR-CH73878
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH73922
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH74201
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH74206
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH74208
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH74607
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	30	 	 	[*]
	VR-CH74616
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH74796
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH74885
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH74886
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH75407
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH75454
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH75459
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH75468
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH75484
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH75593
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH75684
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH75687
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH75903
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH75943
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH76018
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH76091
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH76093
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH76097
	 	[*]	 	[*]	 	[*]	 	 	48	 	 	 	30	 	 	[*]
	VR-CH76101
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH76108
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	60	 	 	[*]
	VR-CH76207
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	60	 	 	[*]
	VR-CH76583
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH76666
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH76677
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-CH76884
	 	[*]	 	[*]	 	[*]	 	 	48	 	 	 	30	 	 	[*]
	VR-CH76937
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH77032
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH77118
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH77302
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH77303
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH77304
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH77305
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH77306
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH77307
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH77356
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH77368
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH77405
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH77408
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	60	 	 	[*]
	VR-CH77512
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH77527
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-CH77581
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH80163
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	30	 	 	[*]
	VR-CH81332
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-CH81421
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH81422
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH81423
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH81424
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH81427
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-CH81429
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH81431
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-CH81582
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH81584
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-CH81757
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-CH84263
	 	[*]	 	[*]	 	[*]	 	 	20	 	 	 	0	 	 	[*]
	VR-CH84955
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH84956
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-CH84957
	 	[*]	 	[*]	 	[*]	 	 	1	 	 	 	0	 	 	[*]
	VR-CH89563
	 	[*]	 	[*]	 	[*]	 	 	3	 	 	 	0	 	 	[*]
	VR-CH89702
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-CH89712
	 	[*]	 	[*]	 	[*]	 	 	20	 	 	 	0	 	 	[*]
	VR-CHT00367
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	30	 	 	[*]
	VR-P_57836
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P_69506
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P_X0818
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P102754
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P104615
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P10573
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P17868
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P17956
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P17959
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P17962
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P18142
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P18936
	 	[*]	 	[*]	 	[*]	 	 	20	 	 	 	0	 	 	[*]
	VR-P18937
	 	[*]	 	[*]	 	[*]	 	 	20	 	 	 	0	 	 	[*]
	VR-P19048
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P19049
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19050
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19055
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-P19056
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P19057
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P19058
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19072
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P19073
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P19075
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19076
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-P19086
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19087
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19130
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P19130R
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P19131
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19132
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P19133
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P19134
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19134R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19135
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P19135R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19154
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P19154R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P19160
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P19161
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P19162
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P19163
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P19164
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P19165
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P19193
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P19194
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19195
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19199
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19207
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P19210
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P19211
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P19213
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P19214
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P19215
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P19224
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P19225
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P19228
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P19234
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P19235
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19261
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P19275
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P19277
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-P19279
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P19302
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P19303
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P19306
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P19307
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P19308
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P19309
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P19313
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19314
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19319
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P19320
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19320R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19355
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19356
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19357
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P19380
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-P19398
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P19402
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-P19458
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P19458R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P19459
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P19459R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P19460
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P19460R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P19461
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P19461R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P19476
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P19477
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P19486
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P19487
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P19488
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19509
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-P19516
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P19518
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P19520
	 	[*]	 	[*]	 	[*]	 	 	90	 	 	 	30	 	 	[*]
	VR-P19529
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19530
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-P19531
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P19532
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P19533
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P19540
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P19540R
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P19542
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P19542R
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P19544
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P19554
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19555
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P19574
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P19577
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19578
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P19579
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19587
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19628
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P19629
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P19648
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19651
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P19652
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P19657
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P19678
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P19679
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19687
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P19688
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P19689
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P19690
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P19691
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P19693
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P19731
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P19734
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P19750
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P19751
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P19755
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P19777
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P19784
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P19793
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-P19795
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19799
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-P19802
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	0	 	 	[*]
	VR-P19819
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19819R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19820
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19820R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19821
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19821R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19835
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P19845
	 	[*]	 	[*]	 	[*]	 	 	20	 	 	 	0	 	 	[*]
	VR-P19855
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P19858
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19860
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P19863
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P19876
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19908
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	0	 	 	[*]
	VR-P19913
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P19941
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P19973
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P19980
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P19981
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P20000
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P20006
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P20007
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P20009
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P20010
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P20018
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P20019
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20023
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20024
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20031
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P20053
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20054
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P20055
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P20066
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	0	 	 	[*]
	VR-P20067
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

p

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-P20068
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20079
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20092
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P20093
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P20119
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20129
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20138
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20139
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20140
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20159
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20160
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20161
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20162
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20164
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20167
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20168
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20170
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20171
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20172
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20177
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20182
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20184
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20187
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20189
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20190
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20191
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20203
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20209
	 	[*]	 	[*]	 	[*]	 	 	20	 	 	 	0	 	 	[*]
	VR-P20210
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20215
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20232
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P20243
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P20283
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P20286
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20287
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20288
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-P20333
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-P20333R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20334
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P20334R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20335
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20335R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20336
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P20336R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20337
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20342
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20343
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20344
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20345
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20353R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20354R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20355R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20356
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20356R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20361
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P20361R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20362R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20363R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20364R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20396
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P20401
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20411
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20450
	 	[*]	 	[*]	 	[*]	 	 	20	 	 	 	0	 	 	[*]
	VR-P20451
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20452
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P20466
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P20467
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P20468
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P204877
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20498
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P20499
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20500
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	30	 	 	[*]
	VR-P20500R
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	0	 	 	[*]
	VR-P20532
	 	[*]	 	[*]	 	[*]	 	 	20	 	 	 	0	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-P20536
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P20537
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P20554
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20559
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20571
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20573
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20585
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20586
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20587
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20587R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20594
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	30	 	 	[*]
	VR-P20594R
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	0	 	 	[*]
	VR-P20598
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P20603
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P20612
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20612R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20619
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P20620
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P20642
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	30	 	 	[*]
	VR-P20642R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20643
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P20643R
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P20644
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20644R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20645
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20645R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20647
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20651
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20652
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20652R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20653
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20654
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20655
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20655R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20663
	 	[*]	 	[*]	 	[*]	 	 	20	 	 	 	30	 	 	[*]
	VR-P20665
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20665R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-P20666
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20666R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20671
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20672
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20675
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P20675R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20694
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20694R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20697
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20697R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20699
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20699R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20702
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20702R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20703
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20706
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20711
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P20711R
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P20712
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20712R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20715
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P20715R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20716
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20716R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20719
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20720
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20722
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P20729
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20729R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20730
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P20731
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P20731R
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P20732
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20732R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20733
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20735
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20737
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-P20737R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P20751
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20751R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20752
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20752R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20758
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20766
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20766R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20767
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20767R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20779
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20779R
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P20797
	 	[*]	 	[*]	 	[*]	 	 	70	 	 	 	0	 	 	[*]
	VR-P20798
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20830
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20830R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20844
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20848
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P20848R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P20849
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P20849R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P20850
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-P20850R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20851
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20859
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-P20859R
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-P20863
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20863R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20873
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20873R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20877
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20878
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20890
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	30	 	 	[*]
	VR-P20891
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	30	 	 	[*]
	VR-P20895
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20895R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20901
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-P20902
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-P20909
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	0	 	 	[*]
	VR-P20910
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	0	 	 	[*]
	VR-P20911
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	0	 	 	[*]
	VR-P20912
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	0	 	 	[*]
	VR-P20913
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	0	 	 	[*]
	VR-P20915
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20921
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20925
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20927
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20930
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20934
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20934R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20935
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	30	 	 	[*]
	VR-P20935R
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	0	 	 	[*]
	VR-P20936
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P20936R
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P20937
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	30	 	 	[*]
	VR-P20940
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20940R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20944
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20944R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20947
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P20947R
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P20948
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P20948R
	 	[*]	 	[*]	 	[*]	 	 	#N/A	 	 	 	0	 	 	[*]
	VR-P20949
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P20949R
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P20950
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P20950R
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P20951
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P20951R
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P20952
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P20952R
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P20961
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20961R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20962R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-P209641
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20984
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-P20984R
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P20985
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-P20986R
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-P20987
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20987R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20988
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20988R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P20989
	 	[*]	 	[*]	 	[*]	 	 	80	 	 	 	30	 	 	[*]
	VR-P20989R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P20991
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20992
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-P20993
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	30	 	 	[*]
	VR-P20993R
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	0	 	 	[*]
	VR-P20994
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	30	 	 	[*]
	VR-P20994R
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	0	 	 	[*]
	VR-P20998R
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	0	 	 	[*]
	VR-P21006
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	0	 	 	[*]
	VR-P21018R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P21019R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P21020R
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-P21024R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P21034R
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-P304066
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P304555
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-P69105
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-PZ10025
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ10195
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-PZ10209
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ10210
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ10398
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-PZ10522
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ10523
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ11075
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ11146
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ11147
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-PZ11153
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ11154
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ11155
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ11156
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ11309
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-PZ11310
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-PZ11505
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ11507
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-PZ11509
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ11511
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-PZ11673
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-PZ11850
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ11851
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ11958
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-PZ12056
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ12057
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ12138
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ12139
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ12140
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ12405
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-PZ12443
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-PZ12472
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-PZ13048
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-PZ13049
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-PZ13057
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ13134
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-PZ13166
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-PZ13176
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-PZ13178
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-PZ13233
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ13377
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ13667
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ13675
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ13677
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ13679
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ13680
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ14516
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-PZ14592
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	30	 	 	[*]
	VR-PZ14648
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-PZ14801
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-PZ14867
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ15405
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ15406
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ15407
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ15408
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ15495
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ15631
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ15640
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-PZ15641
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ15722
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ15724
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ15726
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ15728
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ15939
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-PZ15978
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-PZ15979
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-PZ16151
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ16152
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ16153
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ16251
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-PZ16268
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ16269
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ16270
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ16271
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ16272
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ16507
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ16535
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ16544
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-PZ16756
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-PZ16762
	 	[*]	 	[*]	 	[*]	 	 	70	 	 	 	60	 	 	[*]
	VR-PZ16776
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ16964
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ16965
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	0	 	 	[*]
	VR-PZ16966
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	1	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-PZ17035
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ17041
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ17042
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ17097
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-PZ17098
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ17099
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ17128
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ17152
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ17213
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-PZ17222
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-PZ17346
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-PZ17347
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-PZ17375
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ17424
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ17487
	 	[*]	 	[*]	 	[*]	 	 	70	 	 	 	60	 	 	[*]
	VR-PZ17501
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ17502
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ17503
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ17504
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ17505
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ17542
	 	[*]	 	[*]	 	[*]	 	 	70	 	 	 	60	 	 	[*]
	VR-PZ17544
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ17545
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ17555
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ17556
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ17629
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ17630
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ17631
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ17632
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ17650
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-PZ17651
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-PZ17652
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ17776
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-PZ17777
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-PZ17778
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-PZ17831
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ17834
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-PZ17846
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ17850
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-PZ17934
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-PZ17948
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-PZ17949
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-PZ17950
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-PZ17953
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-PZ17955
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-PZ17956
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ17966
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ17967
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ17968
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ17969
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ17970
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ17971
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ17983
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ17984
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ17985
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ17987
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ18020
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-PZ18021
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-PZ18022
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-PZ18035
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-PZ18036
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-PZ18037
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-PZ18059
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-PZ18064
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-PZ18088
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ18109
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ18111
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ18112
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ18113
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ18132
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ18133
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ18134
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ18198
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ18199
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-PZ18202
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ18210
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ18211
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ18212
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ18213
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ18214
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ18216
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ18250
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-PZ18251
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-PZ18370
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	60	 	 	[*]
	VR-PZ18372
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ18373
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	30	 	 	[*]
	VR-PZ18407
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ18408
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ18442
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ18443
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ18452
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ18453
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ18454
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ18458
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ18458R
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-PZ18514
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-PZ18606
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ18607
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ19556
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-PZ19909
	 	[*]	 	[*]	 	[*]	 	 	25	 	 	 	0	 	 	[*]
	VR-PZ3101
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-PZ3117
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-PZ3158
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-PZ3159
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-PZ3160
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-PZ6654
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ6655
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ6782
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ6783
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-PZ6783R
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	0	 	 	[*]
	VR-PZ6953
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-PZ6963
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ7067
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ7299
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ7576
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ7577
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ7692
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ7693
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ7694
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ7695
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ7696
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ7708
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	0	 	 	[*]
	VR-PZ7709
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ7892
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ7896
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ7897
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ7898
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ7899
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ7900
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ7901
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ8061
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ8066
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ8261
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-PZ8291
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-PZ8372
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-PZ8387
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ8392
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ8408
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ8462
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	0	 	 	[*]
	VR-PZ8463
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ8464
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ8476
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	0	 	 	[*]
	VR-PZ8477
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ8478
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	0	 	 	[*]
	VR-PZ8479
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ8487
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-PZ8488
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-PZ8489
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Item	 	Description	 	MOQ	 	MPQ	 	LT	 	CW	 	Manuf
	VR-PZ8533
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ8688
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-PZ8688R
	 	[*]	 	[*]	 	[*]	 	 	30	 	 	 	30	 	 	[*]
	VR-PZ8748
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]
	VR-PZ8750
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ8769
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ8836
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ8860
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ8861
	 	[*]	 	[*]	 	[*]	 	 	55	 	 	 	0	 	 	[*]
	VR-PZ8865
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ8883
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ8884
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ8885
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ8886
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-PZ8887
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ8891
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ8893
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ8895
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-PZ8897
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ8900
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ8907
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-PZ8908
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-PZ8909
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-PZ8910
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	30	 	 	[*]
	VR-PZ8928
	 	[*]	 	[*]	 	[*]	 	 	45	 	 	 	0	 	 	[*]
	VR-PZ8929
	 	[*]	 	[*]	 	[*]	 	 	40	 	 	 	0	 	 	[*]
	VR-PZ9064
	 	[*]	 	[*]	 	[*]	 	 	60	 	 	 	0	 	 	[*]
	VR-PZ9106
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ9120
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	0	 	 	[*]
	VR-PZ9263
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	30	 	 	[*]
	VR-PZ9904
	 	[*]	 	[*]	 	[*]	 	 	50	 	 	 	60	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

Exhibit 4.1.8 – Quality and Other Requirements 

Veraz Qa Requirements

For Turn Key Manufacturing And Assembly

by Flextronics

PROPRIETARY DATA

This controlled document is the property of Veraz Networks LTD. Any duplication; reproduction or
transmission to unauthorized parties without the permission of Veraz Networks LTD. is prohibited.

 

Veraz Networks LTD.

43 Hasivim St.

Petach-Tikva, 49517

ISRAEL

 

[*] Confidential information in this Exhibit has been omitted and filed separately with the Commission.
Confidential treatment has been requested with respect to the omitted portions.

1.

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	1.	 	QUALITY ASSURANCE
	 
	1.1	 	General
	 
	1.1.1	 	This chapter specifies Veraz Networks requirements for a Quality Management System from the
supplier of equipment and services.
	 
	1.1.2	 	The supplier1 shall submit his quality manual to Veraz Networks QM.
	 
	1.1.3	 	The quality assurance program for the product shall be presented to Veraz. It will refer to
incoming inspection, process control, I.C.T, final tests, packing and acceptance tests.
	 
	1.1.4	 	Any part of the product manufactured for the main contractor by sub-contractors, or any of
its subsidiaries, shall be subject to final inspection and approval of the main contractor.
	 
	1.1.5	 	It is understood that despite any inspection carried out by Veraz, the workmanship, material
and conformity of any of the parts is the sole responsibility of the main contractor.
	 
	1.1.6	 	Beginning of mass on-going production of new line/product, is subjected to Veraz operational
and Quality Management approval.
	 
	1.1.7	 	The contractor will collect, analyze report and archive the production quality data in a
computerized system agreed with Veraz. As default requirement all Veraz products tests records
will be collected in the QMS system.
	 
	1.1.8	 	The contractor will enable max visibility of the production data to Veraz QM including
direct Web access to collected data if feasible.
	 
	1.1.9	 	Status Reports
	 
	 	 	The contractor shall provide Veraz’s with activity and progress reports. The reports will be
reviewed in detail, on a 1-month basis, unless agreed otherwise by Veraz. The progress made
since the latest report compared with the plans and will alert on any schedule slip. The
contractor should indicate what corrective actions are necessary and taken to bridge gaps.
In addition, the report shall overview the activities that are planned until the next report
is issued.
	 
	1.2	 	Quality Certifications
	 
	 	 	Contractor is obliged to maintain the ISO 9001 and ISO 14001 certification. Manufacturing
and testing will be according to agreed workmanship standards and the approved relevant
drawings, supplied by Veraz.
	 
	1.3	 	Quality records disclosure
	 
	 	 	Contractor is obliged to disclose (for reading only) all quality records upon request. The
quality records that should he disclosed include [but not limited to]:

	 	a)	 	Systematic Failure reports
	 
	 	b)	 	External ISO quality audits.
	 
	 	c)	 	QC records visual inspection results etc.
	 
	 	d)	 	MRBs
	 
	 	e)	 	Failure Analysis
	 
	 	f)	 	Subcontractors audits and quality reports
	 
	 	g)	 	ICT results
	 
	 	h)	 	Functional Test results

 

			
	1	 	The terms Supplier or Contractor are
equivalent to Flextronics in this document.

[*] Confidential information in this Exhibit has been omitted and filed separately with the Commission.
Confidential treatment has been requested with respect to the omitted portions.

Page 2. of 18

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	1.4	 	Source Inspection
	 
	 	 	Any work carried out by the contractor may be subjected to tests and inspection of Veraz
quality control on the contractor’s premises, or at other premises.
	 
	 	 	Veraz is privileged to decide to either perform sample tests or 100% tests.
	 
	 	 	The contractor shall set up space and working facilities [i.e. table, chair, internal phone,
use of available fax, access to contractors production files via computer and internet,
network access for relevant documentation and data] and allow the use of equipment to Veraz
Q.C. representatives at any time and with no extra charges.
	 
	 	 	Veraz preserves the right to decide to use services of a third party for the performance of
Q.C. tests. In such a case, the terms mentioned above apply and the 3rd party as
if it was Veraz personnel.
	 
	1.5	 	Certificate of Compliance
	 
	1.5.1	 	The contractor shall attach per requirement from Veraz a C of C [COC] with all the card’s
serial numbers, signed by its Q.C., certifying that all characteristics of the shipment
conformed to Veraz requirements. The COC may be a QMS declaration with shipment report, with
format agreed with Veraz QM. COC content will:

	 	•	 	Certify that the materials on the referenced order meet the applicable specification requirements.
	 
	 	•	 	Certify that all relevant electrical and visual test were successfully passed
	 
	 	•	 	Certify that the goods that this C.O.C. referring to is described in the
relevant packing list of the shipment and that shipment was checked and
approved by Q.C.

	1.6	 	Non-conformance Report & MRB
	 
	 	 	When F.F.F. may be affected by a decision to accept mechanical parts with discrepancies by
approving a non-conformance report or a M.R.B, Veraz contract manager and Q.A. manager will
be notified and the contractor shall have Veraz’s Operation and quality approval, prior to
the acceptance.
	 
	1.7	 	Material Purchasing and Control
	 
	1.7.1	 	The contractor will purchase material only from the vendors listed in the Q.V.L.
	 
	1.7.2	 	Purchase of process production materials such as soldering paste, no-clean fluxes and so on,
must comply with those listed in Veraz’s Qualified List of Process Materials.
	 
	1.7.3	 	Any new suggested material should get the approval of Veraz by transferring its full data
sheet, characteristics, the manufacturer and vendor names and addresses and if needed samples
of the suggested material.
	 
	1.7.4	 	Veraz reserves the right to supply the contractor with special materials as agreed by both
sides.
	 
	1.7.5	 	Non catalogue items or different manufacturers and vendors will require the transfer of
specifications and data sheets to Veraz including samples for qualification and approval. The
contractor is also responsible for qualification performed by the supplier or contractor.
	 
	1.7.6	 	The contractor will send the qualification reports, samples and all relevant test reports to
Veraz for approval.
	 
	1.7.7	 	The contractor shall perform incoming inspection according to Veraz instruction and notify
the contract manager in Veraz of any discrepancy within 5-working days from receipt of the
shipment. The control should fit to the following requirements:
	 
	1.7.8	 	It is the responsibility of the contractor to control and maintain all the components and
material in a good condition.
	 
	1.7.9	 	The maximum scrap from receiving components and material through all operation process
(storage, kiting, manufacturing, testing, packing etc.) will be lower than 1% of the total
value and lower than 1% from the total quantity.

[*] Confidential information in this Exhibit has been omitted and filed separately with the Commission.
Confidential treatment has been requested with respect to the omitted portions.

Page 3. of 18

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	1.7.10	 	It is the responsibility of the contractor to inform Veraz in any case of exceeding the above limited scrap.
	 
	1.8	 	Incoming Inspection
	 
	1.8.1	 	The contractor will perform the incoming inspection on the bare boards and all components or
assemblies according to procedures agreed with Veraz.
	 
	1.8.2	 	Veraz is privileged to demand a few samples of supplied items for quality tests in case a
change of supplier is approved.
	 
	1.8.3	 	Contractor will analyze incoming inspection data and will report Veraz of the worse 5
suppliers on a quarterly basis.
	 
	1.8.4	 	The contractor will maintain a documented corrective and preventive process with the
suppliers.
	 
	1.9	 	Devices Date Codes
	 
	 	 	Date codes for electronic purchased and used devices [components and PCBs] will be subjected
to inspection based on contractors procedures:
	 
	 	 	PCB: procedure WI-PR-021 05 — storage and handling of PCBs.
	 
	 	 	Components: WI-PR-01 021 — management and control of date expired components.
	 
	1.9.1	 	Contractor will refer to Veraz Engineering for any deviation [non-conformance] from the
required dates found in incoming inspection or before use [production line]. Contractor
must receive written approval/instructions from Veraz Engineering for accepting/using
those devices.
	 
	1.9.2	 	Veraz engineering may request to examine the devices e.g. to do solderability test.
	 
	1.9.3	 	The preferred tool to manage non-conformances is Veraz tracker. Veraz may require accepting
non-conformances approval requests using the Tracker tool only.
	 
	1.10	 	Dry Packs
	 
	1.10.1	 	Electronic devices with more than 44 terminals must be dry vacuum packed. If they arrive
with an open package, they should be rejected or dried as defined in 4.2 below.
	 
	1.10.2	 	If any vacuum package is opened, the devices shall be used (assembled) within 48 hours
(unless the manufacturer defined different on the component package) or replaced or sealed in
another vacuum package.
	 
	1.10.3	 	If these devices stay for 48 hours in the open air (unless the manufacturer defined
different on the component package), they should be dried in an oven for 24 hours at 125oc or
196 hours at 40oc and then repackaged into another vacuum package.
	 
	1.11	 	Warehouse Conditions
	 
	1.11.1	 	Order and proper organization that will enable the warehouse employees to locate the right
component immediately with proper identification method and FIFO management.
	 
	1.11.2	 	E.S.D. procedures for components handling.
	 
	1.11.3	 	Computer stock control and flow control.
	 
	1.11.4	 	Dry vacuum packs for sensitive components with more than 44 terminals.

[*] Confidential information in this Exhibit has been omitted and filed separately with the Commission.
Confidential treatment has been requested with respect to the omitted portions.

Page 4. of 18

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	1.12	 	Production
	 
	1.12.1	 	Production floor will be covered with E.S.D. anti static surface, as required and periodical
testing of the surface resistance shall be carried out.
	 
	1.12.2	 	All production employees will test their E.S.D. wrist and leg straps in the proper facility.
	 
	1.12.3	 	Handling of components is subjected to prior connection of straps to ground and the wearing
of anti static a 100% cotton jackets.
	 
	1.12.4	 	The tables will be covered with an anti static and conductive surfaces and connected to ground.
	 
	1.12.5	 	All production areas should be temperature and humidity monitored.
	 
	1.12.6	 	The production areas should be clean and with low dust level.
	 
	1.12.7	 	Any major changes in the production condition (transfer to another line, machines
changes...) will be notified to Veraz and subjected to Veraz QM and Operation approval.
	 
	1.12.8	 	Assembly profiles will be approved for any new card by running the process with sensors and
consideration of the mask data and manufacturers requirements.
	 
	1.12.9	 	X-RAY inspections will be recorded and saved for 12 months. The X-RAY data and photos will
be available for Veraz review.
	 
	1.12.10	 	Testing Equipment and setups status will be reviewed for all new cards unless agreed
otherwise, in the NPI review.
	 
	1.12.11	 	Testing equipment and setups will be configuration controlled.
	 
	1.12.12	 	Process flow route card will be prepared and used for all Veraz Items and systems
production, indicating the steps of production and inspection required and performed.
	 
	1.12.13	 	BGA — BGA components handling and considerations will be agreed with Veraz. Veraz may
require special attention and process for using and handling BOA components.
	 
	1.12.14	 	The contractor shall not deviate from the requirements and the instructions included in the
Production Folder without the Veraz contract manager’s written approval.
	 
	1.12.15	 	Configuration Control; Only Veraz’s contract manager is responsible for the submission of
E.C.Ns to the contractor. Implementation of the E.C.N is the contractor’s responsibility.
	 
	1.12.16	 	The contractor is responsible for the comprehensiveness of the Production Folder; making
sure that it contains all the needed information and that every piece of information is
entirely clear. The contractor will confirm that the Production Folder is complete.
	 
	1.12.17	 	In the event of contradicting information or discrepancies, the contractor will be
responsible to notify Veraz’s contract manager, within 7-working days from receiving the
documents.
	 
	1.12.18	 	The Production quality will meet the requirements of IPC standards applicable version class
3 – e.g. IPC 610 C as general requirements, IPC 7711 for rework. Visual testing will be
accordingly.

[*] Confidential information in this Exhibit has been omitted and filed separately with the Commission.
Confidential treatment has been requested with respect to the omitted portions.

Page 5. of 18

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	1.13	 	Production yield, Repair, Failure Analysis & Corrective Action
	 
	1.13.1	 	The yield acceptance criteria required for mature production line is:

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	1st yield	 	FUNC TEST	 	HASS/BI	 	System	 	QC	 	DOA
	Targets – cards level:
	 	[*]%	 	 	[*]	%	 	 	[*]	%	 	 	[*]	%	 	 	[*]	%	 	 	[*]	%
	 
	 	[*]%	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	[*]%	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Targets
– cards level exceptional cards:
	 	[*]%	 	 	[*]	%	 	 	[*]	%	 	 	[*]	%	 	 	[*]	%	 	 	0[*]	%
	[  *  ], [  *  ], [  *  ], [  *  ]
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 

	 	 	The criterion for maturity is after [*] lots of
on-going production i.e. from the [*] lot but not including the [*].
	 
	1.13.2	 	The yield measurement is at the key test station agreed with Veraz i.e. ICT, JTAG, QC visual
inspection after touchup, FTP final test, BI/HASS, QC after FTP. Yield measurement will not
take in account test equipment problems and engineering problems.
	 
	1.13.3	 	In case the Yield is lower than the above defined acceptance levels for 2 lots and more ,
the following rules apply :

	 	 	 	 	 
	severity	 	Yield requirement gap	 	Actions
	Minor

	 	Gap = 0-100%
	 	Operations QC shall present to Veraz
QA corrective & preventive actions
plan and be followed in the
periodical meetings
	 
	 	 	 	 
	Major

	 	Gap = 100%-200%
	 	Failure cause analysis will be
performed by the contractor with
Veraz Engineering support. Results
and C&P plan will be reviewed in a
dedicated meeting not longer than 3
weeks from discovery.
	 
	 	 	 	 
	Critical

	 	Gap > 200%
	 	MRB shall be called.
Veraz has the right to reject the lot.
Failure cause analysis will be
performed by the contractor with
Veraz Engineering support. Results
and C&P plan will be reviewed in a
dedicated meeting not longer than 1
weeks from discovery.

	1.13.4	 	The contractor is required to achieve the quality targets Agreed with Veraz QM and
Operation. Targets may be updated based on Veraz expectations and contractors performance. As
a start [after production is matured– see 1.13] the targets will apply as defined above.
	 
	1.13.5	 	The contractor is required to improve his quality targets on a quarterly basis, the new
quality targets will be discussed in the monthly quality meetings.
	 
	1.13.6	 	The contractor will examine his quality records on a monthly basis to achieve the above
quality targets, in case of deviation, corrective action will be implemented.
	 
	1.14	 	Systematic failures
	 
	1.14.1	 	Systematic workmanship failure is defined as: a failure that had been observed in more than
10% of the cards or 0.5% in component level for repeating components failures] and may be
caused by a certain fault (not necessarily related to certain location on the inspected item
but is characterized by specific irregular repeating failure with same failure type such as
shorts, opens, missing screw, electrical etc.)
	 
	 	 	Supplier shall repair systematic workmanship failures and perform, failure analysis &
corrective action upon customer request.

[*] Confidential information in this Exhibit has been omitted and filed separately with the Commission.
Confidential treatment has been requested with respect to the omitted portions.

Page 6. of 18

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	The systematic failures may be observed at one or more of the working stations in customer
process such as: ongoing inspection (for not STS products), mechanical assembly, functional
tests, integration tests, HASS, aging etc. or due to customer complaints. In case of
sampling inspection in customer (such as in mechanical assembly), also a screening will be
performed by supplier whenever a workmanship systematic failure is observed.
	 
	 	 	Supplier is obliged to response according to the failure severity as following:

Critical – Delay in Shipments

Repair 1 day

Failure Analysis – 15 working days

Corrective Action – 17 working days

Major – No delay in shipments, but very low yield (more than 10% defects)

Repair – 5 working days

Failure Analysis – 15 working days

Corrective Action – 17 working days

Minor –No delay in shipments, low yield (5% to 10%)

Repair –10 working days

Failure Analysis – 20 days

Corrective Action – 25 days
	 
	1.14.2	 	Supplier will submit Veraz a “systematic failure report” for systematic workmanship failures
observed in its workstations, no later than 1 day after observation.
	 
	1.14.3	 	Supplier will send a copy of the closure report of the systematic failure detailing the
failure analysis and corrective action.
	 
	1.14.4	 	Systematic failures will be reviewed in the periodical quality meetings.
	 
	1.15	 	Cleanliness
	 
	 	 	The contractor shall perform the required work only with Veraz approved materials, which are
C.F.O free. No O.D.C. (Ozone Depleting Compounds) shall be used. The process and soldering
materials shall be No Clean type.
	 
	 	 	The contractor shall perform the work using work areas; process and materials that guaranty
that the product will pass the cleanliness acceptability requirements of IPC-A-610C [or
newer] class 3.
	 
	 	 	The contractor shall perform periodical, at least once per year, cleanliness tests on
assembled boards and send the results to Veraz.
	 
	 	 	Veraz reserves the right to review the process material list, the periodical test reports
and process control reports.
	 
	1.16	 	In Circuit Tests
	 
	1.16.1	 	In Circuit Tester Designed by Contractor
	 
	1.16.1.1	 	Veraz will submit, the comprehensive information needed to design and manufacture I.C.T
adapters and the design of I.C.T test program. The test software will be written by the
contractor.
	 
	1.16.1.2	 	Veraz demands its approval of the test program — the program readiness will be reviewed
with Veraz e.g. in the NPI review.
	 
	1.16.1.3	 	The contractor shall check and verify that the tester is properly functioning prior to
continuance the production after the first series.
	 
	1.16.1.4	 	Veraz demands that test report results of every batch will be saved and available for analysis ..
	 
	1.16.1.5	 	Changes applied to the ICT will be notified to Veraz QA and Eng. And will be configuration controlled.

[*] Confidential information in this Exhibit has been omitted and filed separately with the Commission.
Confidential treatment has been requested with respect to the omitted portions.

Page 7. of 18

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	1.16.2	 	In Circuit Tester Supplied by Veraz
	 
	1.16.2.1	 	The property of the tester and its software is the property of Veraz.
	 
	1.16.2.2	 	The contractor shall check and verify that the tester is properly functioning prior to
starting the ongoing production.
	 
	1.16.2.3	 	It is the responsibility of the contractor to make basic maintenance and to keep the
adapter serviceable.
	 
	1.16.2.4	 	Changes applied to the ICT will be under Veraz Engineering responsibility and will be
coordinated with contractor’s engineering.
	 
	1.16.3	 	Changes approval
	 
	 	 	Veraz approval is required for any change in the limits of the tests or any test skip.
Engineering department and QA must be notified about test skips.
	 
	1.17	 	First Samples [NPI]
	 
	1.17.1	 	The contractor will manufacture a first off batch in order to check the full documents,
techniques, facilities, adapters; jigs, materials, processes and the product performance.
	 
	1.17.2	 	The contractor will inspect the outcomes from the first production, the readiness of the
line and production file, the knowledge and know-how of the workers to perform the work,
identify, gaps to be completed, corrective actions required and training required. The
contractor will perform an NPI meeting with Veraz to review the FAI [first article inspection]
results before continuance to on going production. Veraz will review the FAI /NPI data with
the contractor and decide upon approval continuation of setting corrective action before
continuation.
	 
	1.17.3	 	If Veraz has performed tests of the samples/fist series the test reports will be delivered
from Veraz to the contractor with failure description. The contractor should give explanations
to the failures and present current and future corrective actions made and that are to be
taken.

	 	1.1	 	All corrective actions shall be bound to a certain agreed timetable.
	 
	 	1.2	 	Veraz may decide that the failures justify another round of sampling and qualification.
	 
	 	1.3	 	The production process will start only after Veraz’s approval.
	 
	 	1.4	 	Veraz reserves the right to perform additional tests throughout the duration of the contract.

	1.17.4	 	We shall distinguish between 4 types of “First Batch”:

	 	A)	 	R&D samples
	 
	 	B)	 	New Item —“Zero Series”
	 
	 	C)	 	New operation site/manufacturer/line/item type
	 
	 	D)	 	Functional Testing

	1.17.5	 	Veraz will notify Contractor in advance about additional products that should go through a First Batch process.
	 
	1.17.6	 	Contractor will notify Veraz in advance about products that should go through a First Batch process type C.
	 
	1.17.7	 	Upon such notification Contractor will act as following:

	 	•	 	Notify Veraz for completion of the First Batch.
	 
	 	•	 	Submit the First Batch to Veraz/call Veraz for local tests. The batch would
be marked with a “First Batch” or equivalent label.
	 
	 	•	 	Deliveries shall be permitted after Veraz’s “First Batch” approval.
	 
	 	•	 	Contractor will submit Veraz feedback report for the first batch regarding
process, testing, stability, readiness, manufacturability etc.
	 
	 	•	 	Veraz’s Engineering will review the feedback report and will respond by
defining corrective action and schedule for implementation
	 
	 	•	 	QC Veraz may perform a complimentary tests, audit and mechanical & visual
inspections. According to the results QA will approve or reject the
First Batch.

[*] Confidential information in this Exhibit has been omitted and filed separately with the Commission.
Confidential treatment has been requested with respect to the omitted portions.

Page 8. of 18

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	•	 	Contractor shall perform Analysis & Corrective actions according to the report.
	 
	 	•	 	In case of rejection, Contractor is required to perform another First Batch.
	 
	 	•	 	Approving the First Batch is mandatory gate for mass production.

	1.18	 	Visual Inspections
	 
	1.18.1	 	Minimum requirements

First article inspection should be performed:

	 	 	 	ü Each time SET-UP is changed
	 
	 	 	 	ü At the beginning of each shift.
	 
	 	 	 	ü Each time the process is stopped for more then 1 hour.

Note: At each reel or stick replacement the contractor must ensure by double check
that the same components arc used (ID and shape).

	1.18.2	 	Minimum requirements for visual inspection

First Article Inspection requirements:

	 	 	 	ü Check implementation of last ECN or engineering instruction according to production file
	 
	 	 	 	ü Check that all components are present on CS and PS according to PL.
	 
	 	 	 	ü Check correct polarity of components (capacitors, diodes) according to a list, which defines the relevant components or a      specific instruction
	 
	 	 	 	ü Check soldering quality which must include:
	 
	 	 	 	ü Visual check by magnifying glass (*5) of solder joints
	 
	 	 	 	ü Visual check by microscope of Fine Pitch solder joints.

	1.18.3	 	Final. Test Procedure
	 
	1.18.3.1	 	Veraz will submit to the contractor the test specifications e.g FTP, FTR and calibration instructions.
	 
	1.18.3.2	 	The contractor will be responsible for the calibration of FTJ. He should be capable of
performing • maintenance and trouble shooting, to a certain agreed level.
	 
	1.18.3.3	 	Veraz will be responsible to perform any needed upgrade that would arise due to, either
ECN, a product modification or any other need.
	 
	1.18.3.4	 	Should any failure of product occur in the final tests, Veraz expects the contractor to
gain the knowledge required to perform the troubleshooting and repair.
	 
	1.18.3.5	 	The repaired product should conform to all workmanship and performance requirements.
	 
	1.18.3.6	 	Changes applied to the Test setups will be configuration controlled.
	 
	1.19	 	QC Final & STS
	 
	1.19.1	 	The production will perform 100% final tests. The contractor’s Q.C. is required to perform
sample tests or 100% tests according to IS0-2859. Reduction of QC test level would be
considered based on the monthly reports reviewed.
	 
	1.19.2	 	The outgoing quality in this stage should be “Zero defects”, which means that only products
that passed successfully the Visual Inspection could be submitted to customers.
	 
	1.19.3	 	In general Contractor will allow Veraz to perform QC inspection for the finish goods.
	 
	 	 	It is the final goal of both parties to work in the STS mode. Working in this mode means
that a product which reached a degree of high quality shall be delivered directly to the
customer w/o going through the customer’s Incoming Inspection.
	 
	 	 	STS will be applied subjected to Vertaz approval based on manufacturing process and supply
quality.

[*] Confidential information in this Exhibit has been omitted and filed separately with the Commission.
Confidential treatment has been requested with respect to the omitted portions.

Page 9.
of 18

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

Once the certification is achieved it should be maintained by assuring high quality. The
product’s quality will be monitored by Veraz by performing Ingoing Inspections from time to
time, process audits and constantly monitoring the product’s quality.

Veraz is privileged to suspend or cancel STS certification where degradation in Quality is
observed. In this case Contractor must tight QC final inspection and to consider adding
inspection stations in the process according to the nature of the problems such as AOI,
X-Ray.

Contractor QC final visual and electrical inspection sampling plan will be as described in
the following tables unless agreed otherwise with Veraz QM:

Assembly only

Contractor QC Visual Final Inspection sampling plan should move from Reduced to Normal and
Tightened according to the plan rules but as minimum should comply to the table bellow:

	 	 	 
	Veraz- incoming Inspection	 	Contractor-QC Visual Final Inspection
	First Batches – 100%

	 	Until approved otherwise – 100%
	Sample

	 	Sample, Tightened, AQL=1%
	STS

	 	Sample, Normal, AQL=1%)

Functional Testing & Turn key

Contractor QC Visual & Electrical Final Inspection sampling plan may change to Reduced ,
Normal and Tightened according to the plan rules but as minimum should comply to the table
bellow:

	 	 	 	 	 
	 	 	Contractor – QC Visual Final	 	Contractor-QC Electrical
	Veraz- Inspection	 	Inspection	 	Final Inspection
	Flexible Sampling

	 	Until approved otherwise – 100%

 Sample, Tightened, AQL=1%

	 	Until approved
otherwise – 100%

Sample, Tightened,
AQL=1%
	 
	 	 	 	 
	 

	 	Sample, Normal, AQL=1%
	 	Sample, Normal, AQL=1%

	 	 	If requested — the contractor’s Q.C shall submit final visual & Electrical reports for
assembled cards Prior to shipment for Veraz QC/QA approval. In on-going normal production
reports will be reviewed monthly.
	 
	1.20	 	PIP
	 
	1.20.1	 	The final test includes at least the following subjects:

	 	ü	—	Electrical tests
	 
	 	ü	—	Configuration test.
	 
	 	ü	—	Final visual test.
	 
	 	ü	—	Verify that all products were successfully passed the previous process stages

	1.20.2	 	The outgoing quality in this stage should be Zero defects, which means that only products
that passed successfully the Final Test could be submitted to customers.
	 
	1.20.3	 	Data Collection
	 
	 	 	The FTJ /other test setup supplied by Veraz may include Quality Data Collection System.
Contractor is responsible to report and collect functional testing results in a computerized
system agreed with Veraz.
	 
	1.20.4	 	The yield at the Final test of each line [i.e. cards production line, System integration
tests etc.] will be monitored by Contractor and corrective actions should be taken in order to
improve the yield and the’ manufacturing process.
	 
	1.21	 	Visual Inspection of Packaging
	 
	 	 	Prior to any shipment, the contractor’s Q.C. will perform visual inspection to
confirm packages content and conformance to the purchase order.
	 
	 	 	Veraz may conduct QC inspection [by itself or using a subcontractor] too on a packaged
shipment ready for customer prior shipment.

[*] Confidential information in this Exhibit has been omitted and filed separately with the Commission.
Confidential treatment has been requested with respect to the omitted portions.

Page 10. of 18

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	1.22	 	Manufacturing Process, Equipment and Tools
	 
	1.22.1	 	Manufacturing process will be done with proper equipment and tools such as: SMT assembly,
Through Hole assembly, wave solder, cleaning PCB and stencil, v-grove cutter, Magnifying lens,
microscopes, Mechanical tools etc.
	 
	1.22.2	 	The production process will be done according to a flow agreed with Veraz Eng and QA. Based
on the production file.
	 
	1.22.3	 	Test equipment calibration
	 
	 	 	Test equipment: should be calibrated according to international standards
	 
	1.23	 	Documentation control
	 
	1.23.1	 	Contractor will submit feedback for the documentation received from Veraz.
	 
	1.23.2	 	Contractor is responsible to distribute, the relevant and updated drawings to each manufacturing workstation.
	 
	1.23.3	 	Contractor will maintain documentation control for each workstation.
	 
	1.23.4	 	All inspections and tests should be documented and saved and available for 3 years.
	 
	1.24	 	Acceptance Tests
	 
	 	 	Veraz preserves the right to make acceptance tests, for each batch before shipment, on the
contractor’s premises either by its Q.C./ 3rd party or by a local representative
/subcontractor who will be authorized by Veraz to make such tests.
	 
	1.25	 	Training and Certification
	 
	1.25.1	 	All activities affecting quality or dealing with special processes must be performed by a
person who has the necessary training and is properly and formerly certified. In case the
sub-contractor chooses to delegate some work to sub-contractors of his choice, it is his
responsibility to verify that they perform the task with properly trained and certified
personnel.
	 
	1.25.2	 	As a minimum all visual inspectors, QC, soldering workers, touch up workers shall be
certified for the standard (IPC-A-610 REVC CLASS 2).
	 
	1.26	 	Third Party Subcontracting
	 
	1.26.1	 	If the contractor has chosen to sub-contract part of the work to another subcontractor
(third party subcontracting) he has to get approval from Veraz’S Purchasing and QA . For this
approval, the contractor has to supply the following requirements:

	 	 	 	ü List dell third party subcontracting according to technological specialization
	 
	 	 	 	ü QA audit report done at the third party subcontracting premises.

	 	 	The work has to be done with great care and defined in writing only.
	 
	 	 	The quality requirement and first of inspection and qualification (if applicable) should be
defined in writing.
	 
	 	 	Special attention must be given to processes that affect appearance, such as painting
and special coating, where there is a fair chance that there will be some difference
between the outputs of different manufacturers.
	 
	 	 	Sub contractor quality must be monitored on a regular basis and actions for quality
improvements should be managed based on the monitoring results.
	 
	1.26.2	 	All third party subcontractors should be periodically audited (at least once per quarter of
a year unless otherwise agreed with Operation QA manager) and certified. The audit’s plan for
the certified subcontractors may be required to be represented and approved by Veraz Operation
QA.
	 
	 	 	The contractor should establish a controlled documented routine that will assure that his
contractor performs the necessary inspection and tests, and documents them prior to
delivery.

[*] Confidential information in this Exhibit has been omitted and filed separately with the Commission.
Confidential treatment has been requested with respect to the omitted portions.

Page 11. of 18

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	This routine must ensure that the products meet all Veraz requirements.
	 
	1.26.3	 	In addition to above, the contractor is not allowed to assemble the entire product in third party subcontractor.
	 
	1.27	 	Inspectors
	 
	 	 	The inspection should be performed by personnel that have been so
certified. They should be trained at least in the following
subjects:

Identification of materials, measurements, workmanship standard, use of statistical
inspection, use of production file, special requirements.
	 
	1.28	 	Audit
	 
	1.28.1	 	Veraz reserves the right to perform audits, and/or a representative of Veraz’s customer, on
subcontractor operation associated with the work done for Veraz Without an advanced notice.
	 
	1.28.2	 	Veraz will carry out periodical audits on a regular basis in order to check the contractor’s
activities according to the requirements of this S.O.W and according to the procedures,
workmanship standards, process control, quality control, packaging and finished products, and
verify that configuration control is being maintained.
	 
	1.28.3	 	In order to perform these audits, Veraz is privileged to post a resident inspector on the
contractor’s premises.
	 
	1.28.4	 	Audit Results
	 
	1.28.4.1	 	Audit results shall be presented to the contractor’s and Veraz’s contract managers and to
their quality control managers.
	 
	1.28.4.2	 	In case no serious deficiencies are found, deliveries will continue but corrective actions
and an implementation timetable will be presented to Veraz.
	 
	1.28.4.3	 	If the deficiencies are not corrected, the following steps shall be taken:

	 	ü	 	New purchase orders shall not be issued.
	 
	 	ü	 	Shipments will be stopped.
	 
	 	ü	 	The contractor will perform screening, inspection and repair on all finished products.
	 
	 	ü	 	The contractor will analyze the cause of deficiency and its impact
on other products that are already manufactured.
	 
	 	ü	 	An effective corrective action will be carried out and reported in
detail to the Veraz quality control manager.
	 
	 	ü	 	Veraz is privileged to make additional auditing.

	1.28.5	 	Third Party Inspection
	 
	 	 	Contractor’s operation may be inspected by a representative of Veraz and/or a
representative of Veraz’s customer.
	 
	1.29	 	Packing and Shipment
	 
	1.29.1	 	Approval for delivery has to be obtained by the contractor prior to each shipment.
	 
	1.29.1.1	 	Veraz will decide to release the product for shipment after performing acceptance testing
or after receipt of documentation.
	 
	1.29.1.2	 	Documentation will include test reports, failure reports, packing list and a copy of
Certificate of Compliance (COC). These documents will be sent to the Quality Control
department of Veraz.
	 
	1.29.1.3	 	The manner of shipment shall be in accordance with the cbaracterisdes of the Product,
including protection against ESD, if required, and other shipping requirements. In any case,
use of accepted practices employed by

[*] Confidential information in this Exhibit has been omitted and filed separately with the Commission.
Confidential treatment has been requested with respect to the omitted portions.

Page 12. of 18

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	the contractor for packaging and shipment shall not
absolve him from the requirement of assuring that the product reaches its destination in good
working condition as specified in the contract.
	 
	1.29.2	 	Markings on the packing shall have as a minimum Veraz’s product description, catalogue
number and quantity of parts sent, Number of P/O.
	 
	1.30	 	Quality Assurance Program
	 
	 	 	The Quality Assurance Program for the product shall be presented to Veraz’s Q.C/QA and
shall define all activities associated with quality.
	 
	 	 	The program shall cover but not be limited to the following points: Purchase control if
relevant, incoming inspection, secondary subcontractor control if relevant, process control
and final inspection instructions The program shall be presented to Veraz for approval,
prior to the beginning of manufacturing.
	 
	1.31	 	Product Testing
	 
	 	 	Every product will be inspected by contractor in accordance with drawings, or relevant
technical specifications. Products that pass Final Test and Inspection and are ready
for delivery shall be so marked.
	 
	 	 	After all the products (100%) have been in process inspection and the results documented,
the subcontractor’s final. inspection department may perform sample testing of the
production output in accordance paragraph. 8
	 
	1.31.1	 	The contractor will examine his quality records on a monthly basis to achieve the above
quality targets, in case of deviation, corrective action will be implemented.
	 
	1.31.2	 	In case that the real failure rate reaches 5% or 3 cards in a batch .or more (electrical &
workmanship) per work order at each of the inspection stages, the contractor shall notify
Veraz and prepare a corrective action plan and shall submit it to Veraz’s QA.
	 
	1.32	 	Quality reports
	 
	1.32.1	 	Data collection will be applied from all production inspection stations. The data will be
collected with SN identification from the first SN reported step [electrical tests] and
partially in XRAY] The contractor will use the best and enhanced system he has for Veraz
production data collection and analysis [e.g. QMS].
	 
	1.32.2	 	The contractor will submit monthly and per request statistical quality reports. The shape
and contents of the reports will be according to Veraz quality assurance requirements But as
minimum will contain: failure rate, failure distribution by failure code and reference
designation, DPU and trend for previous months [DPMO reports will be required per
availability]. For the electrical test it will include also First Yield and NFF rate, test
distribution.
	 
	1.32.3	 	Based on the initial reports Veraz may ask for detailed reports for specific
products/items/work stations for failure analysis. Such reports will include the failure
description, the SN, the components involved/replaced and sometimes the time/point of failure
e.g. in BI the time of failure etc.
	 
	1.32.4	 	The statistics shall be taken from all the inspection stages in the process and will be
available for review once required. Reports shall be submitted on a regular basis only from
some of the stations as detailed in the table bellow — the list of reported stations may be
changed by Veraz based on needs and focus changes:

	 	 	 	 	 
	Stage	 	Data Collection	 	Reports
	SMT
	 	 	 	 
	Wave Soldering
	 	 	 	 
	AOI

	 	ü
	 	Per request
	X-Ray

	 	ü
	 	ü
	Touch up & Visual Inspection

	 	ü
	 	ü
	ICT/Flying Probe

	 	ü
	 	ü

[*] Confidential information in this Exhibit has been omitted and filed separately with the Commission.
Confidential treatment has been requested with respect to the omitted portions.

Page
13. of 18

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 
	Stage	 	Data Collection	 	Reports
	JTAG

	 	ü
	 	ü
	FTJ

	 	ü
	 	ü
	Integration – general

	 	ü
	 	ü
	Integration – FTJ

	 	ü
	 	ü
	Integration – Visual and configuration

	 	ü
	 	ü
	Integration – BI/HASS

	 	ü
	 	ü
	Integration – stability

	 	ü
	 	ü
	Integration – Final tests

	 	ü
	 	ü
	Integration – packaging

	 	ü
	 	ü
	Final QC

	 	ü
	 	ü
	QC Shipment

	 	ü
	 	ü
	Service

	 	ü
	 	ü

	1.32.5	 	The reports shall be reviewed on a periodical basis [1 month usually] for failure analysis
and corrective action need definitions.
	 
	1.32.6	 	Contractor shall perform Failure Analysis for suspected workmanship systematic failures (had
been observed in more than 5% of the cards) or for the 5 most common problems if there are no
systematic failures that had been revealed in Contractor production or in the consequent Veraz
workstations ( JIG, Integration etc..).
	 
	1.32.7	 	Veraz and Contractor shall mutually agree on the corrective actions required. Contractor
obliged to perform corrective action on workmanship failures.
	 
	1.33	 	Reliability
	 
	 	 	Due to reliability performance Veraz may decide on reliability analysis. The contractor will
support Veraz’s analysis in any reasonable way he will be requested including internal
failure analysis based on Veraz request, data sharing, meetings, technological review and
testing etc.
	 
	 	 	If it will be found that contractor has responsibility for reliability reduction/problems,
the contractor on’his own expenses will be obligated to replace and/or fix the relevant
items and covering replacements expenses i.e. transportation. The replacement process will
be managed by Veraz.
	 
	1.34	 	Traceability
	 
	 	 	Veraz requires the contractor to keep a trace-ability system down to lot components level
[picking list] and card’s S/N
	 
	 	 	SN marking will be applied [attached to the PCB] before the first reported station.
	 
	1.35 	 	Service
	 
	 	 	Service performed by the contractor i.e. returned cards fixation will meet the following requirements:
	 
	1.35.1	 	Comply to IPC workmanship std for assembling and for rework
	 
	1.35.2	 	Reporting– The service activity will be reported to a computerized system defined by Veraz.
Veraz may choose to defined it’s own reporting system for that or agree on a local reporting
system. The reporting will include details of the item returned, the tests performed and
result , the correction performed, component replaced, acceptance date and closure date,
handling status etc. Veraz may require a detailed correction report for any item fixed and /
or summary report of the period items.
	 
	1.35.3	 	Systematic failures will be reported to Veraz according to section 1.13.4.

[*] Confidential information in this Exhibit has been omitted and filed separately with the Commission.
Confidential treatment has been requested with respect to the omitted portions.

Page 14. of 18

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	1.35.4	 	Engineering involvement – Veraz engineering may request to be directly involved in some
cases, to receive
cards’ for analysis or to be notified of any specific failure under investigation.
	 
	1.35.5	 	Periodical review [monthly] – the service reports will be reviewed in quality periodical meetings.
	 
	1.35.6	 	Testing– Testing of the fix cards will be performed according to a Veraz approved
specification/procedure and will make use of the production test equipment and test setups.
	 
	1.35.7	 	NFF – NFF found will be reported in a special failure code agreed with Veraz. Card suspected
as NFF will pass screening [BI/HAS] to avoid skipping hidden problems.
	 
	1.35.8	 	2nd and more returns – items that have been returned already for the same
phenomena , specific instructions from Veraz Engineering should be followed. If the item has
returned for the 3rd time – the card should be replaced unless specific MRB was
issued and approved by Veraz Engineering and QA manager.
	 
	1.35.9	 	Response time – the required response time will be monitored [21 days if not defined
otherwise in the contract].
	 
	1.35.10	 	Service procedure principles: returned hem acceptance – first inspection-reporting – defect
verification-[special inspections] — fixation/upgrade-inspection-reporting -shipment
	 
	1.35.11	 	Other producers equipment – if the contractor is responsible for fixation of other
manufacturers equipment, the following procedure will be applied unless approved differently:
returned Item receiving-first inspection-reporting — send to fixation
–acceptance-inspection-reporting-shipment
	 
	1.36	 	Veraz complaints
	 
	 	 	Veraz complaints will be recorded by the Contractor in a computerized system with indication
of the complaints time, subject, severity and required due date if defined.
	 
	1.37	 	Changes
	 
	 	 	Engineering changes will be managed using a computerized system including distribution
and approvals. Veraz engineering will be included in the distribution list. Managed
documentation includes:
	 
	 	 	ECO, ECO-SUB, MCO [manufacturer change order], DA [deviation approval], NPF [new production file]
	 
	1.38	 	Standardization and regulations
	 
	1.38.1	 	EU Directive 2002/95/EC — Restriction of Use of Hazardous Substances (RoHS) will impact to a
great degree the manufacture and sale of electronic products into the EU markets.
	 
	1.38.2	 	Who is responsible for compliance?
	 
	 	 	There are two key areas that impact compliance. The first is the manufacturing
process that is controlled by Flextronics. The second area is the product itself and
the materials and suppliers that are specified in your product design.

	 	•	 	Manufacturing compliance

As a manufacturer Flextronics must ensure that its manufacturing process does not use
any of the restricted substances to make Veraz products. In large part this impacts
manufacturing by requiring that the materials used in processes (such as lead for
soldering) be compliant with maximum levels imposed by the directive. Flextronics has
done a great deal of work in the area of lead free soldering in order to characterize
the different process and reliability characteristics for assembling parts without
lead.

	 	•	 	Product/Materials compliance

In order to ensure that Veraz products will be compliant in the future Veraz will
contact suppliers and validate whether or not they will have a timely RoHS solution.

[*] Confidential information in this Exhibit has been omitted and filed separately with the Commission.
Confidential treatment has been requested with respect to the omitted portions.

Page 15. of 18

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	1.38.3	 	Recommended Actions
	 
	 	 	The implementation of the requirements of the RoHS laws/regulations has many
operational and financial implications
for all parties in the supply chain. The transitioning of Flextronics controlled
processes and Veraz products to a RoHS compliant environment will require both parties
to support each other in a flexible, cooperative and timely manner. Contractor is
committed to support such cooperation and know we can depend upon Veraz diligent
efforts to take actions to smoothly transition Veraz products to be compliant.
	 
	 	 	Flextronics

	 	1.	 	Flextronics has assigned executive and operational committees
to monitor and manage our RoHS implementation plan for our manufacturing
facilities.
	 
	 	2.	 	Flextronics’s corporate technology group has worked to
characterize the manufacturing process to ensure the ability to process the
lead-free materials and components Veraz have specified in product
designs/production files.
	 
	 	3.	 	Flextronics has committed that all pertinent production
processes will be in RoHS compliance by 31 December 2005. It is our goal to
have our PCB assembly production processes compliant by the first of October
2005 and the box build production facilities by 31 December 2005. Certain
production lines may be completed earlier or later depending on separate
agreements in support of Customer specific transition plans.

Veraz Networks Ltd.

	 	1.	 	Veraz set up a process to review, manage and implement the
required RoHS standards for its products.
	 
	 	2.	 	Veraz Collect the material content data for all part numbers on
the pertinent Bills of Materials for its products, and ascertain if the
materials are in compliance with RoHS and any other applicable law/regulations;
	 
	 	3.	 	For traceability and control purposes, via Veraz Engineering
Change Management process, consider to change the related customer part numbers
(CPN) when the parts are determined to be RoHS compliant.
	 
	 	4.	 	Analyze with the pertinent Flextronics site personnel the
inventory levels, materials lead-times and expected time to deplete
noncompliant materials from the supply chain; and
	 
	 	5.	 	Agree to build plans and or other materials disposition plans
for any non-RoHS materials in excess of requirements.

	1.38.4	 	Flextronics’s commitment to Veraz Networks Ltd.
	 
	 	 	As an integral part of Veraz supply chain Contractor is responsible for the
manufacturing processes and their conversion to a RoHS compliant mode per the
scheduled outlined above. Contractor will stand behind this assertion a compliance and
will defend, Indemnify, and bold Veraz harmless against any claims, actions, losses,
expenses, damages, or other liabilities incurred by or assessed against Veraz to the
extent that they arise out of third party claims related to any Flextronics
manufacturing process noncompliance with RoHS and/or similar applicable
laws/regulations. In addition, to the extent that vendors provide and perform their
warranty of compliance, Flextronics will pass through their warranty to Veraz. Any
costs related to correcting the noncompliance that are not covered by the vendor are
Veraz responsibility. For any ODM/CDM products, Flextronics is responsible for
materials selected and qualified that become part of the product design. This is in
addition to its manufacturing process obligations as noted above. Note ; Any
components that are specified by Veraz are excluded from contractors responsibility.

	1.38.5	 	Veraz Networks Ltd. commitment to Flextronics

	 	1.	 	Veraz have received and have carefully reviewed this
communication regarding Rola compliance.
	 
	 	2.	 	Veraz agree that as the owner and controller of Veraz product’s
BOM (Bill of Materials) and approved vendors, that any work necessary in
managing the conversion of Veraz product to become RoHS compliant, Is Veraz
responsibility.
	 
	 	3.	 	With the exception of any claims relating to the manufacturing
process, Veraz agree to defend, indemnify, and hold Flextronics harmless
against any claims, actions, losses, expenses, damages, or other liabilities
incurred by or assessed against us related to any product or materials
noncompliance with the Rol-IS directive and/or similar applicable
laws/regulations.

 

[*] Confidential information in this Exhibit has been omitted and filed separately with the Commission.
Confidential treatment has been requested with respect to the omitted portions.

Page
16. of 18

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	4.	 	Failure to complete the transition in a timely manner due to
lack of or customer requests information outside the logistic agreement could
create financial burdens for which Veraz agree
to be responsible. For instance, obsolete noncompliant materials may arise
because Flextronics has in order to meet orders for Veraz product, continued to
purchase materials which Veraz have not certified as RoHS compliant in the
appropriate timeframe and which subsequently become obsolete by materials that
are compliant. Veraz agree to be responsible for such obsolete noncompliant
materials in this cases There may be other scenarios that could create financial
impacts for which Veraz agree to be responsible if they relate to an area within
Veraz scope of control and responsibility, such as product reliability, for
example.

	1.39	 	Metrics
	 
	 	 	Veraz may request reports regarding related processes effectiveness and efficiency e.g.:
	 
	 	 	•     OTD (On Time Delivery).
	 
	 	 	•     PCT (Problem
Closure Time e.g complaints, service etc.)

     Such reports, if may be achieved from available contractor’s data will be delivered with no
extra charge.

[*] Confidential information in this Exhibit has been omitted and filed separately with the Commission.
Confidential treatment has been requested with respect to the omitted portions.

Page 17. of 18

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

Appendix A — Abbreviations

	 	 	 
	1.

	 	A.P.L  — Approved Parts List
	2.

	 	A.Q.L  — Acceptable Quality Level
	3.

	 	A.T.P  — Acceptance Tests Procedure
	4.

	 	B.O.M  — Bill of Material
	5.

	 	C of C — Certification of Compliance
	6.

	 	E.C.N  — Engineering Change Notice
	7.

	 	E.C.R  — Engineering Change Request
	8.

	 	E.M.O  — Electro Magnetic Compatibility
	9.

	 	E.S.D  — Electro Static Devices
	10.

	 	F.F.F  — Form Fit Function
	11.

	 	FIFO  — First in First Out
	12.

	 	FTJ  — Final Tests Jig
	13.

	 	F.T.P  — Final Tests Procedure
	14.

	 	F.T.R  — Final Tests Report
	15.

	 	F.T.S  — Final Tests Specification
	16.

	 	I.C.T  — In Circuit Tests
	17.

	 	M.R.B  — Material Review Board
	18.

	 	P.C.B  — Printed Circuit Board
	19.

	 	P.N.  — Part Number
	20.

	 	Q.A.  — Quality Assurance
	21.

	 	Q.A.R  — Quality Assurance Requirements
	22.

	 	Q.C.  — Quality Control
	23.

	 	Q.T.P  — Qualification Tests Procedure
	24.

	 	Q.V.L  — Qualified Vendor List
	25.

	 	R.F.I  — Radio Frequency Interference
	26.

	 	S.C.D  — Specifications Control Drawing
	27.

	 	S.O.W  — Statement of Work
	28.

	 	S.T.S  — Ship to Stock
	29.

	 	T.K.  — Turn Key
	30.

	 	QM/QA  — quality management /quality assurance [identical terms in Veraz]

 

[*] Confidential information in this Exhibit has been omitted and filed separately with
the Commission. Confidential treatment has been requested with respect to the omitted
portions.

Page 18. of 18

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

Exhibit 4.1.13 Report and Metrics

The following are reports and metrics that are needed by Veraz for control and measurements
purposes, these reports and metrics are intended to enable Veraz to follow up FLEXTRONICS’s
compliance with its operational obligations pursuant to this Agreement.

FLEXTRONICSS will provide to Veraz the reports and the metrics, set forth below, on a
monthly basis, , without derogating from, and in addition to any other obligation to provide
any other report as forth in this Agreement. 

1. Excess Inventory Report

2. Inventory Turnovers

3. Delivery Report.

4. Price comparison Report actual VS last quarter

5. Quality and Failure Report

6. Eco implementation Cycle time

7. Non-Cancelable / open purchase orders Report (from FLEXTRONICSS to its vendors)

8. Heshavon Report;

9. Usage Report (see section 6.7.2)

	 	 	 	 	 	 	 	 	 
	a 	 	b	 	c 	 	d	 	e
	 	 	 	 	 	 	 	 	Usage
	 	 	 	 	 	 	 	 	value
	catalog number	 	item description	 	Usage 	 	price	 	‘e=c*d
	 	 	 	 	Qty	 	$	 	$

[*] Confidential information in this Exhibit has been omitted and filed separately with
the Commission. Confidential treatment has been requested with respect to the omitted
portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

10. Warranty coverage report (all the terms and conditions related to Warranty provided
by any applicable manufacturer) (see section 8.1)

11. New Price List Report (see section 9.5.2)

	 	 	 	 	 	 	 	 	 	 	 
	a	 	b	 	c	 	d	 	e	 	f
	 	 	 	 	New 	 	 	 	 	 	 
	catalog	 	 	 	price	 	 	 	Variance	 	var % (d-
	number	 	item description	 	List	 	Old price list	 	(d-e)	 	e)/d
	 	 	 	 	$	 	$	 	$	 	%

12. Pricing Variances Per Item Report (see section 9.5.3)

	 	 	 	 	 	 	 	 	 	 	 
	a	 	b	 	c	 	d	 	e	 	f
	 	 	 	 	 	 	 	 	current	 	 
	 	 	 	 	 	 	 	 	quarter	 	 
	 	 	 	 	quantity	 	previous	 	price item	 	credit /
	 	 	 	 	within	 	quarter item	 	“New price	 	debit
	catalog number	 	item description	 	stock	 	price	 	list”	 	f=c(d-e)
	 	 	 	 	Qty	 	$	 	$	 	$

13. Excess Inventory Valuation Variances Report (see section 6.8.4)

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	a	 	b	 	c	 	d	 	e	 	f	 	g	 	h	 	I	 	J	 	K
	 	 	 	 	 	 	 	 	 	 	current	 	Excess	 	Excess	 	current	 	 	 	 
	 	 	 	 	Excess	 	Excess	 	 	 	quarter	 	inventory	 	inventory	 	value less	 	 	 	 
	 	 	 	 	inventory	 	inventory	 	previous	 	item price	 	value	 	value	 	previous	 	New	 	Old qty
	catalog	 	item	 	preceding	 	present	 	quarter	 	“New price	 	preceding	 	present	 	quarter	 	Qty old	 	new
	number	 	description	 	quarter	 	quarter	 	item price	 	list”	 	quarter	 	quarter	 	value h-g	 	prices	 	prices
	 	 	 	 	Qty	 	Qty	 	$	 	$	 	$	 	$	 	$	 	$	 	$

[*] Confidential information in this Exhibit has been omitted and filed separately with
the Commission. Confidential treatment has been requested with respect to the omitted
portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

14. Forecast of Excess Inventory Report — at the end of the quarter

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	a	 	b	 	c	 	d	 	e	 	f	 	g	 	h
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	OLAV to	 	 	 	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	excess	 	 	 	 
	 	 	 	 	 	 	 	 	 	 	Excess	 	estimated	 	inventory	 	 	 	 
	 	 	 	 	 	 	 	 	 	 	inventory at	 	usage	 	(open PO’s	 	Estimation	 	 
	 	 	 	 	 	 	current	 	Flex premises	 	according to	 	in non	 	of quarter	 	 
	 	 	 	 	 	 	quarter item	 	end of	 	MPS run	 	cancellation	 	end	 	 
	catalog	 	item	 	price “New	 	previous	 	during the	 	period	 	excess	 	Estimation of quarter end
	number	 	description	 	price list”	 	quarter	 	quarter	 	window)	 	inventory	 	excess inventory value
	 
	 	 	 	 	 	$	 	 	 	Qty	 	Qty	 	Qty	 	 	=d-e+f	 	 	 	=c*(d-e+f	)

15. Forecast of Total Inventory Report — at the end of quarter

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	a	 	b	 	c	 	d	 	e	 	f	 	g
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	OLAV to	 	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	excess	 	OLAV to excess
	 	 	 	 	 	 	current	 	Excess	 	 	 	 	 	inventory (open	 	inventory ( open
	 	 	 	 	 	 	quarter item	 	inventory at Flex	 	 	 	 	 	PO’s in non	 	PO’s in
	catalog	 	 	 	 	 	price “New	 	premises end of	 	 	 	 	 	cancellation	 	cancellation period
	number	 	item description	 	price list”	 	previous quarter	 	FLEX inventory	 	period window)	 	window)
	 
	 	 	 	 	 	$	 	 	 	$	 	 	 	$	 	 	 	$	 	 	 	$	 	 

[*] Confidential information in this Exhibit has been omitted and filed separately with
the Commission. Confidential treatment has been requested with respect to the omitted
portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

Exhibit 4.2
— Vendor sources

[*] Confidential information in this Exhibit has been omitted and filed separately with
the Commission. Confidential treatment has been requested with respect to the omitted
portions. This exhibit 4.2 consists of one page, which has been omitted and filed separately with the Commission.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED

Exhibit 5.4
— Loaned Items 

	 	 	 	 	 	 	 	 	 
	PC	 	PROJECT	 	DATE	 	 	SN
	MD6420A+MDO

2XRACKS
	 	func 4000     	 	 	10/4/2005	 	 	N/A
	75/50 adapter
	 	func 4001	 	 	10/4/2005	 	 	308564
	md-6420
	 	func pro	 	 	10/4/2005	 	 	2691
	md-6420
	 	func pro	 	 	10/4/2005	 	 	2696
	BACK TO BACK
	 	 	 	 	10/4/2005	 	 	 
	cable 120 ohm
	 	     ftj	 	 	10/4/2005	 	 	 
	cable 75 ohm
	 	     ftj	 	 	10/4/2005	 	 	 
	cable 75 to 120 ohm
	 	     ftj	 	 	10/4/2005	 	 	 
	cable pc to vxi
	 	     ftj	 	 	10/4/2005	 	 	 
	clo box
	 	     ftj	 	 	10/4/2005	 	 	 
	clock cable *2
	 	     ftj	 	 	10/4/2005	 	 	 
	dvm cable
	 	     ftj	 	 	10/4/2005	 	 	 
	ECI SIMULATOR
	 	 	 	 	 	 	 	 
	fall+cable
	 	     ftj	 	 	10/4/2005	 	 	 
	FULL PC
	 	FTJ	 	 	10/4/2005	 	 	210534
	FULL PC
	 	sys-4000	 	 	10/4/2005	 	 	225482
	FULL PC
	 	sys-pro	 	 	10/4/2005	 	 	210682
	FULL PC
	 	data-progr	 	 	10/4/2005	 	 	233635
	FULL PC
	 	data-progr	 	 	1/25/2006	 	 	225219
	FULL PC
	 	func-4000	 	 	10/4/2005	 	 	401414
	FULL PC
	 	burn in	 	 	10/4/2005	 	 	303792
	FULL PC
	 	pro	 	 	10/5/2005	 	 	300020
	FULL PC
	 	pro	 	 	10/6/2005	 	 	401422
	FULL PC
	 	pro	 	 	10/7/2005	 	 	264622
	FULL PC
	 	4000	 	 	10/8/2005	 	 	320184
	FULL PC
	 	FTJ	 	 	10/4/2005	 	 	210302
	gx1405b
	 	func 4000	 	 	10/4/2005	 	 	8628
	gx1405b(slot 3,4)
	 	 	 	 	 	 	 	8,175

[*] Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED

	 	 	 	 	 	 	 	 	 
	PC	 	PROJECT	 	DATE	 	 	SN
	HP
	 	 	 	 	 	 	 	 
	HP3722A
	 	PRO	 	 	11/27/2005	 	 	5819
	hp-3722a
	 	sys-4000	 	 	10/4/2005	 	 	5818
	hp-3722a
	 	sys-4000	 	 	10/4/2005	 	 	3211
	hp-3722a
	 	sys-pro	 	 	1/19/2006	 	 	8196
	igate 4000 sub rack
	 	pro	 	 	10/4/2005	 	 	 
	jmatrix
	 	func 4000	 	 	10/4/2005	 	 	N/A
	Laptop
	 	 	 	 	 	 	 	 
	Laptop
	 	PRO-Hdge	 	 	 	 	 	324244
	Laptop
	 	4000	 	 	 	 	 	325688
	MATRIX CARD
	 	func 4000	 	 	10/4/2005	 	 	 
	md-6420
	 	func-pro	 	 	10/4/2005	 	 	1673
	md-6420
	 	func-pro	 	 	10/4/2005	 	 	2428
	md-6420
	 	FTJ	 	 	10/4/2005	 	 	2424
	ml7710
	 	func 4000	 	 	10/4/2005	 	 	N/A
	MONITOR
	 	data-progr	 	 	10/4/2005	 	 	878
	MONITOR
	 	func-pro	 	 	10/4/2005	 	 	103098
	MONITOR
	 	func 4000	 	 	10/4/2005	 	 	1008
	mp-1570+moduls
	 	func-pro	 	 	1/19/2006	 	 	SN-7900
	MP0111 - Optical
	 	func-pro	 	 	10/4/2005	 	 	 
	MP0121A - 156M Module
	 	func-pro	 	 	10/4/2005	 	 	 
	MP0122A - 45M Module
	 	func-pro	 	 	10/4/2005	 	 	 
	MU150007A – Jitter
	 	func-pro	 	 	10/4/2005	 	 	 
	mp-1570+moduls
	 	func-pro	 	 	1/19/2006	 	 	SN - 9003
	MP0111 - Optical
	 	func-pro	 	 	 	 	 	 
	MP0121A - 156M Module
	 	func-pro	 	 	 	 	 	 
	MP0122A - 45M Module
	 	func-pro	 	 	 	 	 	 
	power supply 220/48v
	 	sys-4000	 	 	10/4/2005	 	 	 
	power supply 220/48v
	 	fun-pro	 	 	10/4/2005	 	 	 
	power supply 220/48v
	 	ftj	 	 	10/4/2005	 	 	 
	power supply 220/48v
	 	ftj	 	 	10/4/2005	 	 	 
	power supply 220/48v
	 	 	 	 	10/4/2005	 	 	 
	power supply small w
	 	fun-4000	 	 	10/4/2005	 	 	 
	power supply small bl
	 	floting	 	 	10/4/2005	 	 	 

[*] Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED

	 	 	 	 	 	 	 	 	 
	PC	 	PROJECT	 	DATE	 	 	SN
	pro
PSU 18016-2080
	 	func 4000	 	 	10/4/2005	 	 	 
	scope TDS 510a
	 	func 4000	 	 	26.12.2005	 	 	4029
	scope TDS524a
	 	func-pro	 	 	26.12.2005	 	 	4274
	Shelf
	 	sync	 	 	10/4/2005	 	 	N/A
	Shelf
	 	func	 	 	10/4/2005	 	 	 
	Shelf
	 	data-progr	 	 	10/4/2005	 	 	 
	Shelf
	 	master	 	 	10/4/2005	 	 	 
	Shelf
	 	floting	 	 	10/4/2005	 	 	 
	Shelf
	 	master	 	 	10/4/2005	 	 	 
	Shelf +door
	 	floting	 	 	10/4/2005	 	 	 
	Shelf +door
	 	sync	 	 	10/4/2005	 	 	 
	Shelf +door
	 	data-progr	 	 	10/4/2005	 	 	 
	Shelf +door
	 	func	 	 	10/4/2005	 	 	 
	Shelf Pro
	 	 	 	 	 	 	 	 
	Shelf 4000
	 	 	 	 	 	 	 	 
	SISTEM JIG CABLE
	 	 	 	 	 	 	 	 
	SmartBits 200 should
	 	func 4000	 	 	10/4/2005	 	 	 
	Sonnet option, SDH
	 	func-pro	 	 	10/4/2005	 	 	 
	Switch
	 	4000	 	 	11/16/2005	 	 	B21K645006517
	sx7410b
	 	func 4000	 	 	10/4/2005	 	 	101390
	sx-7410b(slot 2)
	 	 	 	 	 	 	 	5785
	VXI GPIB CARD
	 	func 4000	 	 	10/4/2005	 	 	 
	VXI MATRIX
	 	 	 	 	 	 	 	 
	VXI MATRIX CARD
	 	func 4000	 	 	10/4/2005	 	 	 
	VXI Rack (BUS)
	 	func 4000	 	 	10/4/2005	 	 	302636
	VXI SWITCH CARD
	 	func 4000	 	 	10/4/2005	 	 	 
	VXI+cable jpib
	 	ftj	 	 	10/4/2005	 	 	 
	Mouse
	 	func 4000 DL8B	 	 	1/11/2006	 	 	usb
	Keyboards
	 	func 4000 DL8B	 	 	1/12/2006	 	 	 
	Monitor 17” MAG
	 	func 4000 DL8B	 	 	1/13/2006	 	 	100699
	Anritsu MD6420A
	 	func 4000 DL8B	 	 	1/14/2006	 	 	2109
	Anritsu MD1570A a
	 	func 4000 DL8B	 	 	1/15/2006	 	 	7283

[*] Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED

	 	 	 	 	 	 	 	 	 
	PC	 	PROJECT	 	DATE	 	 	SN
	 
	 	DL8B	 	 	 	 	 	 
	AQ 3150
	 	func 4000 DL8B	 	 	1/16/2006	 	 	6781
	JMATRIX
	 	func 4000 DL8B	 	 	1/17/2006	 	 	 
	PSU 18016-2080
	 	func 4000 DL8B	 	 	1/18/2006	 	 	 
	2 X Racks
	 	func 4000 DL8B	 	 	1/19/2006	 	 	 

	 	 	 	 	 	 	 	 	 
	Name	 	Model+manuf.	 	S.N.	 	 	Qty
	Power Supply-Variable
	 	Enrtec Psu-4091	 	 	 	 	 	1
	Power Supply-Variable

	 	 	 	 	 	 	 	 
	Power Supply-Blue
	 	ECI	 	 	 	 	 	1
	Scop

	 	 	 	 	 	 	 	 
	Interface Jig u.u.l
	 	 	 	 	 	 	 	5
	Plag Jtag prog-10
	 	 	 	 	241499911	 	 	1
	Plag vip
	 	 	 	 	241499714	 	 	1
	Plag flash prog.
	 	 	 	 	24149915	 	 	1
	Plag bsd
	 	 	 	 	241499817	 	 	1
	Pc+jtag board
	 	 	 	 	 	 	 	1
	Rs-232 8port conn.box
	 	 	 	 	 	 	 	1
	Industrail pod + cable
	 	 	 	 	305500	 	 	1
	Scan I/O-280
	 	Corelis	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 
	 	 	 	 	401471	 	 	 
	Pc+jtag board
	 	Petium IV 3G	 	 	407551	 	 	2
	USB controller -
	 	 	 	 	103688	 	 	1
	USB controller -
	 	 	 	 	103689	 	 	1
	 
	 	 	 	 	 	 	 	2693 - no jitter unit
	Anritsu MD6420
	 	func pro	 	 	3/12/2006	 	 	 
	Scope TDS 500 or other
	 	func pro	 	 	3/12/2006	 	 	2862
	 
	 	 	 	 	 	 	 	unit received from
	120 / 50 Ohm Adapter -
	 	func pro	 	 	3/12/2006	 	 	nir
	IEEE - 488 GPIB CABLE
	 	func pro	 	 	3/12/2006	 	 	 

[*] Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED

	 	 	 	 	 	 	 	 	 
	PC	 	PROJECT	 	DATE	 	 	SN
	AT-GPIB/TNT (PNP
	 	func pro	 	 	3/12/2006	 	 	 
	Anritsu MP1570 with
	 	func pro	 	 	3/12/2006	 	 	6782
	MP0122A - 45M Module
	 	func pro	 	 	3/12/2006	 	 	 
	MP0126A - Jitter Module
	 	func pro	 	 	3/12/2006	 	 	 
	MP1570-02 GPIB Option
	 	func pro	 	 	3/12/2006	 	 	 
	MP1570-07 MUX -
	 	func pro	 	 	3/12/2006	 	 	 
	MP0111- Optical
	 	func pro	 	 	3/12/2006	 	 	 
	MP0121A - 156M Module
	 	func pro	 	 	3/12/2006	 	 	 
	MP1570-06 MUX -
	 	func pro	 	 	3/12/2006	 	 	 
	Sonnet option, SDH
	 	func pro	 	 	3/12/2006	 	 	 
	SmartBits 200 should
	 	func pro	 	 	3/12/2006	 	 	No: 6597
	SX-7410B (slot 2)
	 	func pro	 	 	3/12/2006	 	 	6599+7291
	 
	 	 	 	 	 	 	 	 
	HASS/HALT
	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	JIG FOR
	 	 	 	 	 	 	 	 

	 	 	 	 	 	 	 	 	 
	PC FOR EDGE	 	EDS SN	 	DATE	 	 	VERAZ SN
	FULL PC SYNC
	 	401570	 	 	3/16/2006	 	 	1521
	FULL PC STAB
	 	401588	 	 	3/16/2006	 	 	1520
	PC FOR EDGE
	 	 	 	 	 	 	 	 
	HP
	 	 	 	 	3/16/2006	 	 	4612
	HP
	 	 	 	 	3/16/2006	 	 	5840
	power supply 8X48
	 	5 UNITS	 	 	 	 	 	 
	SWITCHS 2950
	 	3 UNITS	 	 	 	 	 	 
	EDGE Station #1

	 	 	 	 	 	 	 	with 2 Ian
	PC
	 	EDGE	 	 	5/25/2006	 	 	cards225797
	Keyboard
	 	EDGE	 	 	5/25/2006	 	 	 
	Optic Mouse
	 	EDGE	 	 	5/25/2006	 	 	 
	Monitor 17”
	 	EDGE	 	 	5/25/2006	 	 	 
	 
	 	 	 	 	 	 	 	with jitter and
	Anritsu md6420A
	 	EDGE	 	 	5/25/2006	 	 	t12260

[*] Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED

	 	 	 	 	 	 	 	 	 
	PC	 	PROJECT	 	DATE	 	 	SN
	Mini VXI
	 	EDGE	 	 	5/25/2006	 	 	301437/305836
	VXI Rack
	 	EDGE	 	 	5/25/2006	 	 	308551

[*] Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED

Exhibit 6.1 — Purchase Order Form

	 	 	 	 	 	 	 	 	 	 	 	 	 
	 

	 	VERAZ NETWORKS LTD.
	 	 	 	 	 	 	 	PAGE 1 OF 1	 	 
	 

	 	43 HASIVIM ST.
	 	 	 	 	 	 	 	ORDER
	 	DATE
	 
	 	 	 	 	 	 	 	 	 	 	 	 
	 

	 	PETAH TIKVA,
	 	 	 	 	 	 	 	 

	 	 
	 

	 	ISRAEL 49130
	 	P.O.	 	 	 	 	 	 	 	 
	 

	 	 	 	NO.
	 	 
	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 	 	 

FLEXTRONICSs (Israel) Ltd.

1st Hatahsia Street

Migdal-Haemek 23108

P.O. Box 867

Israel

Phone: +972.4.6448200

Fax: +972.4.6040850 FLEXTRONICS

ATTN:                     

PAYMENT TERMS: 60 DAYS                                           SHIPPING TERMS: EX-FACTORY

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	FLEXTRONICS	 	MFG	 	DESCRIPTION	 	QUANTITY	 	UNIT	 	TOTAL	 	DELIVERY DATE
	 	 	CAT #	 	CATALOG	 	 	 	 	 	PRICE	 	PRICE	 	 	 	 
	 	 	 	 	NUMBER	 	 	 	 	 	USD	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 	 	TOTAL P.O USD	 	 	 	 

TERMS:

TERMS & CONDITIONS ACCORDING TO VERAZ-FLEXTRONICS MASTER MANUFACTURING AGREEMENT

SIGNATURE:
                                        

[*] Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED

Exhibit 6.8.1—Existing Ordered Materials

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Flex PO	 	Veraz item	 	item	 	date	 	pos	 	order qty	 	del qty	 	Order Price $	 	Veraz Matched SOs	 	Total $
	 	380001	 	 	CH207621
	 	VR-CH207621	 	 	7/26/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000622	 	 	 	[*]	 
	 	380001	 	 	CH207621
	 	VR-CH207621	 	 	8/24/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000622	 	 	 	[*]	 
	 	380002	 	 	CH213389
	 	VR-CH213389	 	 	8/8/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000584	 	 	 	[*]	 
	 	380002	 	 	CH213389
	 	VR-CH213389	 	 	7/13/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000584	 	 	 	[*]	 
	 	380004	 	 	NG206740
	 	VR-NG206740	 	 	12/11/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000594	 	 	 	[*]	 
	 	380004	 	 	NG206740
	 	VR-NG206740	 	 	12/22/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000594	 	 	 	[*]	 
	 	380005	 	 	CH205956
	 	VR-CH205956	 	 	9/19/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000797	 	 	 	[*]	 
	 	380006	 	 	P19399
	 	VR-P19399B	 	 	10/20/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000761	 	 	 	[*]	 
	 	380006	 	 	P19399
	 	VR-P19399B	 	 	10/20/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000761	 	 	 	[*]	 
	 	380006	 	 	P19873
	 	VR-P19873B	 	 	10/20/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000761	 	 	 	[*]	 
	 	380006	 	 	PZ13379
	 	VR-PZ13379B	 	 	10/20/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000761	 	 	 	[*]	 
	 	380006	 	 	PZ13379
	 	VR-PZ13379B	 	 	10/20/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000761	 	 	 	[*]	 
	 	380006	 	 	PZ15828
	 	VR-PZ15828B	 	 	10/20/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000761	 	 	 	[*]	 
	 	380006	 	 	PZ16989
	 	VR-PZ16989B	 	 	10/20/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000761	 	 	 	[*]	 
	 	380006	 	 	PZ16989
	 	VR-PZ16989B	 	 	10/20/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000761	 	 	 	[*]	 
	 	380006	 	 	PZ17129
	 	VR-PZ17129B	 	 	10/20/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000761	 	 	 	[*]	 
	 	380006	 	 	PZ17129
	 	VR-PZ17129B	 	 	10/20/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000761	 	 	 	[*]	 
	 	380006	 	 	PZ18106
	 	VR-PZ18106B	 	 	10/20/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000761	 	 	 	[*]	 
	 	380006	 	 	PZ18208
	 	VR-PZ18208B	 	 	10/20/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000761	 	 	 	[*]	 
	 	380006	 	 	PZ8325
	 	VR-PZ8325B	 	 	10/20/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000761	 	 	 	[*]	 
	 	380009	 	 	P19124
	 	VR-P19124B	 	 	11/8/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000808	 	 	 	[*]	 
	 	380009	 	 	P19399
	 	VR-P19399B	 	 	11/8/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000808	 	 	 	[*]	 
	 	380009	 	 	P19873
	 	VR-P19873B	 	 	11/8/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000808	 	 	 	[*]	 
	 	380009	 	 	P20020
	 	VR-P20020B	 	 	11/8/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000808	 	 	 	[*]	 
	 	380009	 	 	P20022
	 	VR-P20022B	 	 	11/8/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000808	 	 	 	[*]	 
	 	380009	 	 	PZ15548
	 	VR-PZ15548B	 	 	11/8/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000808	 	 	 	[*]	 
	 	380009	 	 	PZ15550
	 	VR-PZ15550B	 	 	11/8/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000808	 	 	 	[*]	 
	 	380009	 	 	PZ16989
	 	VR-PZ16989B	 	 	11/8/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000808	 	 	 	[*]	 
	 	380009	 	 	PZ17129
	 	VR-PZ17129B	 	 	11/8/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000808	 	 	 	[*]	 
	 	380009	 	 	PZ18102
	 	VR-PZ18102B	 	 	11/8/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000808	 	 	 	[*]	 
	 	380009	 	 	PZ18206
	 	VR-PZ18206B	 	 	11/8/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000808	 	 	 	[*]	 
	 	380009	 	 	PZ11310
	 	VR-PZ11310	 	 	11/8/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000808	 	 	 	[*]	 
	 	380009	 	 	PZ11309
	 	VR-PZ11309	 	 	11/8/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000808	 	 	 	[*]	 
	 	380009	 	 	PZ15495
	 	VR-PZ15495	 	 	11/22/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000808	 	 	 	[*]	 
	 	380009	 	 	P19520
	 	VR-P19520	 	 	11/22/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000808	 	 	 	[*]	 
	 	380010	 	 	P19124
	 	VR-P19124B	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000796	 	 	 	[*]	 

 

			
	[*] 	 	 Confidential information in this Exhibit has been omitted and filed separately with the Commission.
Confidential treatment has been requested with respect to the omitted portions.

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Flex PO	 	Veraz item	 	item	 	date	 	pos	 	order qty	 	del qty	 	Order Price $	 	Veraz Matched SOs	 	Total $
	 	380010	 	 	PZ13379
	 	VR-PZ13379B	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000796	 	 	 	[*]	 
	 	380010	 	 	PZ15548
	 	VR-PZ15548B	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000796	 	 	 	[*]	 
	 	380010	 	 	PZ15550
	 	VR-PZ15550B	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000796	 	 	 	[*]	 
	 	380010	 	 	PZ15828
	 	VR-PZ15828B	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000796	 	 	 	[*]	 
	 	380010	 	 	PZ16989
	 	VR-PZ16989B	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000796	 	 	 	[*]	 
	 	380010	 	 	PZ17129
	 	VR-PZ17129B	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000796	 	 	 	[*]	 
	 	380010	 	 	PZ18195
	 	VR-PZ18195B	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000796	 	 	 	[*]	 
	 	380010	 	 	PZ18208
	 	VR-PZ18208B	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000796	 	 	 	[*]	 
	 	380010	 	 	PZ18447
	 	VR-PZ18447B	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000796	 	 	 	[*]	 
	 	380013	 	 	P19132
	 	VR-P19132	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000807	 	 	 	[*]	 
	 	380013	 	 	P19193
	 	VR-P19193	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000807	 	 	 	[*]	 
	 	380013	 	 	P19195
	 	VR-P19195	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000807	 	 	 	[*]	 
	 	380013	 	 	P19460
	 	VR-P19460	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000807	 	 	 	[*]	 
	 	380013	 	 	P19574
	 	VR-P19574	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000807	 	 	 	[*]	 
	 	380013	 	 	P19802
	 	VR-P19802	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000807	 	 	 	[*]	 
	 	380013	 	 	P19821
	 	VR-P19821	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000807	 	 	 	[*]	 
	 	380013	 	 	PZ7067
	 	VR-PZ7067	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000807	 	 	 	[*]	 
	 	380013	 	 	PZ8750
	 	VR-PZ8750	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000807	 	 	 	[*]	 
	 	380013	 	 	PZ8769
	 	VR-PZ8769	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000807	 	 	 	[*]	 
	 	380013	 	 	CH14278
	 	VR-CH14278	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000807	 	 	 	[*]	 
	 	380013	 	 	CH14279
	 	VR-CH14279	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000807	 	 	 	[*]	 
	 	380013	 	 	CH28477
	 	VR-CH28477	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000807	 	 	 	[*]	 
	 	380013	 	 	CH29298
	 	VR-CH29298	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000807	 	 	 	[*]	 
	 	380013	 	 	CH30594
	 	VR-CH30594	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000807	 	 	 	[*]	 
	 	380013	 	 	CH32846
	 	VR-CH32846	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000807	 	 	 	[*]	 
	 	380013	 	 	CH37484
	 	VR-CH37484	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000807	 	 	 	[*]	 
	 	380013	 	 	CH40599
	 	VR-CH40599	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000807	 	 	 	[*]	 
	 	380013	 	 	CH47677
	 	VR-CH47677	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000807	 	 	 	[*]	 
	 	380013	 	 	CH71942
	 	VR-CH71942	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000807	 	 	 	[*]	 
	 	380013	 	 	CH74796
	 	VR-CH74796	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000807	 	 	 	[*]	 
	 	380013	 	 	CH75684
	 	VR-CH75684	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000807	 	 	 	[*]	 
	 	380013	 	 	P_69506
	 	VR-P_69506	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000807	 	 	 	[*]	 
	 	380013	 	 	PZ11505
	 	VR-PZ11505	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000807	 	 	 	[*]	 
	 	380013	 	 	PZ11507
	 	VR-PZ11507	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000807	 	 	 	[*]	 
	 	380013	 	 	PZ11511
	 	VR-PZ11511	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000807	 	 	 	[*]	 
	 	380013	 	 	PZ15724
	 	VR-PZ15724	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000807	 	 	 	[*]	 
	 	380013	 	 	PZ15726
	 	VR-PZ15726	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000807	 	 	 	[*]	 

 

			
	[*] 	 	 Confidential information in this Exhibit has been omitted and filed separately with the Commission.
Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Flex PO	 	Veraz item	 	item	 	date	 	pos	 	order qty	 	del qty	 	Order Price $	 	Veraz Matched SOs	 	Total $
	 	380013	 	 	PZ16535
	 	VR-PZ16535	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000807	 	 	 	[*]	 
	 	380013	 	 	CH100182
	 	VR-CH100182	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000807	 	 	 	[*]	 
	 	380013	 	 	CH103092
	 	VR-CH103092	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000807	 	 	 	[*]	 
	 	380013	 	 	CH105845
	 	VR-CH105845	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000807	 	 	 	[*]	 
	 	380013	 	 	CH105849
	 	VR-CH105849	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000807	 	 	 	[*]	 
	 	380013	 	 	CH200128
	 	VR-CH200128	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000807	 	 	 	[*]	 
	 	380013	 	 	CH200132
	 	VR-CH200132	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000807	 	 	 	[*]	 
	 	380013	 	 	CH200134
	 	VR-CH200134	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000807	 	 	 	[*]	 
	 	380013	 	 	CH205649
	 	VR-CH205649	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000807	 	 	 	[*]	 
	 	380013	 	 	CH205650
	 	VR-CH205650	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000807	 	 	 	[*]	 
	 	380013	 	 	CH205651
	 	VR-CH205651	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000807	 	 	 	[*]	 
	 	380013	 	 	CH206918
	 	VR-CH206918	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000807	 	 	 	[*]	 
	 	380013	 	 	CH211521
	 	VR-CH211521	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000807	 	 	 	[*]	 
	 	380013	 	 	CH213058
	 	VR-CH213058	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000807	 	 	 	[*]	 
	 	380013	 	 	CH300678
	 	VR-CH300678	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000807	 	 	 	[*]	 
	 	380013	 	 	CH105848
	 	VR-CH105848	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000807	 	 	 	[*]	 
	 	380014	 	 	PZ11310
	 	VR-PZ11310	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000926	 	 	 	[*]	 
	 	380014	 	 	PZ11309
	 	VR-PZ11309	 	 	11/27/2005	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000926	 	 	 	[*]	 
	 	380030	 	 	CH207338
	 	VR-CH207338	 	 	1/15/2006	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000905	 	 	 	[*]	 
	 	380030	 	 	CH309978
	 	VR-CH309978	 	 	1/15/2006	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000905	 	 	 	[*]	 
	 	380031	 	 	P19265
	 	VR-P19265	 	 	1/17/2006	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000900	 	 	 	[*]	 
	 	380031	 	 	P19060
	 	VR-P19060	 	 	1/17/2006	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000900	 	 	 	[*]	 
	 	380031	 	 	P19061
	 	VR-P19061	 	 	1/17/2006	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000900	 	 	 	[*]	 
	 	380043	 	 	CH210969
	 	VR-CH210969	 	 	2/6/2006	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000940	 	 	 	[*]	 
	 	380046	 	 	P_57836
	 	VR-P_57836	 	 	2/14/2006	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000927	 	 	 	[*]	 
	 	380054	 	 	CH104801
	 	VR-CH104801	 	 	3/7/2006	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000967	 	 	 	[*]	 
	 	380055	 	 	CH213751
	 	VR-CH213751	 	 	3/9/2006	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	[*]	 	 	 	1000966	 	 	 	[*]	 

 

			
	[*] 	 	 Confidential information in this Exhibit has been omitted and filed separately with the Commission.
Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED

Exhibit 6.8.3—Insurance

Appendix [A]

Insurance Certificate

Date: 28.2.06

To: Vera Networks Ltd.

(Hereinafter: “Veraz”)

Dear Sir/Madam,

			
	RE:	 	Insurance Certificate also in connection with the Services provided pursuant to the
Manufacturing agreement dated                      signed between Veraz and Flextronics (Israel) Ltd. (the
“Contractor.”)

We hereby confirm that as from the 1.7 day of 2005 until the 30.6 day of
2006, we have effected the following insurances also in connection with the above
referenced agreement, in the name of the Contractor:

(1) Third Party Liability Insurance: Policy No. 49-0000-0520-05.

Period of Insurance: From 1.7.05 to 30.6.06

Covering the Contractor’s legal liability towards third parties respect of bodily injury or damage
to property that may be suffered or incurred during the duration of the policy, including
consequential damage with a liability limit of $1,000,000 per event and for the insurance period.

This Insurance is not subject to any limitation regarding liability deriving from lifting devices,
cranes, or elevators, loading and unloading, strikes and look-outs, riots and commotion,
contractors and sub-contractor and their workers, damage to property on which the insured or any
person in its service are or were working on at the time of the occurrence of the insurance event,
vehicles (with the exception of liability under the Israeli Road Accident Victims Compensation Law,
5735-1975, as applicable) up to the sum of $150,000 above the insurance amount covered under the
vehicle insurance within the scope of third party property insurance. Any person employed under die
Agreement not being a direct employee of the insured, will be deemed to be a third party under this
policy.

The policy shall be extended to indemnify Veraz and/or its Directors & Officers and/or employees in
respect of their liability for acts and/or omissions of the Contractor and/or employees, and/or any
Sub-Contractor acting on its behalf or in its name, subject to a cross-liability clause pursuant
whereto the insurance shall be deemed to have been taken out separately for each of the insured
listed on the policy.

(2) Employers Liability Insurance: Policy No. 57-0000-0050-05.

Period of insurance: From 1.7.05 to 30.6.06

Employers’ liability insurance covering the Contractor’s legal liability for those engaged by it
with a limit of liability of $5,000,000 per claimant, per event and for the period of insurance.
The

 

			
	[*] 	 	 Confidential information in this Exhibit has been omitted and filed separately with the Commission.
Confidential treatment has been requested with respect to the omitted portions.

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED

policy is extended to include Veraz should it be considered as an employer of any person employed
by the Contractor

General Article to be enforced on all of the above insurance policies:

(a) The policies described above shall not be reduced or cancelled, without 60 days prior written
notification thereof, sent to the Veraz via registered mail.

(b) All of the above policies include a provision whereby insurer waives right of subrogation
against Veraz and/or any one on its behalf, including their employees and officers. The waiver of
subrogation shall not apply towards a party that caused the damage intentionally or by willful
misconduct.

(c) The above policies have preference over any other insurance procured by Veraz, and the insurer
hereby waives any claim or demand, which it may have with respect to the participation of Veraz’s
insurance.

(d) Policy wording in respect of each of the above mentioned policies shall not be less than the
applicable AIG Golden Corporate Guard wording or a similar wording.

This confirmation Is subject to the terms, conditions and provisions of the original policies
Insofar as not expressly altered by the aforegoing.

	 	 	 	 	 
	/s/ AlG Golden Insurance Ltd.
	 	 	 	 
	 

	 	/s/ [Signature Illegible]	 	 
	 

Insurance Company

	 	 

Signed by
	 	 
	 

	 	Date 28.2.06	 	 

 
 

			
	[*] 	 	 Confidential information in this Exhibit has been omitted and filed separately with the Commission.
Confidential treatment has been requested with respect to the omitted portions.

2.

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED

Certificate Addendum

1. Excess/Umbrella Liability — 

Period of Insurance: From July 1, 2005 to June 30, 2006

Limit of Liability will be $5,000,000 (Five million US Dollars) any one occurrence and in the
aggregate for the period of Insurance.

The Policy has no exclusion regarding Fire, Explosion, Flood, Panic, Cranes and Lifting Devices,
Loading and Unloading, Accidental Contamination, Strike and Riot and Civil Commotion, and
Subrogation Claims by the National Insurance. The policy is extended to include Veraz Networks Ltd.
as Additional Insured in respect of its legal liability due to an act committed by the contractor
subject to a “Cross Liability Clause”,

The policy covers the Contractor’s legal liability resulting from bodily injury and/or property
damage caused in connection with any completed operation or product manufactured, repaired,
installed, supplied, sold marketed or handled in any other way by the Contractor.

The exclusion of damage to the product applies only to that particular part of the product or
completed operation that must be replaced or repaired because of faulty manufacture or workmanship.

2. Professional Liability — 

Period of insurance: From July 1, 2005 to June 30, 2006

Retroactive date not later than the commencement of operation under the Agreement

Limit of Liability of not be less than $5,000,000 (Five million US Dollars) any one occurrence and
in the aggregate.

The policy does not exclude loss of use or delay, loss of documents.

The policy will provide extended discovery period of not less than 12 months

The policy is extended to indemnify Veraz Networks Ltd. for its legal liability for any wrongful
act or omission of the Contractor.

Authorized Representative:

	 	 	 
	 

	 	Bruce Wineman

 

			
	[*] 	 	 Confidential information in this Exhibit has been omitted and filed separately with the Commission.
Confidential treatment has been requested with respect to the omitted portions.

3.

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED

Schedule XX - Insurance

Date: 27 Feb. 2006

To

Flextronics (Israel) Ltd,

1 Industry St. Industrial Area

Ramat Gavriel, Migdal Haeemak 23108

(Hereinafter, “Subcontractor

Re: Certificate of Insurance

Our Insured — Veraz Network Ltd. (Hereinafter: “Veraz”)

We the undersigned hereby confirm that we have effected the following insurance coverage in the
name of Veraz in order to cover Veraz’ interests in connection with the services provided by
Subcontractor under the Contract Manufacturing Agreement to which this Schedule is attached hereto.

The following insurance policies have been issued / effected on behalf of our insured:

(1) Third Party Liability Insurance: Policy No. 50-5-5072720-2

Period of Insurance: From 01 July 2005 to 30 June 2006

Third Party Liability Policy with a limit of liability of $1000,000 any one occurrence and in the
aggregate for the period of insurance. The Policy has no exceptions concerning fire, explosion,
flood, panic, cranes and lifting devices, loading and unloading, accidental contamination, strike
and riot and civil commotion, and subrogation claims by the “National Insurance Institute”. The
Policy will be extended to cover the legal liability of Subcontractor and/or Mivne Taasia Ltd. as a
result of an act, negligent act, error or omission of Veraz and/or its employees or managers
subject to a cross liability clause.

(2) Employers Liability Insurance: Policy No. 70-5-5072909-8

Period of Insurance: From 01 July 2005 to 30 June 2006.

Limit of liability shall he $5,000,000 any one occurrence and in the aggregate for the period of
Insurance. The policy is extended to include Subcontractor and/or Mivne Taasia Ltd. should they be
considered and/or claimed as an employer of any person employed by Veraz.

(3) Property & Consequential Loss Insurance: Policy Nos. 80-5-5072695-1 & 81-5-5032702-1

Period of Insurance: From 01 July 2005 to 30 June 2006.

The Policy provides Extended Fire property insurance covering the equipment owned or under the
responsibility of Veraz up to their full value subject to the sum insured while being at the
custody or control of Subcontractor including but not limited whilst in storage (including at

 

			
	[*] 	 	 Confidential information in this Exhibit has been omitted and filed separately with the Commission.
Confidential treatment has been requested with respect to the omitted portions.

4.

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED

Subcontractor premises), inland transit; against any loss or damage caused by “Extended Fire”
perils including but not limited to fire, lightning, explosion, riot, civil commotion, earthquake,
storm and tempest, flood, water damage, damage caused by vehicles and other devices (“impact”),
inland transit and burglary, subject to sublimits and Limits of Indemnity as per the Policy wording
and Schedule..

The policy shall include consequential loss insurance in respect of an indemnity period of 12
months due to a loss or damage covered under the Extended Fire policy as detailed above include
inability to access premises. The policy shall be extended to include cover in respect of any
consequential loss occurring due to an event occurring to Subcontractor and/or Mivne Taasia’s
property and/or to property relating to any one on their behalf.

This Policy will include a provision whereby insurer waives right of subrogation against
Subcontractor and/or any one on behalf of Subcontractor and/or Mivne Taasia Ltd and/or towards any
one which Subcontractor committed to waive its right of subrogation and/or Subcontractor customers
for any lose or damage. The waiver of subrogation shall not apply towards a party that caused the
damage intentionally or by willful misconduct.

(4) General Article to be enforced on all of the above insurance policies:

The policies mentioned above will not be diminished or cancelled without a prior written
notification to be sent to Subcontractor by registered mail 30 days in advance.

All of the above policies shall include a provision whereby insurer waives right of subrogation
against Flex and/or any one on behalf of Flex. The waiver of subrogation shall not apply towards a
party that caused damage intentionally or by willful conduct.

Policy wording in respect of each of the above mentioned policies shall be                      the applicable Bit
wording.

Subject to the terms and conditions of the original policies as much as not specifically altered by
this certificate.

	 	 	 	 
	/s/ Clal Insurance Company, Ltd

	 	/s/ [Signature Illegible]	 
	 

	 	 	 
	Insurance Company

	 	Signed by	 
	 

	 	Date 28.2.06	 

 

			
	[*] 	 	 Confidential information in this Exhibit has been omitted and filed separately with the Commission.
Confidential treatment has been requested with respect to the omitted portions.

5.

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED

Exhibit 8.5 — Additional Services

     - Veraz may ask FLEXTRONICS to purchase on Veraz’s behalf, additional materials, not for the
purpose of the production of the Products.

     - Veraz may ask FLEXTRONICS to store at its premises, material of Veraz, not required for the
purpose of the production of the Products.

     - Veraz may ask FLEXTRONICS to perform testing and integration services to any Product after
its delivery to Veraz, whether the Products are subject to warranty per section 8 of the
Agreement or not.
For the removal of doubt, if the Products are found not to be working properly and the
Products are still under warranty per section 8, then FLEXTRONICS shall perform its warranty
obligations free of charge, as set forth in section 8 of the Agreement. If the Products are
found not to be working properly and the Products are not under warranty, then FLEXTRONICS
shall provide these services as additional services per this Exhibit.

     - Veraz may also ask FLEXTRONICS to provide incoming inspection, warehousing and packaging
services.

[*] Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED

Exhibit 8.7
— RMA Process 

RMA process – Translation from Hebrew

Veraz Networks Israel – Operations and engineering division

April 27, 2006

Our ref: 194

Version: B

Prepared by: Moni Nahum

Subject: Definition of the reverse logistics processes of Veraz at Flex

	1.	 	Purpose of the document

	 	a)	 	To define the reverse logistics processes to be carried out at Flex for Veraz
equipment that is returned for the following reasons:

	 	1)	 	Faulty cards for repair (RMA)
	 
	 	2)	 	Cards for upgrading (RMA)
	 
	 	3)	 	Cards returned from field trials (FT)
	 
	 	4)	 	Cards returned from loan to Development/ Engineering

	 	b)	 	The above inventory shall be managed in Veraz ERP system by Flex people, in
accordance with directions prepared by MALAM in coordination with Yifat Cornblit and
David Avraham in Veraz.

	2.	 	Processes of treatment of RMA cards

	 	a)	 	During the RMA processes three categories are distinguished:

	 	1)	 	Repair and return
	 
	 	2)	 	Upgrade
	 
	 	3)	 	Repair

	 	 	 	Cards in categories 1 and 2 must be returned to the customer. Cards in category 3
that were returned because of advance replacement undergo repair and are sent to the
FT inventory.
	 
	 	b)	 	The cards undergo the following processes during integration:

[*] Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED

	 	1)	 	Upgrade
	 
	 	2)	 	Test at the card level
	 
	 	3)	 	Repair (if necessary)
	 
	 	4)	 	Test at the card level
	 
	 	5)	 	Test at the system level

	 	c)	 	The cards undergo the following logistics processes:

	 	1)	 	Entry into the inventory to the RMA RECEIPT location.
	 
	 	2)	 	After repair and test they are moved to the RMA ON HAND location
except for cards in the repair category that will be moved to the FT ON HAND
location.
	 
	 	3)	 	If the card cannot be repaired it will be moved to the RMA/FT
—SCRAP location.
	 
	 	4)	 	If Engineering decides to investigate the cards that have been
returned, they shall be moved to the RMA/FT Engineering Investigation location.
When the card is transferred to Engineering in PT it will be moved to the RMA/FT
Engineering Investigation PT location.

	3.	 	Treatment process for cards that have been returned from field trials (FT)

	 	a)	 	The cards undergo the following processes during integration:

	 	1)	 	Upgrade
	 
	 	2)	 	Test at the card level
	 
	 	3)	 	Repair (if necessary)
	 
	 	4)	 	Test at the card level

	 	b)	 	The cards undergo the following logistics processes:

	 	1)	 	Entry into the inventory to the FT RECEIPT location.
	 
	 	2)	 	After testing/ repair they are moved to the FT ON HAND location.
	 
	 	3)	 	If the card cannot be repaired it is moved to the RMA/FT-SCRAP
location.

[*] Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED

	 	4)	 	If Engineering decides to investigate the cards that have been
returned, they shall be moved to the RMA/FT Engineering Investigation location.
When the card is sent to Engineering in PT it will be transferred to the RMA/FT
Engineering investigation PT location.

	4.	 	Process of treatment of cards returned from loan to Development/ Engineering

	 	a)	 	Before being returned to the inventory, visual quality inspection is performed
on the cards, at the responsibility of Veraz. If they are rejected for sale to the
customer they are treated as cards that have returned from field trials (FT) (see
section 3). If they are approved for sale they will undergo the following stages:
	 
	 	b)	 	The cards undergo the following processes during integration:

	 	1)	 	Upgrade
	 
	 	2)	 	Test at the card level
	 
	 	3)	 	Repair (if necessary)
	 
	 	4)	 	Test at the card level

	 	c)	 	The cards undergo the following logistics processes:

	 	1)	 	Entry into the inventory for the LOAN CARDS RECEIPT location.
	 
	 	2)	 	After testing/ repair they are moved to the LOAN CARDS ON HAND
location.

	 	d)	 	On completion of the above process the cards will be sold to Flex. This process
shall be agreed upon separately with Flex.

	5.	 	Lead time of processes
	 
	 	 	For all the processes a lead time of 10 working days is required in order to move the cards
from RECEIPT to ON HAND, after they undergo all the test processes.
	 
	6.	 	Model for covering the above expenses of Flex for activities:
	 
	 	 	A fixed monthly payment that will be evaluated once every 6 months, in accordance with the
Flextronics proposal dated 21.2.06. (This document is attached at the end.)
	 
	7.	 	Beginning of activities: 1.5.06

[*] Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED

VERAZ Project

February 21, 2006

Prepared by Danny Londoner

Subject: Price quotation for RMA treatment for REVERSE LOGISTICS

The following is our proposal for REVERSE LOGISTICS treatment as defined in the document of Moni
dated 2.2.06 (Ref: 194, Version A).

The proposal for all the monthly activities is $[*], based on the following estimate:

Cost of work: $[*] working hour

Work time: [*] working hours

Fixed costs:      $[*] (for logistic services, engineering services, upgrade services, and raw materials.)

Total per unit: $[*]

The scope of the work is estimated at about [*] cards per month ([*] x [*] = [*]).

The scope of the work will be re-examined in another [*] months.

[*] Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

CONFIDENTIAL

CERTAIN INFORMATION HAS BEEN REDACTED

CONFIDENTIAL TREATMENT REQUESTED

Exhibit 9.2 — Packing

	 	1.	 	During Q1 and Q2-2006 Veraz will cover Flextronics reasonable packing expenses based on
current packing practices existing between the parties and on reports presented by
Flextronics and approved by Veraz at the end of each quarter.
	 
	 	2.	 	The packing price list per delivered item that will prevail from Q3-2006 onwards, will
be mutually determined and agreed to in writing between Veraz and Flextronics based on the
packing data collected during Q1 and Q2, 2006 as per section 1 above.

[*] Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

CONFIDENTIAL

CERTAIN
INFORMATION HAS BEEN REDACTED

CONFIDENTIAL
TREATMENT REQUESTED

Commercial Department

Exhibit
9.6.1 — Prices

	 	 	 	 	 	 	 	 	 	 	 
	Products Price list
	 	 	 	 	 	 	 	 	 	 
	 

	 	Customer:
	 	Veraz
	 	Over head percentage:
	 	[*]
	 

	 	Review Date:
	 	 	 	 	 	Batch Quantity:	 	 
	 

	 	Currency:
	 	US $
	 	Reviewed By:
	 	Irit Bar Sade

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Product’s unit price	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Product’s Part Number	 	 	 	Product’s Description	 	Revision	 	 	 	 	 	Cost Description	 	 	 	 
	Flex.	 	Customer	 	Customer	 	Flex.	 	Cust.	 	BOM	 	Over Head	 	Labor	 	Total
	VR-P19399

	 	P19399
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ11314

	 	PZ11314
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ11316

	 	PZ11316
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ15548

	 	PZ15548
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ15550

	 	PZ15550
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ15730

	 	PZ15730
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ15732

	 	PZ15732
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ15828

	 	PZ15828
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ16989

	 	PZ16989
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ17129

	 	PZ17129
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ17459

	 	PZ17459
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ17548

	 	PZ17548
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ18116

	 	PZ18116
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ18195

	 	PZ18195
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ18206

	 	PZ18206
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ18207

	 	PZ18207
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ18208

	 	PZ18208
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ18209

	 	PZ18209
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ18447

	 	PZ18447
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ8325

	 	PZ8325
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ13379

	 	PZ13379
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P18500

	 	P18500
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19060

	 	P19060
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19061

	 	P19061
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19124

	 	P19124
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19265

	 	P19265
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19280

	 	P19280
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19414

	 	P19414
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN
INFORMATION HAS BEEN REDACTED

CONFIDENTIAL
TREATMENT REQUESTED

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Product’s unit price	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Product's Part Number	 	 	 	Product’s Description	 	Revision	 	 	 	 	 	Cost Description	 	 	 	 
	Flex.	 	Customer	 	Customer	 	Flex.	 	Cust.	 	BOM	 	Over Head	 	Labor	 	Total
	VR-PZ18101

	 	PZ18101
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ18102

	 	PZ18102
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ18104

	 	PZ18104
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ18105

	 	PZ18105
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ18106

	 	PZ18106
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ18107

	 	PZ18107
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19747

	 	P19747
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19833

	 	P19833
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19873

	 	P19873
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20020

	 	P20020
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20022

	 	P20022
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20691

	 	P20691
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20748

	 	P20748
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20871

	 	P20871
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20893

	 	P20893
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20617

	 	P20617
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20896

	 	P20896
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20615

	 	P20615
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20611

	 	P20611
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20885

	 	P20885
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20887

	 	P20887
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20976

	 	P20976
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20896

	 	P20896
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20976

	 	P20976
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ8870

	 	PZ8870
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19205

	 	P19205
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20782

	 	P20782
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20900

	 	P20900
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20990

	 	P20990
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20899

	 	P20899
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20997

	 	P20997
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19223

	 	P19223
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ16433

	 	PZ16433
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ15645

	 	PZ15645
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19202

	 	P19202
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ15564

	 	PZ15564
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19192

	 	P19192
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN
INFORMATION HAS BEEN REDACTED

CONFIDENTIAL
TREATMENT REQUESTED

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Product’s unit price	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Product’s Part Number	 	 	 	Product’s Description	 	Revision	 	 	 	 	 	Cost Description	 	 	 	 
	Flex.	 	Customer	 	Customer	 	Flex.	 	Cust.	 	BOM	 	Over Head	 	Labor	 	Total
	VR-P19511

	 	P19511
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19200

	 	P19200
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ16102

	 	PZ16102
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ15737

	 	PZ15737
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19204

	 	P19204
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ15739

	 	PZ15739
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19201

	 	P19201
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19233

	 	P19233
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ8958

	 	PZ8958
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19630

	 	P19630
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ15630

	 	PZ15630
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19907

	 	P19907
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20011

	 	P20011
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ17156

	 	PZ17156
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19602

	 	P19602
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19797

	 	P19797
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20204

	 	P20204
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ11088

	 	PZ11088
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ11086

	 	PZ11086
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19699

	 	P19699
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19489

	 	P19489
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19933

	 	P19933
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19798

	 	P19798
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20246

	 	P20246
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20255

	 	P20255
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19491

	 	P19491
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20402

	 	P20402
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20326

	 	P20326
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20302

	 	P20302
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20277

	 	P20277
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20474

	 	P20474
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20497

	 	P20497
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20565

	 	P20565
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PCH206918

	 	PCH206918
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20600

	 	P20600
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ17627

	 	PZ17627
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ17624

	 	PZ17624
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN
INFORMATION HAS BEEN REDACTED

CONFIDENTIAL
TREATMENT REQUESTED

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Product’s unit price	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Product’s Part Number	 	 	 	Product’s Description	 	Revision	 	 	 	 	 	Cost Description	 	 	 	 
	Flex.	 	Customer	 	Customer	 	Flex.	 	Cust.	 	BOM	 	Over Head	 	Labor	 	Total
	VR-PZ15738

	 	PZ15738
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ15736

	 	PZ15736
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ11087

	 	PZ11087
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20577

	 	P20577
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20664

	 	P20664
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20773

	 	P20773
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20709

	 	P20709
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20776

	 	P20776
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20996

	 	P20996
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH104068

	 	CH104068
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20333

	 	P20333
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20334

	 	P20334
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH16373

	 	CH16373
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH16374

	 	CH16374
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH213398

	 	CH213398
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH213512

	 	CH213512
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH213516

	 	CH213516
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH213713

	 	CH213713
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20335

	 	P20335
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20675

	 	P20675
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20733

	 	P20733
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20735

	 	P20735
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20333

	 	P20333
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20334

	 	P20334
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20335

	 	P20335
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20675

	 	P20675
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH213747

	 	CH213747
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH213748

	 	CH213748
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH104068

	 	CH104068
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH213746

	 	CH213746
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH213512

	 	CH213512
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH213516

	 	CH213516
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH213593

	 	CH213593
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH16374

	 	CH16374
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH16373

	 	CH16373
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH213713

	 	CH213713
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH213398

	 	CH213398
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN
INFORMATION HAS BEEN REDACTED

CONFIDENTIAL
TREATMENT REQUESTED

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Product’s unit price	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Product’s Part Number	 	 	 	Product’s Description	 	Revision	 	 	 	 	 	Cost Description	 	 	 	 
	Flex.	 	Customer	 	Customer	 	Flex.	 	Cust.	 	BOM	 	Over Head	 	Labor	 	Total
	VR-P20961

	 	P20961
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH28023

	 	CH28023
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH213822

	 	CH213822
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH100334

	 	CH100334
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19235

	 	P19235
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH84955

	 	CH84955
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19460

	 	P19460
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19483

	 	P19483
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19529

	 	P19529
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19458

	 	P19458
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19477

	 	P19477
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19554

	 	P19554
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P57836

	 	P57836
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ10209

	 	PZ10209
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ8910

	 	PZ8910
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ14648

	 	PZ14648
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ3158

	 	PZ3158
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19164

	 	P19164
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19165

	 	P19165
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ7897

	 	PZ7897
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ7896

	 	PZ7896
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ7892

	 	PZ7892
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH204647

	 	CH204647
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19531

	 	P19531
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19532

	 	P19532
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19215

	 	P19215
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ3117

	 	PZ3117
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH102693

	 	CH102693
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH14278

	 	CH14278
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH14279

	 	CH14279
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH209919

	 	CH209919
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH300678

	 	CH300678
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH70413

	 	CH70413
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH300404

	 	CH300404
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH101680

	 	CH101680
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH300405

	 	CH300405
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH30594

	 	CH30594
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN
INFORMATION HAS BEEN REDACTED

CONFIDENTIAL
TREATMENT REQUESTED

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Product’s unit price	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Product’s Part Number	 	 	 	Product’s Description	 	Revision	 	 	 	 	 	Cost Description	 	 	 	 
	Flex.	 	Customer	 	Customer	 	Flex.	 	Cust.	 	BOM	 	Over Head	 	Labor	 	Total
	VR-CH59018

	 	CH59018
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH28477

	 	CH28477
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH29298

	 	CH29298
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH29394

	 	CH29394
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19784

	 	P19784
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH100182

	 	CH100182
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19530

	 	P19530
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH310126

	 	CH310126
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH84956

	 	CH84956
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH304434

	 	CH304434
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH206918

	 	CH206918
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH309470

	 	CH309470
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH211457

	 	CH211457
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ19909

	 	PZ19909
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH211288

	 	CH211288
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19476

	 	P19476
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19908

	 	P19908
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH309705

	 	CH309705
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19802

	 	P19802
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH211287

	 	CH211287
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH211932

	 	CH211932
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH309967

	 	CH309967
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH309968

	 	CH309968
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19691

	 	P19691
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19693

	 	P19693
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20053

	 	P20053
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19533

	 	P19533
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH310563

	 	CH310563
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19587

	 	P19587
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19648

	 	P19648
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH211619

	 	CH211619
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH310951

	 	CH310951
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH211289

	 	CH211289
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH211458

	 	CH211458
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20209

	 	P20209
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH73055

	 	CH73055
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH211460

	 	CH211460
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN
INFORMATION HAS BEEN REDACTED

CONFIDENTIAL
TREATMENT REQUESTED

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Product’s unit price	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Product’s Part Number	 	 	 	Product’s Description	 	Revision	 	 	 	 	 	Cost Description	 	 	 	 
	Flex.	 	Customer	 	Customer	 	Flex.	 	Cust.	 	BOM	 	Over Head	 	Labor	 	Total
	VR-P20342

	 	P20342
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20536

	 	P20536
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20537

	 	P20537
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH211462

	 	CH211462
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH213061

	 	CH213061
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20344

	 	P20344
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH307863

	 	CH307863
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH307862

	 	CH307862
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH309469

	 	CH309469
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH309480

	 	CH309480
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH309505

	 	CH309505
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ18064

	 	PZ18064
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ18059

	 	PZ18059
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ17424

	 	PZ17424
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH304675

	 	CH304675
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19845

	 	P19845
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH308340

	 	CH308340
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20066

	 	P20066
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH89903

	 	CH89903
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20117

	 	P20117
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20119

	 	P20119
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH309800

	 	CH309800
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20067

	 	P20067
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ11625

	 	PZ11625
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH310950

	 	CH310950
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH310952

	 	CH310952
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH204494

	 	CH204494
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH211283

	 	CH211283
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH311044

	 	CH311044
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH311020

	 	CH311020
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20450

	 	P20450
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH28050

	 	CH28050
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH28502

	 	CH28502
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH29285

	 	CH29285
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH29305

	 	CH29305
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH311142

	 	CH311142
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20396

	 	P20396
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN
INFORMATION HAS BEEN REDACTED

CONFIDENTIAL
TREATMENT REQUESTED

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Product’s unit price	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Product’s Part Number	 	 	 	Product’s Description	 	Revision	 	 	 	 	 	Cost Description	 	 	 	 
	Flex.	 	Customer	 	Customer	 	Flex.	 	Cust.	 	BOM	 	Over Head	 	Labor	 	Total
	VR-P20571

	 	P20571
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH310968

	 	CH310968
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20343

	 	P20343
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ3159

	 	PZ3159
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH300322

	 	CH300322
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ3160

	 	PZ3160
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH40118

	 	CH40118
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH210275

	 	CH210275
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ9263

	 	PZ9263
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH89563

	 	CH89563
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH213379

	 	CH213379
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH311574

	 	CH311574
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH213058

	 	CH213058
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20079

	 	P20079
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH310671

	 	CH310671
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH211461

	 	CH211461
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH211463

	 	CH211463
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH211464

	 	CH211464
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH213377

	 	CH213377
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH213378

	 	CH213378
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH213380

	 	CH213380
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH213383

	 	CH213383
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH213384

	 	CH213384
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH213385

	 	CH213385
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH213386

	 	CH213386
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH300479

	 	CH300479
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19160

	 	P19160
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19161

	 	P19161
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19162

	 	P19162
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19163

	 	P19163
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19213

	 	P19213
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19214

	 	P19214
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20129

	 	P20129
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20182

	 	P20182
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20184

	 	P20184
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20210

	 	P20210
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ16776

	 	PZ16776
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN
INFORMATION HAS BEEN REDACTED

CONFIDENTIAL
TREATMENT REQUESTED

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Product’s unit price	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Product’s Part Number	 	 	 	Product’s Description	 	Revision	 	 	 	 	 	Cost Description	 	 	 	 
	Flex.	 	Customer	 	Customer	 	Flex.	 	Cust.	 	BOM	 	Over Head	 	Labor	 	Total
	VR-PZ17776

	 	PZ17776
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20663

	 	P20663
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20991

	 	P20991
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20992

	 	P20992
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH28962

	 	CH28962
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH28964

	 	CH28964
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH29397

	 	CH29397
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH29403

	 	CH29403
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH50101

	 	CH50101
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH70293

	 	CH70293
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH70294

	 	CH70294
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH70295

	 	CH70295
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P21024R

	 	P21024R
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ15640

	 	PZ15640
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH103948

	 	CH103948
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH213058

	 	CH213058
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH213060

	 	CH213060
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH213724

	 	CH213724
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH309177

	 	CH309177
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CHT00367

	 	CHT00367
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19074

	 	P19074
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19307

	 	P19307
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19308

	 	P19308
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19398

	 	P19398
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19459

	 	P19459
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19751

	 	P19751
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19980

	 	P19980
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P19981

	 	P19981
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20007

	 	P20007
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20092

	 	P20092
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20093

	 	P20093
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20585

	 	P20585
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20586

	 	P20586
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20612

	 	P20612
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20619

	 	P20619
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20620

	 	P20620
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20643

	 	P20643
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN
INFORMATION HAS BEEN REDACTED

CONFIDENTIAL
TREATMENT REQUESTED

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Product’s unit price	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Product’s Part Number	 	 	 	Product’s Description	 	Revision	 	 	 	 	 	Cost Description	 	 	 	 
	Flex.	 	Customer	 	Customer	 	Flex.	 	Cust.	 	BOM	 	Over Head	 	Labor	 	Total
	VR-P20654

	 	P20654
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20671

	 	P20671
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20711

	 	P20711
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20844

	 	P20844
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20851

	 	P20851
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20936

	 	P20936
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20947

	 	P20947
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20948

	 	P20948
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20949

	 	P20949
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20950

	 	P20950
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20951

	 	P20951
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20952

	 	P20952
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20984

	 	P20984
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH28308

	 	CH28308
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH31066

	 	CH31066
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH34394

	 	CH34394
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH35105

	 	CH35105
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH37484

	 	CH37484
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH37622

	 	CH37622
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH40599

	 	CH40599
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH51514

	 	CH51514
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH51878

	 	CH51878
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH58848

	 	CH58848
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH71769

	 	CH71769
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-P20948R

	 	P20948R
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ18134

	 	PZ18134
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-PZ18458

	 	PZ18458
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH100419

	 	CH100419
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH102184

	 	CH102184
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH102420

	 	CH102420
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH105596

	 	CH105596
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH200874

	 	CH200874
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH204915

	 	CH204915
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH206094

	 	CH206094
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH206715

	 	CH206715
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH207635

	 	CH207635
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH208012

	 	CH208012
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

 

 

CONFIDENTIAL

CERTAIN
INFORMATION HAS BEEN REDACTED

CONFIDENTIAL
TREATMENT REQUESTED

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Product’s unit price	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Product’s Part Number	 	 	 	Product’s Description	 	Revision	 	 	 	 	 	Cost Description	 	 	 	 
	Flex.	 	Customer	 	Customer	 	Flex.	 	Cust.	 	BOM	 	Over Head	 	Labor	 	Total
	VR-CH208062

	 	CH208062
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH209850

	 	CH209850
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH210792

	 	CH210792
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH211078

	 	CH211078
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH211165

	 	CH211165
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH211649

	 	CH211649
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH211761

	 	CH211761
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH212531

	 	CH212531
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH212681

	 	CH212681
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH212824

	 	CH212824
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH212865

	 	CH212865
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH213066

	 	CH213066
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH213553

	 	CH213553
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH305222

	 	CH305222
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH305339

	 	CH305339
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH305509

	 	CH305509
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH306014

	 	CH306014
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH308339

	 	CH308339
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH309435

	 	CH309435
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH309682

	 	CH309682
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH310189

	 	CH310189
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH310366

	 	CH310366
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH310720

	 	CH310720
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	VR-CH311219

	 	CH311219
	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]
	 	[*]
	 	 	[*]	 	 	[*]

	 	 	 	 	 	 	 	 	 	 	 	 	 
	Product’s fixed price	 	 	 	 	 	 	 	 
	Products Part Number	 	 	 	Fixed cost per product (one time charge)	 	Fixed Cost per Bach	 	 
	Flex.	 	Customer	 	 	 	Setup	 	Other	 	Total
	 

	 	 
	 	 	 	 	 	 	 	 	 	 	 

 

			
	[*]	 	Confidential information in this Exhibit has been omitted and filed separately with the
Commission. Confidential treatment has been requested with respect to the omitted portions.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00119-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00119-of-00352.parquet"}]]